Interactive Strength (TRNR) 10-Q 20 May 24 2024 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2024	May 16, 2024
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	001-41610
Entity Registrant Name	INTERACTIVE STRENGTH INC.
Entity Central Index Key	0001785056
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	82-1432916
Entity Address, Address Line One	1005 Congress Ave
Entity Address, Address Line Two	Suite 925
Entity Address, City or Town	Austin
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	78701
City Area Code	512
Local Phone Number	885-0035
Title of 12(b) Security	Common stock, $0.0001 par value per share
Trading Symbol	TRNR
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Ex Transition Period	false
Entity Emerging Growth Company	true
Entity Small Business	true
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		19,855,863

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 0	$ 0
Accounts receivable, net of allowances	177	1
Inventories, net	6,074	2,607
Vendor deposits	1,830	1,815
Prepaid expenses and other current assets	798	933
Total current assets	8,879	5,356
Property and equipment, net	392	444
Right-of-use-assets	641	283
Intangible assets, net	8,488	2,254
Long-term inventories, net	2,897	2,908
Vendor deposits long term	310	309
Goodwill	13,231	0
Other assets	4,726	5,248
Total Assets	39,564	16,802
Current liabilities:
Accounts payable	13,251	10,562
Accrued expenses and other current liabilities	5,647	906
Operating lease liability, current portion	322	54
Deferred revenue	192	77
Loan payable	14,745	5,806
Senior secured notes	0	3,096
Income tax payable	7	7
Embedded derivatives	68	122
Convertible note payable	4,301	904
Total current liabilities	38,533	21,534
Operating lease liability, net of current portion	348	229
Warrant liabilities	937	591
Total liabilities	39,818	22,354
Commitments and contingencies (Note 13)
Stockholders' deficit
Common stock, par value $0.0001; 900,000,000 shares authorized as of March 31, 2024 and December 31, 2023, respectively; 19,433,801 and 14,192,083 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively.	7	7
Additional paid-in capital	178,216	161,252
Accumulated other comprehensive income	139	100
Accumulated deficit	(178,305)	(166,911)
Total stockholders' deficit	(2,942)	(5,552)		$ (2,733)
Total liabilities, preferred stock and stockholders' deficit	39,564	16,802
Series A preferred stock
Stockholders' deficit
Preferred stock value	1	0
Series A Preferred Stock subscription receivable, 1,500,000 shares	(3,000)	0
Series B preferred stock
Stockholders' deficit
Preferred stock value	$ 2,688	$ 0

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Common stock, par value	$ 0.0001	$ 0.0001
Common stock shares authorized	900,000,000	900,000,000
Common stock, shares Issued	19,433,801	14,192,083
Common stock, shares outstanding	19,433,801	14,192,083
Preferred stock, par value	$ 0.0001
Preferred stock, shares authorized	200,000,000
Preferred Class A [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	0
Preferred Stock, Shares Issued	4,930,895	0
Preferred stock shares outstanding	4,930,895	0
Preferred Stock subscription receivable, shares	1,500,000	1,500,000
Preferred Class B [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,500,000	0
Preferred Stock, Shares Issued	1,500,000	0
Preferred stock shares outstanding	1,500,000	0

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue:
Fitness product revenue	$ 53	$ 72
Membership revenue	155	24
Training revenue	155	61
Total revenue	363	157
Cost of fitness product revenue	(379)	(743)
Cost of membership	(1,019)	(962)
Cost of training	(165)	(103)
Total cost of revenue	(1,563)	(1,808)
Gross loss	(1,200)	(1,651)
Operating expenses:
Research and development	2,023	3,113
Sales and marketing	256	600
General and administrative	5,962	15,847
Total operating expenses	8,241	19,560
Loss from operations	(9,441)	(21,211)
Other income (expense), net:
Other (expense) income, net	(370)	117
Interest (expense) income	(2,000)	208
Gain upon debt forgiveness	0	2,595
Loss upon extinguishment of debt and accounts payable	(1,066)	0
Change in fair value of convertible notes	(316)	(80)
Change in fair value of warrants	1,799	2,410
Total other income (expense), net	(1,953)	5,250
Loss before provision for income taxes	(11,394)	(15,961)
Income tax expense	0	0
Net loss attributable to common stockholders	$ (11,394)	$ (15,961)
Net loss per share - basic	$ (0.67)	$ (2.09)
Net loss per share - diluted	$ (0.67)	$ (2.09)
Weighted average common stock outstanding - basic	16,994,445	7,653,940
Weighted average common stock outstanding - diluted	16,994,445	7,653,940

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS 2 (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (11,394)	$ (15,961)
Foreign currency translation gain (loss)	39	(115)
Total comprehensive loss	$ (11,355)	$ (16,076)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($) $ in Thousands	Total	Series B Convertible Preferred Stock	Series A Convertible Preferred Stock	Common Stock [Member]	Common Stock [Member] Class A Common Stock [Member]	Common Stock [Member] Class B Common Stock	Subscription Receivable Preferred Stock Series A	Additional Paid In Capital	Accumulated Other Comprehensive (Income) Loss	Accumulated Deficit
Beginning balance at Dec. 31, 2022	$ (2,733)				$ 4			$ 112,436	$ 365	$ (115,538)
Beginning balance, shares at Dec. 31, 2022					2,416,698	34,224
Issuance of stock	4,452			$ 3				4,449
Issuance of stock, shares				8,676,924
Issuance of Common stock upon conversion of Common Stock				$ 4	$ (4)
Issuance of Common stock upon conversion of Common Stock, shares				2,416,698	(2,416,698)
Issuance of Common stock upon exercise of stock options	14							14
Common stock converted, shares				680,657		(680,657)
Issuance of Common stock upon exercise of stock options, shares						646,433
Stock-based compensation	15,057							15,057
Net exercise of options	323							323
Foreign currency translation loss	(115)								(115)
Net Income (Loss)	(15,961)									(15,961)
Ending balance at Mar. 31, 2023	1,037			$ 7				132,279	250	(131,499)
Ending balance, shares at Mar. 31, 2023				11,774,279
Beginning balance at Dec. 31, 2023	(5,552)			$ 7				161,252	100	(166,911)
Beginning balance, shares at Dec. 31, 2023				14,192,083
Issuance of preferred stock Series A upon conversion of debt, Shares			3,430,895
Issuance of preferred stock Series A upon conversion of debt	10,082		$ 1					10,082
Subscription receivable for issuance of Series A preferred stock, shares			1,500,000
Subscription receivable for issuance of Series A preferred stock	(3,000)						$ (3,000)
Issuance of preferred stock series B upon acquisition of CLMBR, Inc, Shares		1,500,000
Issuance of preferred stock series B upon acquisition of CLMBR, Inc.		$ 2,688
Issuance of common stock upon acquisition of CLMBR, Inc, Shares				1,428,922
Issuance of common stock upon acquisition of CLMBR, Inc.	1,014			$ 0				1,014
Issuance of Common stock upon waiver to enter into Note Agreement				250,000
Issuance of Common stock upon waiver to enter into Note Agreement,Value	177			$ 0				177
Issuance of shares upon issuance of convertible notes, shares				750,000
Issuance of shares upon issuance of convertible notes	547			$ 0				547
Issuance of common stock from equity line of credit				1,311,081
Issuance of common stock from equity line of credit	692			$ 0				692
Issuance upon conversion of convertible notes, shares				1,485,943
Issuance of Common stock upon conversion of convertible notes	866			$ 0				866
Issuance of Common stock upon exercise of stock options, shares				15,772
Stock-based compensation	3,586							3,586
Foreign currency translation loss	39								39
Net Income (Loss)	(11,394)									(11,394)
Ending balance, shares at Mar. 31, 2024		1,500,000	4,930,895
Endng balance at Mar. 31, 2024		$ 2,688	$ 1
Ending balance at Mar. 31, 2024	$ (2,942)			$ 7			$ (3,000)	$ 178,216	$ 139	$ (178,305)
Ending balance, shares at Mar. 31, 2024				19,433,801

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flows From Operating Activities:
Net loss	$ (11,394)	$ (15,961)
Adjustments to reconcile net loss to net cash used in operating activities:
Foreign currency	(49)	106
Depreciation	191	276
Amortization	1,697	1,323
Non-cash lease expense	54	27
Inventory valuation loss	0	73
Stock-based compensation	3,366	14,639
Gain Loss On Extinguishment Of Debt And Accounts Payable	1,066	0
Gain upon debt forgiveness	0	(2,595)
Interest expense (income)	671	(208)
Amortization of debt discount	1,329	0
Common stock issued to lender in connection with entering Equity Line of Credit Agreement	368	0
Change in fair value of convertible notes	316	80
Warrants issued to service providers and warrant issuance expense	345	0
Change in fair value of derivatives	(54)	0
Change in fair value of warrants	(1,799)	(2,410)
Changes in operating assets and liabilities
Accounts receivable	(42)	(11)
Inventories	(130)	(21)
Prepaid expenses and other current assets	198	150
Vendor deposits	46	116
Other assets	5	19
Accounts payable	123	257
Accrued expenses and other current liabilities	936	(572)
Deferred revenue	(146)	6
Operating lease liabilities	(56)	(32)
Net cash used in operating activities	(2,959)	(4,738)
Cash Flows From Investing Activities:
Acquisition of business, cash paid, net of cash acquired	(1,447)	0
Acquisition of software and content	(263)	(416)
Net cash used in investing activities	(1,710)	(416)
Cash Flows From Financing Activities:
Payments of related party loans	(240)	(96)
Proceeds from senior secured notes	0	2,000
Redemption on convertible notes	(90)	0
Payment of loans	(135)	0
Proceeds from issuance of convertible notes, net of issuance costs	4,756	0
Proceeds from the issuance of common stock A	0	4,247
Proceeds from the exercise of common stock options	0	30
Proceeds from the issuance of common stock from equity line of credit	324	0
Net cash provided by financing activities	4,615	6,181
Effect of exchange rate on cash	54	(203)
Net Change In Cash and Cash Equivalents	0	824
Cash and restricted cash at beginning of year	0	226
Cash and restricted cash at end of year	0	1,050
Supplemental Disclosure Of Cash Flow Information:
Property & equipment in AP	18	18
Inventories in AP and accrued	650	1,078
Capitalized software and content in AP	0	18
Issuance of common stock and Series B Preferred Stock for the acquisition of business	3,702	0
Offering costs in AP and accrued	69	1,598
Issuance of Series A Preferred Stock through conversion of debt	10,082	0
Subscription receviable for issuance of Series A Preferred Stock for modification of loan	3,000	0
Conversion of convertible notes into common stock	866	0
Decrease in right-of-use asset and operating lease liabilities due to lease termination	0	61
Issuance of Common Stock from convertible notes	547	0
Issuance of Common Stock from Rights Offering	0	202
Net exercise of options	0	313
Stock-based compensation capitalized in software	$ 220	$ 0

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (11,394)	$ (15,961)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Rule 10b5-1 Arrangement Modified	false
Non-Rule 10b5-1 Arrangement Modified	false

Description of Business and Bas

Description of Business and Basis of Presentation	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business and Basis of Presentation	1. Description of Business and Basis of Presentation Description and Organization Interactive Strength Inc. is the parent company of two leading brands serving the commercial and at-home markets with specialty fitness equipment and virtual training: CLMBR and FORME. CLMBR manufactures vertical climbing equipment and provides a unique digital and on-demand training platform. FORME is a hardware manufacturer and digital fitness service provider that combines award-winning smart gyms with live 1:1 personal training (from real humans) to deliver an immersive experience. The combination of technology with expert training leads to better outcomes for both consumers and trainers alike. CLMBR and FORME offer unique fitness solutions for both the commercial and at-home markets. Our Members are defined as any individual who has a Forme or CLMBR account through a paid connected fitness membership. Initial Public Offering In May 2023, the Company closed its initial public offering ("IPO") in which we issued and sold 1.5 million shares of common stock at a public offering price of $ 8.00 per share and excluding shares sold in the IPO by certain of our existing stockholders. Total proceeds, after deducting underwriting commissions of $ 1.2 million and other offering expenses of $ 4.6 million, was $ 6.2 million. Acquisition of CLMBR, Inc. On October 6, 2023, the Company entered into an asset purchase agreement (the “Asset Purchase Agreement”) with CLMBR and CLMBR1, LLC (collectively, the “Sellers”) to purchase and acquire substantially all of the assets and assume certain liabilities of the Sellers. On January 22, 2024, the Company and the Sellers entered into an amended and restated Asset Purchase Agreement (the “Amended Agreement”). On February 2, 2024, pursuant to the Amended Agreement, the Company completed the acquisition for a total purchase price of approximately $ 15.9 million, consisting of (i) cash of $ 30,000 , (ii) shares of the Company’s common stock with a fair value of $ 1.0 million, 1,428,922 shares, (iii) shares of the Company’s non-voting Series B preferred stock with a fair value of $ 2.7 million, 1,500,000 shares, (iv) contingent consideration with a fair value of $ 1.3 million, and (v) the retirement of $ 9.4 million of senior debt and $ 1.4 million in related fees, such retirement to be in the form of a $ 1.4 million cash payment to the lender of the senior debt and the issuance of an $ 8.0 million promissory note to such lender (the “Acquisition”). The Acquisition was accounted for under the acquisition method of accounting under ASC 805, Business Combinations. Assets acquired and liabilities assumed were recorded in the condensed consolidated balance sheet at their estimated fair values as of February 2, 2024, with the remaining unallocated purchase price recorded as goodwill. See Note 21 that outlines the Company’s consideration transferred and the identifiable net assets acquired at their estimated fair value as of February 2, 2024. Basis of Presentation and Consolidation The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The condensed consolidated financial statements include the accounts of Interactive Strength Inc. and its subsidiaries in which the Company has a controlling financial interest. All intercompany balances and transactions have been eliminated. In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, cash flows, and the changes in equity for the interim period. Liquidity and Capital Resources In accordance with Accounting Standards Update ASU No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (Subtopic 205-40), or ASU 205-40, management evaluated whether there are certain conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying condensed consolidated financial statements were issued. As an emerging growth company, the Company is subject to certain inherent risks and uncertainties associated with the development of an enterprise. In this regard, since the Company’s inception, substantially all of management’s efforts have been devoted to making investments in research and development including the development of revenue generating products and services and the development of a commercial organization, all at the expense of short-term profitability. As of the date the accompanying condensed consolidated financial statements were issued (the “issuance date”), management evaluated the following adverse conditions and events present at the Company in accordance with ASU 205-40: • Since its inception, the Company has incurred significant operating losses and used net cashflows in its operations. For the three months ended March 31, 2024, the Company incurred a net operating loss of $ 9.4 million and used net cash in its operations of $ 2.9 million. As of March 31, 2024, the Company had an accumulated deficit of $ 178.3 million. Management expects the Company will continue to incur significant operating losses and use net cash in its operations for the foreseeable future. • As of the issuance date, the Company had approximately $ 0 million of cash or cash equivalents available to fund its operations and no available sources of financing or capital to sustain its operations for a period of 12 months beyond the issuance date. • The Company expects to incur substantial expenditures to invest in its operations and growth for the foreseeable future. In order to fund these investments, the Company will need to secure additional sources of credit from lenders or capital investment from public and private investors (collectively “outside capital”). While the Company is actively seeking to secure additional outside capital (and has historically been able to successfully secure such capital) to fund its operations, no additional outside capital has been secured or was deemed probable of being secured as of the issuance date. In addition, management can provide no assurance the Company will be able to secure additional outside capital or on acceptable terms. Absent an ability to secure additional outside capital in the very near term, the Company will be unable to meet fund its operations over the next 12 months beyond the issuance date. • As of March 31, 2024, the Company had total outstanding debt of approximately $ 19.1 million, all of which was classified as current in the accompanying condensed consolidated balance sheet. Approximately $ 4.9 million of this debt pertains to personal loans from certain individual related parties disclosed in Note 20. Several of these loans matured prior to March 31, 2024, but their repayment has been temporarily waived, and the remaining loans are scheduled to mature over the next 12 m onths beyond the issuance date. On March 29, 2024, the Company issued 1,500,000 shares of the Company’s Series A Convertible Preferred Stock to the Lender. On April 24, 2024, the Company entered into a Loan Modification agreement reducing the outstanding debt and increasing stockholders deficit by $ 3.0 million and extending the maturity date to December 31, 2024 . Accordingly, as of the issuance date, the Company’s total outstanding debt was approximately $ 16.1 million, including accrued, but unpaid interest and penalties on delayed interest payments, all of which is currently due or scheduled to mature over the next 12 twelve months beyond the issuance date. While the Company is actively seeking to secure additional outside capital (and has historically been able to successfully secure such capital) to repay these outstanding borrowings, no additional outside capital has been secured or was deemed probable of being secured as of the issuance date. In addition, management can provide no assurance the Company will be able to secure additional outside capital or on acceptable terms. In the event the Company is unable to secure additional outside capital and/or secure amendments or waivers from its lenders to defer or modify the repayment terms of the Company’s outstanding indebtedness, management will be required to seek other strategic alternatives, which may include, among others, a significant curtailment of the Company’s operations, a sale of certain of the Company’s assets, a sale of the entire Company to strategic or financial investors, and/or allowing the Company to become insolvent by filing for bankruptcy protection under the provisions of the U.S. Bankruptcy Code. • The Company received a deficiency letter from the Nasdaq Stock Market (“Nasdaq”) on January 26, 2024 notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock, par value $ 0.0001 per share (the “Common Stock”) has been below the minimum $ 1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (“Rule 5550(a)(2)”). The Nasdaq deficiency letter has no immediate effect on the listing of the Common Stock, and the Common Stock will continue to trade on The Nasdaq Capital Market under the symbol “TRNR” at this time. The Company has 180 calendar days, or until July 24, 2024, to regain compliance. To regain compliance, the closing bid price of the Company’s securities must be at least $ 1.00 per share for a minimum of ten consecutive business days. If compliance is not regained by July 24, 2024, the Company may be eligible for additional time to regain compliance or if otherwise not eligible, the Company may request a hearing before a hearings panel. In the Company fails regain compliance and/or secure an extension, the Company will be subject to being delisted from the Nasdaq market. If a delisting occurs, the Company will be faced with a number of material adverse consequences, including limited availability of market quotations for its common stock; limited news and analyst coverage; decreased ability to obtain additional financing or failure to comply with the covenants required by the Company’s borrowing arrangement; limited liquidity for the Company’s stockholders due to thin trading; and a potential loss of confidence by investors, employees and other third parties who do business with the Company. These uncertainties raise substantial doubt about our ability to continue as a going concern. The accompanying condensed consolidated financial statements have been prepared on the basis that the Company will continue to operate as a going concern, which contemplates that the Company will be able to realize assets and settle liabilities and commitments in the normal course of business for the foreseeable future. Accordingly, the accompanying condensed consolidated financial statements do not include any adjustments that may result from the outcome of these uncertainties.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Unaudited Interim Financial Information The accompanying unaudited interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, or GAAP, for interim financial reporting and as required by Regulation S-X, Rule 10-01. The unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited condensed consolidated annual financial statements for the years ended December 31, 2023 and 2022 and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair statement of the Company’s condensed consolidated balance sheet as of March 31, 2024, the condensed consolidated statements of operations and comprehensive loss for the three months ended March 31, 2024 and 2023, the condensed consolidated statement of convertible preferred stock and stockholders' equity (deficit) as of March 31, 2024 and condensed consolidated statements of cash flows for the three months ended March 31, 2024 and 2023. The financial data and other information disclosed in these notes related to the three months ended March 31, 2024 and 2023 are unaudited. The results for the three months ended March 31, 2024, are not necessarily indicative of results to be expected for the year ending December 31, 2024 , any other interim periods, or any future year or period. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to revenue related reserves, the realizability of inventory, fair value measurements, useful lives of long lived assets, including property and equipment and finite lived intangible assets, product warranty, stock-based compensation expense, warrant liabilities, accrual of acquisition earn-outs, estimated legal accruals, valuation of deferred taxes, valuation of embedded derivatives, and commitments and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable. Actual results may differ from these estimates. Segment Information Operating segments are defined as components of an enterprise for which separate and discrete information is available for evaluation by the chief operating decision-maker (“CODM”) in deciding how to allocate resources and assess performance. The Company has one operating segment, the development and sale of its at-home fitness technology platform. The Company’s chief operating decision maker, its chief executive officer, manages the Company’s operations on a consolidated basis for the purpose of allocating resources. As the Company has one reportable segment, all required segment financial information is presented in the condensed consolidated financial statements. The Company currently operates in the United States, the United Kingdom, and Taiwan. As of March 31, 2024 and 2023 , substantially all of the Company’s long-lived assets are held in the United States. Cash Cash consists of cash on deposit in banks. Deferred Offering Costs The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A “ Expenses of Offering” . Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO. The Company incurred offering costs amounting to $ 4.6 million through the IPO and subsequently classified the costs to additional paid in capital in 2023. Property and Equipment Property and equipment purchased by the Company are stated at cost less accumulated depreciation. Major updates and improvements are capitalized, while charges for repairs and maintenance which do not improve or extend the lives of the respective asset, are expensed as incurred. The Company capitalizes the cost of pre-production tooling which it owns under a supply arrangement. Pre-production tooling, including the related engineering costs the Company will not own or will not use in producing products under long-term supply arrangements, are expensed as incurred. Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives: Pre-production tooling 2 – 5 years Machinery and equipment 2 – 10 years Furniture and fixtures 3 – 5 years Leasehold improvements Lesser of lease term or estimated useful life Inventories, net Inventories, which are comprised of finished goods, are stated at the lower of cost or net realizable value, with cost determined using actual costs. The Company maintains inventory in a third-party warehouse. Reserves are established to reduce the cost of inventories to their estimated net realizable value and are reflected in cost of revenues in the condensed consolidated statement of operations. The Company assessed the obsolescence reserve by evaluating factors such as inventory levels, historical sales, and the remaining life of its products. Inventory losses are written-off against the reserve. Inventory not expected to be sold in the next twelve months is classified as long-term in the accompanying condensed consolidated balance sheets. Vendor Deposits Vendor deposits represent prepayments made to the third-party manufacturers of the Company’s inventory. In general, the Company’s manufacturers require that the Company pay a portion of the costs for a manufacturing purchase order in advance, with the remaining cost being invoiced upon delivery of the products. Prior to receipt of the goods, any costs associated with the prepayments made by the Company are reflected as vendor deposits on the Company’s condensed consolidated balance sheet. Capitalized Studio Content Capitalized Studio content costs include certain expenditures to develop video and live content for the Company’s customers. The Company capitalizes production costs for recorded content in accordance with ASC 926-20, Entertainment-Films - Other Assets - Film Costs. The Company recognizes capitalized content, net of accumulated amortization, within other non-current assets in the condensed consolidated balance sheets and recognizes the related amortization expense as a component of cost of revenue in the condensed consolidated statements of operations and comprehensive loss. Costs which qualify for capitalization include production costs, development costs, direct costs, labor costs, and production overhead. Expenditures for capitalized content are included within operating activities in the condensed consolidated statements of cash flows. Based on certain factors, including historical and estimated user viewing patterns, the Company amortizes individual titles within the Studio content library on a straight-line basis over a three-year useful life. The Company reviews factors impacting the amortization of the capitalized Studio content on an ongoing basis. Estimates related to these factors require considerable management judgment. The Company considered certain factors in determining the useful life of the content, including expected periods over which the content will be made available through the platform and related viewership, the lack of “obsolescence” of such content over such period given the nature of its videos (i.e., exercise classes which are not significantly impacted by changes in markets or customer preferences, and/or for which the content is expected to significantly change or evolve over time), and the expected significant growth of its subscriber base which will contribute to substantial increases in viewership over time given the recent launch of its product and membership offerings. Based on these factors, the Company has determined that a three-year (3-year) amortization period is reasonable for the content. The Company will continue to review factors impacting the amortization of the capitalized content on an ongoing basis. The Company’s business model is membership based as opposed to generating revenues at a specific title level. Therefore, all content assets are monetized as part of a single asset group. The content is assessed at the group level when an event or change in circumstances indicates a change in the expected usefulness of the content or that fair value may be less than unamortized cost. Unamortized costs are assessed for impairment regardless of whether the produced content is completed. To date, the Company has recognized one impairment with regards to the carrying value of its content portfolio. If circumstances in the future suggest that an impairment may exist, these aggregated content assets will be stated at the lower of unamortized cost or fair value. In addition, unamortized costs for assets that have been, or are expected to be, abandoned are written off. The unamortized cost of content is approximately $ 1.8 million and $ 2.4 million as of March 31, 2024 and December 31, 2023, re spectively. Capitalized Software Costs The Company capitalizes certain eligible software development costs incurred in connection with its internal use software in accordance with ASC 350-40, Internal-use Software and ASC 985, Software. These capitalized costs also relate to the Company’s Studio software that is accessed by its customers on a membership basis as well as certain costs associated with its information systems. Capitalized software costs are amortized over the estimated useful life is three years. Capitalization begins once the application development stage begins, management has authorized and committed to funding the project, it is probable the project will be completed, and the software will be used to perform the function intended. Internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use. The Company expenses all costs incurred that relate to planning and post-implementation phases of development. Intangible assets are assessed for impairment when events or circumstances indicate the existence of a possible impairment, and none were identified in the quarter ended March 31, 2024. During the three months ended March 31, 2024 and year ended December 31, 2023, the Company capitalized $ 0.0 million and $ 0.4 million, respectively, under ASC 350 included in intangible assets. During the three months ended March 31, 2024 and year ended December 31, 2023, the Company capitalized $ 0.5 million and $ 1.9 million, respectively, under ASC 985 included in other assets. Amortization is computed on a straight-line basis over the following estimated useful lives: Capitalized software and internal-use software  3 years Music Royalty Fees The Company recognizes music royalty fees as these fees are incurred in accordance with the terms of the relevant license agreement with the music rights holder. The incurrence of such royalties is primarily driven by the number of paid subscribers each month and it is classified as cost of membership and training within the Company’s statement of operations. The Company’s license agreements with music rights holders generally include provisions for advance royalties as well as minimum guarantees. When a minimum guarantee is paid in advance, the guarantee is recorded as a prepaid asset and amortized over the shorter of the period consumed or the term of the agreement. As of March 31, 2024 and December 31, 2023 there were no music guarantee-related prepaids, respectively. Fair Value Measurements Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Subsequent changes in fair value of these financial assets and liabilities are recognized in earnings when they occur. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurement or assumptions that market participants would use in pricing the assets or liabilities, such as inherent risk, transfer restrictions, and credit risk. The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: • Level 1 inputs are based on quoted prices in active markets for identical assets or liabilities. • Level 2 inputs are based on observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3 inputs are based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities, and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The Company’s material financial instruments consist primarily of cash and cash equivalents, accounts payable, accrued expenses, convertible notes, and warrants. The carrying amounts of current financial instruments, which include cash, accounts receivable, accounts payable and accrued expenses, contingent consideration, approximate their fair values due to the short-term nature of these instruments. Impairment of Long-Lived Assets The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset (or asset group) to the future undiscounted cash flows expected to be generated by the assets (or asset group). If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds their fair value. Leases The Company adopted the Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842) (“ASU 2016-02” or “ASC 842”) as of January 1, 2022, using the modified retrospective method and utilized the effective date as its date of initial application, with prior periods presented in accordance with previous guidance under Accounting Standards Codification (“ASC”) 840, Leases. At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present in the arrangement. Leases with a term greater than one year are recognized on the balance sheet as right-of-use assets and current and non-current lease liabilities, as applicable. Bridge Notes As permitted under ASC Topic 825, Financial Instruments, we have elected the fair value option to account for our November 2023 Bridge Notes. In accordance with ASC Topic 825, we record these bridge notes at fair value with changes in fair value recorded as a component of other (expense) income, net in the condensed consolidated statement of operations and comprehensive loss. As a result of applying the fair value option, direct costs and fees related to the bridge notes were expensed as incurred and were not deferred. In addition, the bridge notes meet other applicable criteria for electing fair value option under ASC Topic 825. The November 2023 Bridge Notes were converted to Series A Preferred Stock in February 2024 and March 2024. As of March 31, 2024 and December 31, 2023, there were $ 0.0 million and $ 1.7 million, respectively of notes outstanding measured at fair value related to the November 2023 Bridge Notes. Convertible Notes As permitted under ASC Topic 825, Financial Instruments, the Company has elected the fair value option to account for its November 2022 convertible notes. In accordance with ASC Topic 825, the Company records these convertible notes at fair value with changes in fair value recorded as a component of other (expense) income, net in the condensed consolidated statement of operations and comprehensive loss. As a result of applying the fair value option, direct costs and fees related to the convertible notes were expensed as incurred and were not deferred. In addition, the convertible notes meet other applicable criteria for electing fair value option under ASC Topic 825. In May 2023, upon closing of the Company's IPO, the convertible notes were converted into an aggregate of 565,144 shares of common stock. In connection with the Company’s issuance of the December 2023 Convertible Notes (the “December 2023 Notes”), the Company bifurcated the embedded conversion option and redemption rights and recorded embedded conversion option and redemption rights as a short term derivative liability in the Company’s balance sheet in accordance with FASB ASC 815, Derivatives and Hedging. The convertible debt and the derivative liability associated with the December 2023 Notes is presented on the condensed consolidated balance sheet as convertible note payable and the embedded derivatives, respectively. The convertible debt is carried at amortized cost. The derivative liability will be remeasured at each reporting period using the lattice model with changes in fair value recorded in the condensed consolidated statements of operations in other expense (income). See Note 10 for further details. The Company issued Convertible Notes in February 2024 (the “February 2024 Notes”). The convertible debt is presented in on the condensed consolidated balance sheet as convertible note payable. The convertible debt is carried at amortized cost. See Note 10 for further details. Warrants The Company account for common stock warrants as either equity-classified instruments or liability-classified instruments based on an assessment of the warrant terms. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all the requirements for equity classification under ASC 815, including whether the warrants are indexed to our Common Stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance, and, for liability-classified warrants, at each reporting period end date while the warrants are outstanding. The warrants are revalued on each subsequent balance sheet date until such instruments are exercised or expire, with any changes in the fair value between reporting periods recorded in the condensed consolidated statements of operations and comprehensive loss. Commitments and Contingencies Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. If a loss is reasonably possible and the loss or range of loss can be reasonably estimated, the Company discloses the possible loss or states that such an estimate cannot be made. Revenue Recognition On January 1, 2020, the Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASC 606”) and all subsequent amendments. As the Company had not recognized any revenue prior to the adoption of the new standard, there was no impact on the measurement or timing of revenue recognition as a result of the adoption. Revenue is recognized when control of the promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Refer to Note 3 for additional information. Cost of Fitness Product Revenue Cost of fitness product revenue relates to the Fitness Product costs, including manufacturing costs, duties and other applicable importing costs, shipping and handling costs, packaging, warranty replacement costs, fulfillment costs, warehousing costs, and certain allocated costs related to management, facilities, and personnel-related expenses associated with supply chain logistics. Cost of fitness product revenue also contains valuation losses related to the Company’s inventory lower of cost or market reserve. Cost of Membership and Training Membership costs include costs associated with the creation of content and training, including associated payroll, filming and production costs, other content specific costs, hosting fees, music royalties, amortization of capitalized software development costs, and warranty replacement and servicing costs associated with extended warranty contracts. Advertising Costs Advertising and other promotional costs to market the Company’s products are expensed as incurred. Advertising expenses were $ 0.02 million and $ 0.2 million for the three months ended March 31, 2024 and 2023, respectively, and are included within sales and marketing expenses in the condensed consolidated statements of operations and comprehensive loss. Research and Development Costs Research and development expenses consist primarily of personnel- and facilities-related expenses, consulting and contractor expenses, tooling and prototype materials software platform expenses, and depreciation of property and equipment. Substantially all of the Company’s research and development expenses are related to developing new products and services and improving existing products and services. Research and development expenses are expensed as incurred. Stock-Based Compensation In December 2020, the Board of Directors adopted the 2020 Equity Incentive Plan (“the 2020 Plan”) and in April 2023, our board of directors adopted the 2023 Equity Incentive Plan (the “2023 Plan”). Stock-based awards are measured at the grant date based on the fair value of the award and are recognized as expense, net of actual forfeitures, on a straight-line basis over the requisite service period, which is generally the vesting period of the respective award. The Company estimates the fair value of stock options using the Black-Scholes option pricing model. The determination of the grant date fair value of stock awards issued is affected by a number of variables, including the fair value of the Company’s common stock, the expected common stock price volatility over the expected life of the awards, the expected term of the stock option, risk-free interest rates, and the expected dividend yield of the Company’s common stock. The Company derives its volatility from the average historical stock volatilities of several peer public companies over a period equivalent to the expected term of the awards. The Company estimates the expected term based on the simplified method for employee stock options considered to be “plain vanilla” options, as the Company’s historical share option exercise experience does not provide a reasonable basis upon which to estimate the expected term. The risk-free interest rate is based on the United States Treasury yield curve in effect at the time of grant. Expected dividend yield is 0.0 % as the Company has not paid and does not currently anticipate paying dividends on its common stock. Stock-based compensation expense is classified in the accompanying condensed consolidated statement of operations in the same manner in which the award recipient’s payroll costs are classified or in which the award recipient’s service payments are classified. Foreign Currency Transactions The functional currency for the Company’s wholly-owned foreign subsidiaries, Interactive Strength UK and Interactive Strength Taiwan, is the United States dollar. All foreign currency transaction gains and losses are recognized in the condensed consolidated statements of operations and comprehensive loss through other income (expense). The Company recognized material currency transaction gains or losses during the three months ended March 31, 2024 and 2023. Comprehensive Loss Comprehensive loss includes net loss as well as other changes in stockholders’ deficit that result from transactions and economic events other than those with stockholders. For the three months ended March 31, 2024 and 2023, comprehensive loss included $ 0.04 million of foreign currency transaction gains and $ 0.1 million of foreign currency transaction loses, respectively. Loss Per Share The Company computes loss per share using the two-class method required for participating securities. The two-class method requires income available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The Company’s redeemable convertible preferred stock and common stock issued upon early exercise of stock options are participating securities. The Company considers any shares issued upon early exercise of stock options, subject to repurchase, to be participating securities because holders of such shares have non-forfeitable dividend rights in the event a cash dividend is declared on common stock. These participating securities do not contractually require the holders of such shares to participate in the Company’s losses. As such, net losses for the periods presented were not allocated to the Company’s participating securities. Basic loss per share is computed using the weighted-average number of outstanding shares of common stock during the period. Diluted earnings loss per share is computed using the weighted-average number of outstanding shares of common stock and, when dilutive, potential shares of common stock outstanding during the period. Potential shares of common stock consist of incremental shares issuable upon the assumed exercise of stock options, employee stock purchase plan (“ESPP”) shares to be issued, and vesting of restricted stock awards. Income Taxes The Company utilizes the asset and liability method for computing its income tax provision. Deferred tax assets and liabilities reflect the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities as well as operating loss, capital loss, and tax credit carryforwards, using enacted tax rates. Management makes estimates, assumptions, and judgments to determine the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against deferred tax assets. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent the Company believes recovery is not likely, establishes a valuation allowance. The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Interest and penalties related to unrecognized tax benefits, which to date have not been material, are recognized within income tax expense. Goodwill and Intangible Assets with Indefinite Lives Goodwill consists of the excess of cost over the fair value of net assets acquired in business combinations. The Company follows the provisions of ASC Topic 350, “Intangibles —Goodwill and Other”, which requires an annual impairment test for goodwill and intangible assets with indefinite lives. The Company may first choose to perform a qualitative evaluation of the likelihood of goodwill and intangible assets impairment. For the goodwill that was the result of current year acquisitions, the Company chose to perform a qualitative evaluation. If the Company determined a quantitative evaluation was necessary, the goodwill at the reporting unit was subject to a two-step impairment test. The first step compares the book value of a reporting unit, including goodwill, with its fair value. If the book value of a reporting unit exceeds its fair value, the Company completes the second step in order to determine the amount of goodwill impairment loss that should be recorded. In the second step, the Company determines an implied fair value of the reporting unit’s goodwill by allocating the fair value of the reporting unit to all of the assets and liabilities other than goodwill. For the periods presented, the Company did not recognize any goodwill impairment as the estimated fair value of its reporting units with goodwill exceeded the book value of these reporting units. For additional information refer to Note 6—Goodwill and Intangible Assets. The Company estimates the fair value of intangible assets based on an income approach using the relief-from-royalty method. This methodology assumes that, in lieu of ownership, a third party would be willing to pay a royalty in order to exploit the related benefits of these types of assets. This approach is dependent on a number of factors, including estimates of future growth and trends, royalty rates for this category of intellectual property, discount rates and other variables. The Company bases its fair value estimates on assumptions it believes to be reasonable, but which are unpredictable and inherently uncertain. Actual future results may differ from those estimates. The Company recognizes an impairment loss when the estimated fair value of the intangible asset is less than the carrying value. For the periods presented, the Company did not recognize any impairment of intangible assets with indefinite lives as the estimated fair value of its intangible assets with indefinite lives exceeded the book value of these reporting units. Identifiable Intangible Assets The Company follows the provisions of ASC Topic 360, “Property, Plant and Equipment”, which establishes accounting standards for the impairment of long-lived assets such as property, plant and equipment and intangible assets subject to amortization. The Company reviews long-lived assets to be held and-used for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. If the sum of the undiscounted expected future cash flows over the remaining useful life of a long-lived asset group is less than its carrying amount, the asset is considered to be impaired. Impairment losses are measured as the amount by which the carrying amount of the asset group exceeds the fair value of the asset. The Company estimates fair value using the expected future cash flows discounted at a rate commensurate with the risks associated with the recovery of the asset. During the three months ended March 31, 2024 and 2023, there was no impairment of the identified intangible assets. The Company’s intangible assets subject to amortization consist of developed technology, customer related intangibles, trademark and tradenames, and content that are amortized on a straight-line basis over the estimated useful lives of the related intangible asset. The estimated useful lives of the respective intangible assets range from 3 years to 13 years. Business Combinations The Company accounts for business combinations under the provisions of ASC 805, Business Combinations, which requires that the acquisition method of accounting be used for all business combinations. Assets acquired and liabilities assumed are recorded at the date of acquisition at their respective fair values. ASC 805 also specifies criteria that intangible assets acquired in a business combination must be recognized and reported apart from goodwill. Goodwill represents the excess purchase price over the fair value of the tangible net assets and intangible assets acquired in a business combination. Acquisition-related expenses are recognized separately from the business combinations and are expensed as incurred. If t

Revenue Recognition

Revenue Recognition	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	3. Revenue Recognition The Company’s primary source of revenue is solely derived from the United States from sales of its Connected Fitness Products and related accessories and associated recurring Membership revenue, as well as from sales of personal training services recorded within Training revenue. The Company determines revenue recognition through the following steps: • Identification of the contract, or contracts, with a customer; • Identification of the performance obligations in the contract; • Determination of the transaction price; • Allocation of the transaction price to the performance obligations in the contract; and • Recognition of revenue when, or as, the Company satisfies a performance obligation. Revenue is recognized when control of the promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company’s revenue is reported net of sales returns, discounts and incentives as a reduction of the transaction price. The Company estimates its liability for product returns and concessions based on historical trends by product category, impact of seasonality, and an evaluation of current economic and market conditions and records the expected customer refund liability as a reduction to revenue, and the expected inventory right of recovery as a reduction of cost of revenue. If actual return costs differ from previous estimates, the amount of the liability and corresponding revenue are adjusted in the period in which such costs occur. The Company applies the practical expedient as per ASC 606-10-50-14 and does not disclose information related to remaining performance obligations due to their original expected terms being one year or less. The Company expenses sales commissions on its Connected Fitness Products when incurred because the amortization period would have been less than one year. These costs are recorded in Sales and marketing in the Company’s condensed consolidated statements of operations and comprehensive loss. Connected Fitness Products Connected Fitness Products include the Company’s portfolio of Connected Fitness Products and related accessories, delivery and installation services, and extended warranty agreements. The Company recognizes Connected Fitness Product revenue net of sales returns and discounts when the product has been delivered to the customer, except for extended warranty revenue which is recognized over the warranty period. The Company allows customers to return products within thirty days of purchase, as stated in its return policy. Amounts paid for payment processing fees for credit card sales for Connected Fitness Products are included as a reduction to fitness product revenue in the Company’s condensed consolidated statements of operations and comprehensive loss. Membership The Company’s memberships provide unlimited access to content in its library of on-demand fitness classes. The Company’s memberships are offered on a month-to-month basis. Amounts paid for membership fees are included within deferred revenue on the Company’s condensed consolidated balance sheets and recognized ratably over the membership term. The Company records payment processing fees for its monthly membership charges within cost of membership in the Company’s condensed consolidated statements of operations and comprehensive loss. Training The Company’s training services are personal training services delivered through the Connected Fitness Products, third-party mobile devices and in-studio classes. Training revenue is recognized at the time the services are delivered. Standard Product Warranty The Company offers a standard product warranty that its Connected Fitness Products and related accessories will operate under normal, non-commercial use for a period of one year which covers the touchscreen, frame and all incorporated elements, and related accessories from the date of original delivery. The Company has the obligation, at its option, to either repair or replace the defective product. At the time revenue is recognized, an estimate of future warranty costs are recorded as a component of cost of revenue. Factors that affect the warranty obligation include historical as well as current product failure rates, service delivery costs incurred in correcting product failures, and warranty policies and business practices. The Company also offers the option for customers in some markets to purchase a third-party extended warranty and service contract that extends or enhances the technical support, parts, and labor coverage offered as part of the base warranty included with the Connected Fitness Product for an additional period of 24 to 48 months. For third-party extended warranty service sold along with the Company’s Connected Fitness Products, the Company does not obtain control of the warranty before transferring it to the customers. Therefore, the Company accounts for revenue related to the fees paid to the third-party extended warranty provider on a net basis, by recognizing only the net commission it retains. The Company considers multiple factors when determining whether it obtains control of third-party products including, but not limited to, evaluating if it can establish the price of the product, retains inventory risk for tangible products or has the responsibility for ensuring acceptability of the product.

Inventories, Net

Inventories, Net	3 Months Ended
	Mar. 31, 2024
Inventory Disclosure [Abstract]
Inventories, net	4. Inventories, net Inventories consist of the following: March 31, December 31, (in thousands) 2024 2023 Finished products $ 6,074 $ 2,607 Finished products - Long Term 2,319 2,376 Raw materials - Long Term 578 532 Total inventories, net $ 8,971 $ 5,515 Finished products - Long Term represents inventory not expected to be sold in the next twelve months. Raw materials - Long Term represents the components and parts currently being stored in our Taiwan facility that will be shipped to our manufacturing partners. Total inventory of $ 3.5 million was acquired in the Acquisition and recorded at fair value on the acquisition date. Refer to Note 21 Acquisitions for more information.

Property and Equipment, Net

Property and Equipment, Net	3 Months Ended
	Mar. 31, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment, net	5. Property and Equipment, net Property and equipment consisted of the following: March 31, December 31, (in thousands) 2024 2023 Pre-production tooling $ 3,094 $ 3,094 Machinery and equipment 191 125 Leasehold improvements 186 113 Furniture and fixtures 25 25 Software and technology development asset 13 13 Total 3,509 3,370 Less: Accumulated depreciation ( 3,117 ) ( 2,926 ) Total property and equipment, net $ 392 $ 444 Depreciation expense amounted to $ 0.2 million and $ 0.3 million for the three months ended March 31, 2024 and 2023 , respectively.

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Net	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets, net	6. Goodwill and Intangible Assets, net Identifiable intangible assets, net consist of the following: As of March 31, As of December 31, 2024 2023 (in thousands) Cost Accumulated Amortization Net Book Value Cost Accumulated Amortization Net Book Value Internal-Use Software $ 6,248 $ ( 4,515 ) $ 1,733 $ 6,248 $ ( 3,994 ) $ 2,254 Developed Technology 1,500 ( 41 ) 1,459 — — — Customer related 4,400 ( 78 ) 4,322 — — — Trademark and trade name 800 ( 15 ) 785 — — — Content 200 ( 11 ) 189 — — — Total identifiable intangible assets $ 13,148 $ ( 4,660 ) $ 8,488 $ 6,248 $ ( 3,994 ) $ 2,254 Amortization expense amounted to $ 0.7 million and $ 0.5 million for each of the three months ended March 31, 2024 and 2023, respectively. Intangible assets are assessed for impairment when events or circumstances indicate the existence of a possible impairment. As of March 31, 2024, estimated annual amortization expense for each of the next five fiscal years is as follows: Fiscal Years Ending December 31, (in thousands) 2024 (remaining) 1,785 2025 1,389 2026 815 2027 648 2028 582 Thereafter 3,269 Total $ 8,488 Total goodwill of $ 13.2 million and intangible assets of $ 6.9 million were acquired in the Acquisition and were recorded at fair value on the acquisition date. Refer to Note 21 Acquisitions for more information.

Prepaid Expenses and Other Curr

Prepaid Expenses and Other Current Assets	3 Months Ended
	Mar. 31, 2024
Prepaid Expenses and Other Current Assets Disclosure [Abstract]
Prepaid Expenses and Other Current Assets	7. Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following: March 31, December 31, (in thousands) 2024 2023 Security deposit 96 66 Prepaid licenses 7 20 Research and development tax credit 516 516 Other receivables 20 20 Insurance 99 246 Other prepaid 60 65 Total prepaid expenses and other current assets $ 798 $ 933

Other Assets, Net

Other Assets, Net	3 Months Ended
	Mar. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Assets, Net	8. Other Assets, net Other assets consisted of the following: As of March 31, As of December 31, 2024 2023 (in thousands) Cost Accumulated Amortization Net Book Value Cost Accumulated Amortization Net Book Value Capitalized content costs $ 6,589 $ ( 4,753 ) $ 1,836 $ 6,589 $ ( 4,237 ) $ 2,352 Capitalized software $ 6,362 $ ( 3,472 ) $ 2,890 $ 5,879 $ ( 2,983 ) $ 2,896 Total other assets $ 12,951 $ ( 8,225 ) $ 4,726 $ 12,468 $ ( 7,220 ) $ 5,248 Amortization expense amounted to $ 1.0 million and $ 0.8 million for the three months ended March 31, 2024 and 2023 , respectively.

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	3 Months Ended
	Mar. 31, 2024
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	9. Accrued Expenses and Other Current Liabilities Accrued expenses consisted of the following: March 31, December 31, (in thousands) 2024 2023 Accrued bonus $ 330 $ 25 Accrued payroll 124 26 Accrued PTO 21 21 Accrued legal settlement 2,250 — Accrued earn out 1,300 — Accrued royalties 211 208 Accrued professional fees 729 235 Customer deposits 375 46 Other accrued expenses and current liabilities 307 345 Total accrued expenses and other current liabilities $ 5,647 $ 906 Accrued legal settlement of $ 2.25 million represents a pending lawsuit which was an assumed liability as part of the acquisition and is further discussed in Note 14 Commitments and Contingencies. Accrued earn out of $ 1.3 million represents a contingent payment in the form of shares of Common Stock calculated in the manner set forth in the Asset Purchase Agreement based on the 2024 Unit Sales (as defined in the Asset Purchase Agreement) and the volume-weighted average price ("VWAP") for the Company’s Common Stock based on the 10 consecutive trading days ending on (and including) December 31, 2024, subject to the VWAP Collar. In addition, in the event the 2024 Unit Sales include at least 2,400 Units sold in the business-to-business channel, the Sellers shall be entitled to an additional number of Earn-Out Shares calculated in the manner set forth in the Asset Purchase Agreement subject to total maximum number of 22,665,681 Earn-Out Shares. The accrued legal settlement and contingent payment are a result of the Acquisition and are preliminary and subject to change.

Debt

Debt	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Debt	10. Debt Debt consisted of the following: March 31, December 31, (in thousands) 2024 2023 Principal stockholder promissory notes $ 4,975 $ 5,085 Other related party promissory notes — 721 Term Loan 9,770 — Total Loan Payable 14,745 5,806 June 2023 notes — 1,379 November bridge notes — $ 1,717 Total Senior secured notes $ — $ 3,096 Embedded derivatives $ 68 $ 122 December 2023 convertible note 251 904 Other related party convertible notes 174 — Other convertible notes 706 — February 2024 convertible note 3,170 — Total Convertible note payable $ 4,301 $ 904 Total debt current $ 19,114 $ 9,928 Principal Stockholder Promissory Notes During 2019, 2020, and 2021 the Company entered into promissory notes with a then-principal stockholder (the "former principal stockholder”) of the Company. See Note 20. Related Party Transactions. Other Related Party Promissory Notes During 2019, 2020, 2021, and 2022, the Company entered into promissory notes with other related parties. See Note 20. Related Party Transactions. Term Loan On February 1, 2024, the Company, entered into a Credit Agreement (the "Term Loan") with Vertical Investors LLC, (the “Lender”) pursuant to which the Company agreed to borrow from the Lender a term loan in the aggregate principal amount of approximately $ 8 million. The term loan bears interest at Daily Simple SOFR-Based Rate and the Company shall pay a guarantee fee of $ 2.3 million due on the maturity date. The guarantee fee was treated as a debt discount and accreted through interest expense through maturity date. The maturity date of the Note was originally June 28, 2024 . On March 29, 2024, the Company issued 1,500,000 shares of the Company’s Series A Convertible Preferred Stock to the Lender. On April 24, 2024, the Company entered into a Loan Modification agreement reducing the outstanding debt and increasing stockholders deficit by $ 3.0 million and extending the maturity date to December 31, 2024 . The carrying value of the Term Loan is as follows: March 31, December 31, (in thousands) 2024 2023 Principal and interest $ 8,021 $ — Guarantee fees 2,348 — Unamortized debt discount ( 599 ) — Aggregate carrying value $ 9,770 $ — Interest expense recognized on the Term Loan is as follows: March 31, March 31, (in thousands) 2024 2023 Contractual interest expense $ 58 $ — Amortization of debt discount 339 — Total $ 397 $ — Convertible Notes Other Related Party Convertible Notes On February 18, 2020, a $ 0.1 million note with interest at the rate of 12.0 % per annum and a maturity date of February 18, 2021 . The note was amended in January 2024 to include a conversion provision whereby at any time prior to maturity date the lender has the right to convert any outstanding and unpaid principal and accrued interest of the note into shares of the Company's Series A Preferred Stock at a conversion price of $ 2.00 per share. The total outstanding balance at March 31, 2024 including accrued interest is $ 0.2 million and is included in convertible note payable on the condensed consolidated balance sheet. Other Convertible Notes In connection with the acquisition of CLMBR, Inc., the Company assumed three promissory notes for a total of $ 1.9 million in principal and accrued interest. In August 2023, CLMBR, Inc. issued secured promissory notes in the aggregate principal amount of approximately $ 0.5 million, due August 31, 2026 . Interest on the outstanding principal of the notes accrues initially at a rate of 15 % per annum. The note was assumed by the Company in January 2024. The note was amended in January 2024, and subsequently amended in February 2024, to include a conversion provision whereby at any time prior to maturity date the lender has the right to convert any outstanding and unpaid principal and accrued interest of the note into shares of the Company's Series A Preferred Stock at a conversion price of $ 1.82 per share. In February 2024, the convertible note was converted into 398,352 shares of Series A Preferred Stock. The Company recognized a loss equal to $ 0.2 million on the extinguishment of debt upon conversion to Series A Preferred Stock. In October 2023, CLMBR, Inc issued in the aggregate principal amount of approximately $ 0.3 million, due October 15, 2026 . Interest on the outstanding principal of the notes accrues initially at a rate of 15 % per annum. The note was assumed by the Company in January 2024. The note was amended in January 2024, and subsequently amended in February 2024, to include a conversion provision whereby at any time prior to maturity date the lender has the right to convert any outstanding and unpaid principal and accrued interest of the note into shares of the Company's Series A Preferred Stock at a conversion price of $ 1.82 per share. In February 2024, the convertible note was converted into 258,929 shares of Series A Preferred Stock. The Company recognized a loss equal to $ 0.2 million on the extinguishment of debt upon conversion to Series A Preferred Stock of $ 0.6 million for the three months ended March 31, 2024. In November 2023, CLMBR, Inc issued promissory notes in the aggregate principal amount of approximately $ 0.7 million, due January 31, 2025 . Interest on the outstanding principal of the notes accrues initially at a rate of 12 % per annum. The note was assumed by the Company in February 2024 in connection with the acquisition of CLMBR, Inc. The note was amended in February 2024, to include a conversion provision whereby at any time prior to maturity date the lender has the right to convert any outstanding and unpaid principal and accrued interest of the note into shares of the Company's Series A Preferred Stock at a conversion price of $ 1.80 per share. Total outstanding principal balance including accrued interest as of March 31, 2024 was $ 0.7 million. The change in the balance of the Promissory notes as converted to convertible notes is as follows: August 2023 October 2023 November 2023 (in thousands) Promissory Notes Promissory Notes Promissory Notes Total Carrying value at December 31, 2023 $ — $ — $ — $ — Promissory notes assumed in connection with acquisition of CLMBR, Inc. 725 471 691 1,887 Loss on extinguishment of debt 239 155 — 394 Interest Expense — — 15 15 Conversion to Series A Preferred Stock ( 964 ) ( 626 ) — ( 1,590 ) Carrying value at March 31, 2024 $ — $ — $ 706 $ 706 November 2022 Convertible Notes In November 2022, the Company issued convertible notes (the “November 2022 Convertible Notes”) with an aggregate principal amount of $ 4.4 million, pursuant to a private placement offering. The November 2022 Convertible Notes bore interest at 6 % per annum and had a schedule maturing date of 12 months from issuance, at which time the principal and accrued interest would be due and payable. The Company elected the fair value option for the November 2022 Convertible Notes under ASC Topic 825, Financial Instruments, with changes in fair value recorded in earnings each reporting period. The November 2022 Convertible Notes did not include any financial covenants and are subject to acceleration upon the occurrence of specified events of default. The November 2022 Convertible Notes were subject to the following conversion features: • In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $ 10.0 million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. • In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) the price per share in the Next Financing round, or ii) the Original Issue Price of the Company’s Series A-2 Preferred Stock, which is $ 47.67 . The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. The Company recognized losses equal to $ 0.1 million for the three months ended March 31, 2023 related to changes in fair value for the November 2022 Convertible Notes. In May 2023, upon closing of the Company's IPO, the November 2022 Convertible notes were converted into an aggregate of 565,144 shares of common stock. Senior Secured Notes Bridge Secured Notes In March 2023, the Company issued an aggregate of $ 2.0 million of senior secured notes to three investors, including one related party, with associated warrants to purchase the Company’s common stock at an exercise price of $ 0.0001 , in lieu of future cash interest payments under the senior secured notes issued to such investors. In May 2023, the Company repaid the $ 2.0 million in senior secured notes. June 2023 Notes In June 2023, the Company entered into a note purchase agreement (the "June 2023 Notes") pursuant to which the Company agreed to issue up to $ 15.8 million in aggregate principal amount of 10 % senior secured notes due June 25, 2025 at their sole discretion. The June 2023 Notes are the senior secured obligations of the Company, bear interest at a rate of 10.0 % per annum, and contain customary events of default. The June 2023 Notes will mature on June 25, 2025, subject to earlier repurchase by the Company. The Company may redeem the June 2023 Notes, in whole or in part, at a redemption price equal to 100 % of the principal amount of the June 2023 Notes to be redeemed, plus any accrued and unpaid interest to (including any additional interest), but excluding, the redemption date. Additional senior secured notes may become available at the sole discretion of the Lender. As of September 30, 2023, the Company defaulted on the payment of interest due on the June 2023 Notes. On November 3, 2023, the Lender waived their rights to seek remedies resulting from an event of default . The note was amended in January 2024, and subsequently amended in February 2024, to include a conversion provision whereby at any time prior to maturity date the lender has the right to convert any outstanding and unpaid principal and accrued interest of the note into shares of the Company's Series A Preferred Stock at a conversion price of $ 1.82 per share. In February 2024, the convertible note was converted into 769,567 shares of Series A Preferred Stock. The Company recognized a loss equal to $ 0.5 million on the extinguishment of debt upon conversion to Series A Preferred Stock. November Bridge Notes On November 10, 2023, the Company issued secured promissory notes (the "November Bridge Notes") in the aggregate principal amount of approximately $ 1.9 million, of which approximately $ 0.8 million was with a related party, with an original issuance discount of 15 %, due November 10, 2024 . Interest on the outstanding principal of the notes accrues initially at a rate of 3 % per annum, with a step-up interest rate of 8 % per annum after January 31, 2024 until maturity. The Company elected the fair value option for the notes under ASC Topic 825, Financial Instruments, with changes in fair value recorded in earnings each reporting period. The note was amended in January 2024, and subsequently amended in February 2024, to include a conversion provision whereby at any time prior to maturity date the lender has the right to convert any outstanding and unpaid principal and accrued interest of the note into shares of the Company's Series A Preferred Stock at a conversion price of $ 1.82 per share. In February 2024, a portion of the convertible note was converted into 219,780 shares of Series A Preferred Stock. In March the note was amended at a conversion price of $ 1.50 . In March 2024, the remaining portion of the convertible note was converted into 538,039 shares of Series A Preferred Stock. The Company recognized a loss equal to $ 0.3 million on the extinguishment of debt and loss on change in fair value of $ 0.3 million upon conversion to Series A Preferred Stock. The carrying value of the Senior Secured Notes is as follows: March 31, December 31, (in thousands) 2024 2023 June 2023 $ — $ 1,379 November 2023 — 1,717 Aggregate carrying value $ — $ 3,096 The change in the balance of the Senior Secured Notes is as follows: November 10, 2023 June 6, 2023 (in thousands) Bridge Notes Notes Total Carrying value at December 31, 2023 $ 1,717 $ 1,379 $ 3,096 Loss on extinguishment of debt 275 462 737 Change in estimated fair value of convertible notes 316 - 316 Interest Expense — 21 21 Conversion to Series A Preferred Stock ( 2,308 ) ( 1,862 ) ( 4,170 ) Carrying value at March 31, 2024 $ - $ - $ - December 2023 Convertible Note On December 7, 2023, the Company issued the December 2023 Note with an aggregate principal amount of $ 2.2 million. The December 2023 Note carries an original issue discount of 8.0 % and accrues interest at a rate of 7.0 % per annum. The maturity date of the December 2023 Note is December 7, 2024 (the “Maturity Date”). Interest payments are guaranteed through the Maturity Date regardless of whether the December 2023 Note is earlier converted or redeemed. The December 2023 Note is convertible (in whole or in part) at any time prior to the Maturity Date into the number of shares of Common Stock equal to (x) the sum of (i) the portion of the principal amount to be converted or redeemed, (ii) all accrued and unpaid interest with respect to such principal amount, and (iii) all accrued and unpaid Late Charges (as defined in the Purchase Agreement) with respect to such principal and interest amounts, if any, divided by (y) a conversion price of $ 1.25 per share (such shares, the “Note Conversion Shares”). In addition, the Note Investor may, at any time and at its option, convert the Note (in whole or in part) into shares of Common Stock pursuant to the formula included in the preceding sentence at an alternate conversion price equal to 92 % of the lowest dollar volume-weighted average price (“VWAP”) during the ten trading days immediately preceding the date of conversion, subject to a conversion price floor, or, any time following an Event of Default (as defined below), equal to 80 % of the lowest VWAP during the ten trading days immediately preceding the date of conversion, in each case subject to the additional terms and conditions set forth in the Note. The Note sets forth certain standard events of default (each such event, an “Event of Default”), upon the occurrence of which the Company is required to deliver written notice to the Note Investor within one business day (an “Event of Default Notice”). At any time after the earlier of (a) the Note Investor’s receipt of an Event of Default Notice, and (b) the Note Investor becoming aware of an Event of Default, the Note Investor may require the Company to redeem all or any portion of the Note. Upon an Event of Default, the Note shall bear interest at a rate of 14.0 % per annum. In connection with the Company’s issuance of its December 2023 Note, the Company bifurcated the embedded conversion option and redemption rights and recorded embedded conversion option and redemption rights as a short term derivative liability in the Company’s balance sheet in accordance with FASB ASC 815, Derivatives and Hedging. The convertible debt and the derivative liability associated with the December 2023 Notes is presented on the condensed consolidated balance sheet as the convertible debt and derivative liability. The convertible debt is carried at amortized cost. The derivative liability will be remeasured at each reporting period using the lattice model with changes in fair value recorded in the condensed consolidated statements of operations in other expense (income). Total conversions for the three months ended March 31, 2024 was $ 0.9 million for a total of 1,485,943 shares of common stock. The Company recognized gains equal to $ 0.1 million for the three months ended March 31, 2024 related to changes in fair value of the embedded derivative for the December 2023 Note. The carrying value of the December 2023 Note is as follows: March 31, December 31, (in thousands) 2024 2023 Principal and interest $ 1,251 $ 2,169 Unamortized debt discount ( 589 ) ( 801 ) Unamortized issuance costs ( 410 ) ( 464 ) Embedded derivative liability 68 122 Aggregate carrying value $ 320 $ 1,026 Interest expense recognized on the December 2023 Note is as follows: March 31, March 31, (in thousands) 2024 2023 Contractual interest expense $ 38 $ — Amortization of debt discount 211 — Amortization of debt issuance costs 122 — Total $ 371 $ — February 2024 Convertible Notes On February 1, 2024, the Company entered into a Senior Secured Convertible Promissory Note (the "February 2024 Convertible Note") with Treadway Holdings LLC, a lender, in the aggregate principal amount of $ 6.0 million, which is convertible into shares of Common Stock. The Note accrues interest at a rate of 2.0 % per month. The maturity date of the February 2024 Convertible Note is December 15, 2024 . Interest payments are guaranteed through the Maturity date regardless of whether the February 2024 Convertible Note is earlier converted or redeemed. The February 2024 Convertible Note is convertible (in whole or in part) at any time prior to the Maturity Date into the number of shares of Common Stock equal to the quotient resulting by dividing the outstanding principal balance of the February 2024 Convertible Note to be converted by a conversion price of $ 2.00 per share. The February 2024 Convertible Note sets forth certain standard events of default upon the occurrence of which the Company is required to deliver written notice to the Treadway Holdings LLC within two (2) business days. At any time after the earlier of (a) Treadway Holdings LLC’s receipt of a notice of default and (b) Treadway Holdings LLC becoming aware of the event of default, the Treadway Holdings LLC may require the Company to redeem all or any portion of the February 2024 Convertible Note. Upon an event of default, the February 2024 Convertible Note shall bear interest at a rate of 4.0 % per month. Total principal payments for the three months ended March 31, 2024 was $ 0.1 million. The carrying value of the February 2024 Convertible Note is as follows: March 31, December 31, (in thousands) 2024 2023 Principal and interest $ 6,051 $ — Unamortized debt discount ( 1,912 ) — Unamortized issuance costs ( 969 ) — Aggregate carrying value $ 3,170 $ — Interest expense recognized on the February 2024 Convertible Note is as follows: March 31, March 31, (in thousands) 2024 2023 Contractual interest expense $ 240 $ — Amortization of debt discount 436 — Amortization of debt issuance costs 221 — Total $ 897 $ —

Warrants

Warrants	3 Months Ended
	Mar. 31, 2024
Warrants and Rights Note Disclosure [Abstract]
Warrants	11. Warrants The following is a schedule of changes in warrants issued and outstanding from December 31, 2023 to March 31, 2024: Common Common Common Total Common Stock Warrants Outstanding as of December 31, 2023 924,480 — — 924,480 Warrants issued 1,129,555 3,000,000 800,000 4,929,555 Warrants exercised — — — — Outstanding as of March 31, 2024 2,054,035 3,000,000 800,000 5,854,035 November Bridge Warrants In connection with the November Bridge Notes discussed further in Note 10, the Company entered into warrant agreement whereby the holders are eligible to receive warrants based on the occurrence of future events as defined in the agreement. The Company recognized gains equal to $ 0.1 million for the three months ended March 31, 2024 related to changes in fair value of the warrants. December 7, 2023 Warrants On December 7, 2023, the Company issued an aggregate 924,480 warrants to purchase shares of common stock to an accredited investor in conjunction with the issuance of its December 2023 Note. Each warrant has a strike price of $ 1.25 per share. The warrant may be exercised during the period commencing December 7, 2023 and ending June 7, 2029. The warrants are classified as other long-term liabilities within the condensed consolidated balance sheets and are carried at fair value, with changes in fair value recorded in earnings. The Company recognized a gain equal to $ 0.2 million for the three months ended March 31, 2024, related to the change in fair value of the warrants issued in December 2023. The Company converted debt to Series A Preferred Stock on March 29, 2024 at the lowest price of $ 1.50 a share, implying an effective common share price of $ 0.5626 per share and pursuant to the warrant agreement entered into with 3i in December 2023, the warrant to purchase shares of common stock increased to 2,054,035 following the dilutive issuance whereas the exercise price was reduced to an amount equal to the new issuance price. Treadway Warrants On February 1, 2024, the Company issued an aggregate 3,000,000 warrants to purchase shares of common stock to an accredited investor in conjunction with the issuance of its $ 6.0 million Convertible Note with Treadway Holdings, LLC (the "February 2024 Note"). The Warrants are exercisable for 1,500,000 shares of Common Stock, at a price of $ 1.25 per share (“Warrant 1”) and $ 1.75 per share (“Warrant 2” and, together with Warrant 1, the “Warrants”) (the “Exercise Prices”). The Warrants may be exercised during the period commencing February 1, 2024 and ending on February 1, 2034. The Exercise Prices are subject to voluntary adjustments and adjustments upon subdivision or combinations of shares of Common Stock. The warrants are classified as other long-term liabilities within the condensed consolidated balance sheets and are carried at fair value, with changes in fair value recorded in earnings. The Company recognized a gain equal to $ 1.2 million for the three months ended March 31, 2024, related to the change in fair value of the warrants issued in February 2024. Woodway Warrants On February 20, 2024, the Company issued 800,000 warrants in connection with an Exclusive Distribution Agreement with WOODWAY USA, INC. Each warrant has a strike price of $ 1.25 per share. The warrant may be exercised during the period commencing February 20, 2024 and ending February 20, 2034. The warrants are classified as other long-term liabilities within the condensed consolidated balance sheets and are carried at fair value, with changes in fair value recorded in earnings. The Company recognized a gain equal to $ 0.3 million for the three months ended March 31, 2024, related to the change in fair value of the warrants issued in February 2024. The following is a schedule of changes in warrants issued and outstanding from December 31, 2022 to March 31, 2023: Class A Common Class B Common Total Warrants Outstanding as of December 31, 2022 92,296 5,753 98,049 Warrants issued — — — Warrants exercised — — — Outstanding as of March 31, 2023 92,296 5,753 98,049 Class A Common Stock Warrants On November 13, 2022, the Company issued an aggregate 92,296 warrants to purchase Class A Common Stock to various third-party investors in conjunction with the issuance of its November 2022 Convertible Notes. Each warrant has a strike price of $ 0.01 per share and has a contractual term of ten years . The warrants are classified as other long-term liabilities within the condensed consolidated balance sheets and are carried at fair value, with changes in fair value recorded in earnings. The fair value of the warrants issued in 2022 was recorded as a liability on the Balance Sheet and expensed to other (expense) income, net on the Statement of Operations and Comprehensive Loss, at the time of issuance. The Company recognized a gain equal to $ 2.4 million for the three months ended March 31, 2023, related to changes in fair value for the warrants issued in November 2022. In May 2023, upon closing of the Company's IPO, the warrants were exercised and converted into shares of common stock. Class B Common Stock Warrants The Company issued warrants in 2021 to purchase Class B Common Stock to various employees and non-employees. Each warrant has a strike price of $ 0.01 and has a contractual term of seven years . The warrants are classified as permanent equity within the condensed consolidated balance sheets. In May 2023, upon closing of the Company's IPO, the warrants were exercised and converted into shares of common stock.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	12. Fair Value Measurements The Company’s financial instruments consist of its convertible notes and warrants. There were no assets or liabilities measured at fair value on a recurring basis as of March 31, 2024 , and no assets measured at fair value on a recurring basis as of December 31, 2023 . Liabilities measured at fair value on a recurring basis as of March 31,2024 December 31, 2023 were as follows: Fair value measurements as of March 31, 2024 Level 1 Level 2 Level 3 Total (in thousands) Liabilities Embedded derivatives $ — $ — $ 68 $ 68 Accrued earn out — — 1,300 1,300 Warrants — — 937 937 Total $ — $ — $ 2,305 $ 2,305 Fair value measurements as of December 31, 2023 Level 1 Level 2 Level 3 Total (in thousands) Liabilities Embedded derivatives $ — $ — $ 122 $ 122 Bridge Notes — — 1,717 1,717 Warrants — — 591 591 Total $ — $ — $ 2,430 $ 2,430 During the three months ended March 31, 2024, the re were no transfers between Level 1 and Level 2, nor into and out of Level 3. The following tables summarize the activity for the Company Level 3 liabilities measured at fair value on a recurring basis for the three months ended March 31, 2024 : Embedded Derivatives In connection with the Company’s issuance of its December 2023 Note, the Company bifurcated the embedded conversion option and redemption rights and recorded embedded conversion option and redemption rights as a short term derivative liability in the Company’s balance sheet in accordance with FASB ASC 815, Derivatives and Hedging. The fair value of the embedded derivative was determined using a lattice model. The Company recognized gains equal to $ 0.05 million for the three months ended March 31, 2024 related to changes in fair value of the embedded derivative for the December 2023 Note recorded in the condensed consolidated statements of operations in other expense (income). (in thousands) Derivatives Fair value at December 31, 2023 $ 122 Issuance of derivatives — Change in estimated fair value of financial instruments ( 54 ) Fair value at March 31, 2024 $ 68 Accrued Earn Out As part of the Acquisition of CLMBR, Inc. the Sellers shall be entitled to receive a contingent payment in the form of shares of the Company’s common stock (collectively, the “Earn-Out Shares”) calculated in the manner set forth in the Asset Purchase Agreement based on the 2024 Unit Sales (as defined in the Asset Purchase Agreement) and the volume-weighted average price (“VWAP”) for the Company’s common stock based on the 10 consecutive trading days ending on (and including) December 31, 2024, subject to the VWAP Collar. In addition, in the event the 2024 Unit Sales include at least 2,400 Units sold in the business-to-business channel, the Sellers shall be entitled to an additional number of Earn-Out Shares calculated in the manner set forth in the Asset Purchase Agreement subject to total maximum number of 22,665,681 Earn-Out Shares. The fair value of the contingent payment was $ 1.3 million as of March 31, 2024. November 2023 Bridge Notes On November 10, 2023, the Company issued the November Bridge Notes. The fair value of the bridge notes were determined using a discounted cash flow analysis at a discount rate of 21.0 %. The fair value of the bridge notes of $ 1.7 million was recorded as a current liability upon issuance. The Company amended the Bridge notes into convertible notes in January 2024 and subsequently converted the notes into Preferred Stock Series A in February 2024 and March 2024. The Company recognized a loss equal to $ 0.3 million on the extinguishment of debt and loss on change in fair value of $ 0.3 million upon conversion to Series A Preferred Stock. November 10, 2023 (in thousands) Bridge Notes Fair value at December 31, 2023 $ 1,717 Loss on extinguishment of debt 275 Change in estimated fair value of convertible notes 316 Conversion to Series A Preferred Stock ( 2,308 ) Fair value at March 31, 2024 $ — Warrants November 10, 2023 Warrants On November 10, 2023, the Company issued warrants to two accredited investors to purchase shares of common stock of the Company. The fair value of the warrants was determined using the Monte Carlo Simulation, given the variable number of shares issuable upon exercise of the warrant. For the outstanding warrants as of March 31, 2024, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, and (3) and risk free rate of 4.2 %. The fair value of the warrants of $ 0.2 million was recorded as a long-term liability upon issuance. The Company recorded a change in fair value of warrants of $ 0.1 million for the three months ended March 31, 2024. December 7, 2023 Warrants On December 7, 2023, the Company issued warrants in connection with the issuance of the December 2023 Convertible Notes. The fair value of the warrants was determined using a Black-Scholes-Merton model, in which the probability and timing of potential future events is considered in order to estimate the fair value of the warrants as of each valuation date. For the outstanding warrants as of March 31, 2024, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, and (3) a risk free rate of 4.2 %. The fair value of the warrants of $ 0.5 million was recorded as a long-term liability upon issuance. The Company recorded a change in fair value of warrants of $ 0.2 million for the three months ended March 31, 2024. The Company converted debt to Series A Preferred Stock on March 29, 2024 at the lowest price of $ 1.50 a share, implying an effective common share price of $ 0.5626 per share and pursuant to the warrant agreement entered into with 3i in December 2023, the warrant to purchase shares of common stock increased to 2,054,035 following the dilutive issuance whereas the exercise price was reduced to an amount equal to the new issuance price. Treadway Warrants On February 1, 2024, the Company issued an aggregate 3,000,000 warrants to purchase shares of common stock to an accredited investor in conjunction with the issuance of its $ 6.0 million Convertible Note with Treadway Holdings, LLC (the "February 2024 Note"). The fair value of the warrants was determined using a Black-Scholes-Merton model, in which the probability and timing of potential future events is considered in order to estimate the fair value of the warrants as of each valuation date. For the outstanding warrants as March 31, 2024, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, and (3) a risk free rate of 4.2 %. The fair value of the warrants of $ 1.8 million was recorded as a long-term liability upon issuance. The Company recorded a change in fair value of warrants of $ 1.2 million for the three months ended March 31, 2024. Woodway Warrants On February 20, 2024, the Company issued warrants in connection with an Exclusive Distribution Agreement with WOODWAY USA, INC. The fair value of the warrants was determined using a Black-Scholes-Merton model, in which the probability and timing of potential future events is considered in order to estimate the fair value of the warrants as of each valuation date. For the outstanding warrants as March 31, 2024, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, and (3) a risk free rate of 4.2 %. The fair value of the warrants of $ 0.3 million was recorded as a long-term liability upon issuance. The Company recorded a change in fair value of warrants of $ 0.3 million for the three months ended March 31, 2024. November 10, 2023 December 7, 2023 Treadway Woodway Total (in thousands) Warrants Warrants Warrants Warrants Warrants Fair value at December 31, 2023 $ 165 $ 426 $ — $ — $ 591 Issuance of warrants — — 1,800 345 2,145 Change in estimated fair value of financial instruments ( 124 ) ( 179 ) ( 1,245 ) ( 251 ) ( 1,799 ) Exercise of stock warrants — — — — — Fair value at March 31, 2024 $ 41 $ 247 $ 555 $ 94 $ 937 The following tables summarize the activity for the Company Level 3 liabilities measured at fair value on a recurring basis for the three months ended March 31, 2023: Convertible Notes The Company entered into several convertible note arrangements with certain investors during 2022. The Company recorded the liability related to the convertible notes at fair value and subsequently remeasured the instruments to fair value using level 3 fair value measurements. The Company recorded a change in fair value adjustment of $ 0.08 million for the three months ended March 31, 2023. In May 2023, upon closing of the Company's IPO, the November 2022 Convertible notes were converted into an aggregate of 565,144 shares of common stock. (in thousands) Convertible Notes Fair value at December 31, 2022 $ 4,270 Issuance of convertible notes — Change in estimated fair value of financial instruments 80 Fair value at March 31, 2023 $ 4,350 Warrants On November 13, 2022, the Company issued 92,296 common stock warrants in connection with the issuance of the November 2022 Convertible Notes. The Company recorded the liability related to the warrants at fair value and subsequently remeasured the instruments to fair value using level 3 fair value measurements. The Company recorded a change in the fair value of warrants of $ 2.4 million for the three months ended March 31, 2023. In May 2023, upon closing of the Company's IPO, the warrants were exercised and converted into shares of common stock. November 13, 2022 (in thousands) Warrants Fair value at December 31, 2022 $ 3,004 Issuance of warrants — Change in estimated fair value of financial instruments ( 2,410 ) Fair value at March 31, 2023 $ 594

Leases

Leases	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Leases	13. Leases Lease Obligations The Company adopted ASC 842 on January 1, 2022, using the effective date transition method, which requires a cumulative-effect adjustment to the opening balance of retained earnings on the effective date. As a result of the adoption of ASC 842, the Company recognized right-of-use assets and lease liabilities of $ 0.3 million and $ 0.3 million, respectively, as of January 1, 2022, effective date. There was no impact to opening retained earnings from the adoption of ASC 842. The Company has made certain assumptions and judgements when applying ASC 842 including the adoption of the package of practical expedients available for transition. The practical expedients allowed the Company to not reassess (i) whether expired or existing contracts contained leases, (ii) lease classification for expired or existing leases and (iii) previously capitalized initial direct costs. The Company also elected not to recognize right-of-use assets and lease liabilities for short-term leases (leases with a term of twelve months or less). Operating lease arrangements primarily consist of office and warehouse leases expiring at various years through 2028. The facility leases have original lease terms of two to seven years and contain options to extend the lease up to 5 years or terminate the lease. Options to extend are included in leased right-of-use assets and lease liabilities in the condensed consolidated balance sheet when the Company is reasonably certain it will renew the underlying leases. Since the implicit rate of such leases is unknown and the Company is not reasonably certain to renew its leases, the Company has elected to apply a collateralized incremental borrowing rate to facility leases on the original lease term in calculating the present value of future lease payments. As of March 31, 2024, the weighted average discount rate for operating leases was 9.50 % and the weighted average remaining lease term for operating leases was 2.7 years, respectively. As of December 31, 2023, the weighted average discount rate for operating leases was 9.49 % and the weighted average remaining lease term for operating leases was 4.42 years, respectively. The Company has entered into various short-term operating leases for office and warehouse space, with an initial term of twelve months or less. These short-term leases are not recorded on the Company’s condensed consolidated balance sheet and the related lease expense for these short-term leases was $ 0.01 million and $ 0.03 million for the three months ended March 31, 2024 and 2023, respectively. Operating lease cost was $ 0.08 million and $ 0.02 million for the three months ended March 31, 2024 and 2023, respectively. Total operating lease cost was $ 0.09 million and $ 0.05 million for the three months ended March 31, 2024 and 2023, respectively. Right-of-use assets of $ 0.0 million and $ 0.0 million were obtained in exchange for lease liabilities during the three months ended March 31, 2024 and 2023, respectively. Total right-of-use assets of $ 0.4 million and operating lease liabilities of $ 0.4 million were acquired in the Acquisition and recorded at fair value on the acquisition date. The following represents the Company’s minimum annual rental payments under operating leases for each of the next five years and thereafter: Fiscal Year Ending December 31, Operating (in thousands) 2024 (remaining) 270 2025 282 2026 78 2027 78 2028 33 Thereafter — Total future minimum lease payments 742 Less: imputed interest ( 72 ) Present value of operating lease liability $ 670 Less: current portion of lease liability 322 Non-current portion of lease liability 348 Present value of operating lease liability $ 670

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	14. Commitments and Contingencies Royalty Agreement In 2017, the Company entered into a royalty agreement with Fuseproject and agreed to pay 3 % of cumulative net sales up to $ 5.0 million and 1 % of cumulative net sales above $ 5.0 million, up to a maximum total royalty of $ 1.0 million. Regardless of the level of cumulative net sales, a guaranteed minimum payment of $ 0.2 million shall be paid in the first 12 months after the products initial retail release as an advance towards the royalty payments which was accrued as of March 31, 2024. Legal Proceedings On March 7, 2024, a petition was filed by Tung Keng Enterprise Co., Ltd. d/b/a DK City Co., Ltd. (“DK City”) against CLMBR and the Company in the United States District Court for the District of Colorado to enforce a monetary arbitration award of approximately $ 2.25 million against CLMBR (the “Petition”). The Company was not involved in that prior arbitration, which involved alleged breaches of an equipment manufacturing agreement between CLMBR and DK City and was resolved prior to the Company’s purchase of CLMBR. We dispute that we are liable for the amount claimed by DK City in our Petition. We plan to vigorously defend the Petition if and when called to answer or respond to the Petition. The final outcome of this matter, however, cannot be predicted with complete certainty, and our failure to successfully defend against these allegations could have a material adverse effect on our business, financial condition and results of operation. The Company is involved in legal proceedings in the normal course of business. The Company currently believes that any ultimate liability arising out of such proceedings will not have a material adverse effect on the Company’s financial position, results of operations or cash flows.

Stockholders' Deficit

Stockholders' Deficit	3 Months Ended
	Mar. 31, 2024
Stockholders' Equity Note [Abstract]
Stockholders' Deficit	15. Stockholders’ Deficit Common Stock The Company’s authorized common stock consisted of 900,000,000 shares at $ 0.0001 par value, as of March 31, 2024 and December 31, 2023 . The issued and outstanding common stock was 19,433,801 shares and 14,192,083 shares as of March 31, 2024 and December 31, 2023, respectively. In February 2023, the Company completed a rights offering involving the sale of Class A common stock to all existing accredited investors as of December 19, 2022, at a price equal to approximately $ 0.51 per share. In connection with the rights offering, the Company issued a total of 9,749,439 shares of Class A common stock, of which 1,072,438 was issued in December 2022, and 8,677,001 was issued in January and February 2023. Preferred Stock In January 2024, our board authorized the proposed issuance of shares of non-voting Series A and Series B convertible preferred stock. The Company's authorized preferred stock consists of 200,000,000 shares at $ 0.0001 par value as of March 31, 2024. The Series A Certificate designated 5,000,000 shares of the Company’s preferred stock as Series A Preferred Stock. The Series B Certificate designated 1,500,000 shares of the Company’s preferred stock as Series B Preferred Stock. The remaining unissued shares of our authorized preferred stock are undesignated. On April 18, 2024 the Series A Certificate was amended increasing designated shares from 5,000,000 to 7,000,000 . The Series A convertible preferred stock is subject to certain rights, preferences, privileges, and obligations, including voluntary and mandatory conversion provisions, as well as beneficial ownership restrictions and share issuance caps, as described below and as set forth in the Series A Certificate. The Series A convertible preferred stock can be issued at any time and any subsequent mandatory or voluntary conversion into common stock shall be at a conversion price at least equal to or above the closing price per share of the Common Stock as reported on Nasdaq on the last trading day immediately preceding the date that the Series A Certificate was approved by our board of directors, subject to customary adjustments for stock splits and combinations. The Series A convertible preferred stock includes the following: • Subject to certain restrictions specified in the Series A Certificate, and applicable legal and regulatory requirements, including without limitation, the listing requirements of the Nasdaq Stock Market, (i) each share of Series A convertible preferred stock is convertible, at the option of the holder, at any time, provided that such conversion occurs at least 12 months following the Original Issuance Date (as defined in the Series A Certificate), into such whole number of fully paid and non-assessable shares of common stock as is determined by dividing the Original Issue Price (as defined in the Series A Certificate) by the Conversion Price (as defined in the Series A Certificate) in effect at the time of conversion, and (ii) upon the earliest Mandatory Conversion Time (as defined in the Series A Certificate) all outstanding shares of Series A convertible preferred stock shall automatically be converted into shares of common stock; • In no event shall any share of Series A convertible preferred stock convert into shares of common stock if the total number of shares of common stock issued would exceed 19.99 % of the total number of our shares of common stock outstanding as of immediately prior to the adoption of the Series A Certificate; • Dividends accrue on each share of Series A convertible preferred stock at the rate per annum of 8 % of the Original Issue Price of such share, plus the amount of previously accrued dividends, compounded annually, subject to certain restrictions and provisions as set forth in the Series A Certificate; and • The Series A convertible preferred stock does not have any voting rights, other than any vote required by law or our certificate of incorporation (which does not currently provide for any such voting rights). The Series B convertible preferred stock includes the following: • Subject to certain conversion restrictions as specified in the Series B Certificate, and applicable legal and regulatory requirements, including without limitation, the listing requirements of the Nasdaq Stock Market, subject to and upon the receipt of the approval of the stockholders of the Company, and provided that such conversion occurs at least 24 months following the Original Issuance Date (as defined in the Series B Certificate), each share of Series B Preferred Stock shall be automatically converted into such whole number of fully paid and non-assessable shares of Common Stock as is determined by dividing the $ 2.00 original issue price (subject to adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization) by the Conversion Price (as defined in the Series B Certificate) in effect at the time of conversion. • In the event that stockholder approval is not obtained, the holders of the Series B Preferred Stock may voluntarily convert the Series B Preferred Stock into Common Stock, provided that in no event shall the number of shares of Common Stock issued upon such voluntary conversion exceed 19.99 % of the total number of shares of Common Stock outstanding as of immediately prior to the execution of the Asset Purchase Agreement. • The Series B Preferred Stock does not have any voting rights, other than any vote required by law or the Company’s certificate of incorporation (which does not currently provide for any such voting rights) and is not entitled to any dividends. The Company classifies Series B Preferred Stock in accordance with ASC 480, Distinguishing Liabilities from Equity, as there are conversion features that are subject to shareholder approval which is outside of the Company and therefore the securities should be classified outside of permanent stockholders’ deficit. Accordingly, the Company has classified Series B Preferred Stock as mezzanine equity in the accompanying financial statements as of March 31, 2024. Once shareholder approval is completed which is scheduled to take place on May 31, 2024, the Company will reevaluate the presentation of Series B Preferred Stock.

Equity-Based Compensation

Equity-Based Compensation	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Equity-Based Compensation	16. Equity-Based Compensation 2023 and 2020 Equity Incentive Plan Presented below is a summary of the compensation cost recognized in the condensed consolidated statements of operations and comprehensive (loss ) for the three months ended March 31, 2024 and 2023. Three Months Ended March 31, 2024 2023 (in thousands) Research and development $ 1,231 $ 2,131 Sales and marketing 75 222 General and administrative 2,060 12,286 Total stock-based compensation expense $ 3,366 $ 14,639 For the three months ended March 31, 2024 and 2023, $ 0.2 million and $ 0.4 million of stock-based compensation was capitalized as software costs, respectively. During the three months ended March 31, 2024 , the Company granted options to purchase 0 shares under the 2023 and 2020 Plan. The Company has no t granted any restricted stock or stock appreciation rights. In December 2022, the Company enacted a restructuring cost savings initiative which resulted in employee terminations in both December 2022 and January 2023. In association with January 2023 terminations, the Company accelerated the vesting of a number of individual option awards, resulting in the accelerated vesting of 5,938 shares on the date of modification. Also in January 2023, the Company repriced 301,537 option awards. Both the accelerated vesting and repricing were accounted for as an equity award modification under ASC Topic 718 which resulted in adjustment of the award value to reflect the fair value at the modification date and acceleration of the recognition schedule in the case of awards which were modified to have accelerated vesting. The adjustment resulted in additional expense of $ 0.5 million. In June 2023, the Company granted 1,294,998 options to non-employee directors, selected executives and other key employees where vesting is contingent on the Company's share price meeting certain targets. The fair value of each option granted was estimated on the date of grant using the Monte Carlo valuation model and assumes that share price targets are achieved. The following summary sets forth the stock option activity under the 2023 and 2020 Plan: Number of options Weighted average exercise price Weighted average remaining contractual term (in years) Aggregate intrinsic value (in thousands) Outstanding as of December 31, 2023 3,417,932 $ 2.53 9.3 $ 547 Granted — — Exercised — — Cancelled or forfeited ( 6,200 ) 0.51 Outstanding as of March 31, 2024 3,411,732 $ 2.53 9.0 $ — Options exercisable as of March 31, 2024 1,139,304 $ 1.64 8.8 $ — Options unvested as of March 31,2024 2,463,196 $ 3.16 9.1 $ — The aggregate intrinsic value of options outstanding, exercisable and unvested were calculated as the difference between the exercise price of the options and the estimated fair market value of the Company’s common stock, as of March 31, 2024. A summary of unvested common stock from early option exercises that are subject to repurchase by the Company under the 2020 Plan is as follows: Early Option Exercises Number of options Weighted average exercise price Repurchase liability (in thousands) Unvested common stock as of December 31, 2023 13,720 $ — $ 8 Issued — — — Vested ( 3,272 ) — — Repurchased — — — Unvested common stock as of March 31, 2024 10,448 $ 8 For the three months ended March 31, 2024 and 2023 the weighted-average grant date fair value per option was $ 0.00 and $ 18.86 respectively. The fair value of each option was estimated at the grant date using the Black-Scholes method with the following assumptions: March 31, March 31, 2024 2023 Weighted-average risk-free interest rate (1) — % 3.6 % Weighted-average expected term (in years) — 6.03 Weighted-average expected volatility (2) — % 57.9 % Expected dividend yield — % — % (1) Based on U.S. Treasury seven-year constant maturity interest rate whose term is consistent with the expected term of the option. (2) Expected volatility is based on an analysis of comparable public company volatilities and adjusted for the Company’s stage of development. With respect to the 2023 and 2020 Plan, the Company recognized stock compensation expense of $ 3.4 million and $ 14.6 million for the three months ended March 31, 2024 and 2023 , respectively, of which $ 0.2 million and $ 0.4 million was capitalized as software costs for the three months ended March 31, 2024 and 2023, respectively. As of March 31, 2024 and December 31, 2023 , the Company had $ 13.5 million and $ 17.1 million of unrecognized stock-based compensation expense that is expected to be recognized over a weighted-average period of 1.5 years and 1.7 years, respectively. For financial reporting purposes for the awards granted in January 2023, we applied a straight-line calculation between the $ 30.00 per share determined in the contemporaneous third-party valuation as of December 31, 2022 and the $ 6.08 per share determined in the contemporaneous third-party valuation as of March 31, 2023 to determine the fair value of our common stock on the grant date. Using the benefit of hindsight, we determined that the straight-line calculation would provide the most appropriate conclusion for the valuation of our common stock on the interim dates between valuations because we did not identify any single event or series of events that occurred during this interim period that would have caused a material change in fair value. Based on this calculation, we assessed the fair value of our common stock for awards granted in January 2023 to be $ 19.27 per share.

Concentration of Credit Risk an

Concentration of Credit Risk and Major Customers and Vendors	3 Months Ended
	Mar. 31, 2024
Risks and Uncertainties [Abstract]
Concentration of Credit Risk and Major Customers and Vendors	17. Concentration of Credit Risk and Major Customers and Vendors Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. The Company’s cash and cash equivalents are maintained with high-quality financial institutions, the compositions and maturities of which are regularly monitored by management. For the three months ended March 31, 2024 and 2023 , there were no customers representing greater than 10 % of the Company’s total revenue. The Company had three vendors representing greater than 10 % of total finished goods purchases for the three months ended March 2023. The Company had no vendors representing greater than 10 % of total finished goods for the three months ended March 31, 2024.

Benefit Plans

Benefit Plans	3 Months Ended
	Mar. 31, 2024
Retirement Benefits [Abstract]
Benefit Plans	18. Benefit Plans The Company established a defined contribution savings plan under Section 401(k) of the Internal Revenue Code. This plan covers all employees who meet minimum age and service requirements and allows participants to defer a portion of their annual compensation on a pre-tax basis. Matching contributions to the plan may be made at the discretion of the Company’s board of directors. During the three months ended March 31, 2024 and 2023 , the Company did no t make any contributions to the plan.

Loss Per Share

Loss Per Share	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Loss Per Share	19. Loss Per Share The computation of loss per share is as follows: Three months ended March 31, 2024 2023 (in thousands, except share and per share amounts) (in thousands, Numerator: Net loss $ ( 11,394 ) $ ( 15,961 ) Net loss attributable to common stockholders $ ( 11,394 ) $ ( 15,961 ) Denominator: Weighted average common stock outstanding - 16,994,445 7,653,940 Net loss per share attributable to common $ ( 0.67 ) $ ( 2.09 ) The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive: March 31, 2024 2023 Warrants to purchase series Class A common stock (as — 92,296 Warrants to purchase series Class B common stock (as — 5,753 Warrants to purchase common stock 5,854,035 — Stock options to purchase common stock 3,411,732 1,784,263 Total 9,265,767 1,882,312

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2024
Related Party Transactions [Abstract]
Related Party Transactions	20. Related Party Transactions In the ordinary course of business, we may enter into transactions with directors, principal officers, their immediate families, and affiliated companies in which they are principal stockholders (commonly referred to as “related parties”). Principal Stockholder Promissory Notes During 2019, 2020, and 2021 the Company entered into the following promissory notes with a then-principal stockholder (the "former principal stockholder”) of the Company: • On May 17, 2019, a $ 2.0 million note with interest at the rate of 2.5 % per annum and maturity date of May 17, 2021 . The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5 % of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 7.5 %. This note is secured by a lien on and security interest in all right, title and interest of the Company’s assets. The security interest will continue until all obligations under the note are satisfied. The total outstanding principal balance including accrued interest as of March 31, 2024 and December 31, 2023 was $ 2.7 million and $ 2.7 million, respectively. • On August 28, 2019, a $ 1.0 million note with interest at the rate of 5.0 % per annum and a maturity date of August 28, 2021 . The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5.0 % of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0 %. This note is secured by a lien on and security interest in all right, title and interest of the Company’s assets. The security interest will continue until all obligations under the note are satisfied. The total outstanding principal balance including accrued interest as of March 31, 2024 and December 31, 2023 was $ 1.5 million and $ 1.4 million, respectively. • On November 28, 2019, a $ 0.3 million note with interest at the rate of 5.0 % per annum and a maturity date of August 28, 2021 . The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5 % of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0 %. This note is secured by a lien on and security interest in all right, title and interest of the Company’s assets. The security interest will continue until all obligations under the note are satisfied. The total outstanding principal balance including accrued interest as of March 31, 2024 and December 31, 2023 was $ 0.3 million and $ 0.4 million, respectively. • On March 20, 2020, a $ 0.3 million note with interest at the rate of 5.0 % per annum and a maturity date of March 20, 2022 . The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5 % of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0 %. This note is secured by a lien on and security interest in all right, title and interest of the Company’s assets. The security interest will continue until all obligations under the note are satisfied. The total outstanding principal balance including accrued interest as of March 31, 2024 and December 31, 2023 was $ 0.2 million and $ 0.2 million, respectively. • On February 12, 2021, a $ 0.6 million note with interest at the rate of 5.0 % per annum and a maturity date of June 12, 2022 . The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5 % of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0 %. This note is secured by a lien on and security interest in all right, title and interest of the Company’s assets. The security interest will continue until all obligations under the note are satisfied. The total outstanding principal balance including accrued interest as of March 31, 2024 and December 31, 2023 was $ 0.3 million and $ 0.4 million, respectively. As of March 31, 2024, all outstanding promissory notes with respect to the former principal stockholder are included within the loan payable on the condensed consolidated balance sheet for a total of $ 5.0 million, including accrued interest and default interest of $ 1.5 million. As the 2019, 2020 and 2021 notes were not paid upon maturity, these loans were in default as of March 31, 2024, and on August 4, 2023, the Company received a notice of default from the principal stockholder. The Company accrued for the default fee on the date of default and the additional default interest following that date. Interest expense, including default interest, recorded in the condensed consolidated statement of operations was $ 0.09 million for the three months ended March 31, 2024 and $ 0.1 million for the three months ended March 31, 2023. As of December 31, 2022, the former principal stockholder and certain related parties waived their rights to seek remedies resulting from an event of default due to a failure to make payments of principal or interest at the stated maturity or due date, respectively. On October 30, 2023, the Company entered into an agreement with the former principal stockholder regarding a mutually agreed upon repayment schedule with respect to the outstanding promissory notes issued to such former principal stockholder. Other Related Party Promissory Notes During 2019, 2020, 2021, and 2022, the Company entered into the following promissory notes with other related parties: • On September 30, 2019, a $ 0.2 million note with interest at the rate of 12.0 % per annum and a maturity date of September 30, 2021 . The note includes additional interest and fees associated with it upon the occurrence of default for late payment. This loan was made from a company owned by the current CEO. Total payments made to this loan equate to $ 0.2 million. Upon default, on the December 31, 2019, loan the Company shall pay a fee of 5 % of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0 %. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest in the Company’s assets. The total outstanding principal balance including accrued interest as of March 31, 2024 and December 31, 2023 was $ 0.0 million and $ 0.05 million, respectively. The principal and interest of this loan has been paid as of March 31, 2024. • On October 21, 2019, a $ 0.2 million note with interest at the rate of 12.0 % per annum and maturity date of October 21, 2021 . The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5 % of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0 %. This note is secured by a lien on and security interest in all right, title and interest of the Company’s assets. The security interest will continue until all obligations under the note are satisfied. The principal and interest of this loan has been paid as of December 31, 2023. • On February 18, 2020, a $ 0.1 million note with interest at the rate of 12.0 % per annum and a maturity date of February 18, 2021 . The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5 % of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0 %. This note is secured by a lien on and security interest in all right, title and interest of the Company’s assets. The security interest will continue until all obligations under the note are satisfied. The total outstanding principal balance including accrued interest as of March 31, 2024 and December 31, 2023 was $ 0.2 million and $ 0.2 million, respectively. The note was amended in January 2024 to include a conversion provision whereby at any time prior to maturity date the lender has the right to convert any outstanding and unpaid principal and accrued interest of the note into shares of the Company's Series A Preferred Stock at a conversion price of $ 2.00 per share. The $ 0.2 million is included in other related party convertible notes in Note 10. • On June 9, 2020, a $ 75,000 note was entered into by the Company from the president and co-founder of the Company. This note has interest at the rate of 5.0 % per annum and a maturity date of June 9, 2022 . The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5 % of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0 %. The principal and interest of this loan has been paid as of December 31, 2023. • On June 15, 2020, a $ 0.1 million note with interest at the rate of 7.5 % per annum and a maturity date of June 15, 2021 . The note includes additional interest and fees associated with it upon the occurrence of default for late payment. This loan was made from a company owned by the current CEO. Upon default, the Company shall pay a fee of 5 % of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 12.5 %. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest in the Company’s assets. The principal and interest of this loan has been paid as of December 31, 2023. • On November 2, 2020, a $ 50,000 note was entered into by the Company from to the president and co-founder of the Company. This note has interest at the rate of 5.0 % per annum and a maturity date of June 2, 2022 . The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5 % of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0 %. The principal and interest of this loan has been paid as of December 31, 2023. • On January 12, 2021, a $ 0.3 million note with interest at the rate of 12.0 % per annum and a maturity date of June 12, 2022 . The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5 % of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0 %. This note is secured by a lien on and security interest in all right, title and interest of the Company’s assets. The security interest will continue until all obligations under the note are satisfied. The note was amended in January 2024, and subsequently amended in February 2024, to include a conversion provision whereby at any time prior to maturity date the lender has the right to convert any outstanding and unpaid principal and accrued interest of the note into shares of the Company's Series A Preferred Stock at a conversion price of $ 1.82 per share. In February 2024, the note of $ 0.3 million and accrued interest of $ 0.1 million was converted into 242,602 shares of the Company's Series A Preferred Stock. A loss on extinguishment of debt of $ 0.1 million was recorded in the condensed consolidated statement of operations in other income (expense). The total outstanding principal balance including accrued interest as of March 31, 2024 and December 31, 2023 was $ 0.0 million and $ 0.4 million, respectively. • On February 22, 2021, a $ 40,000 note with interest at the rate of 12.0 % per annum and a maturity date of June 22, 2022 . The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5 % of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0 %. This note is secured by a lien on and security interest in all right, title and interest of the Company’s assets. The security interest will continue until all obligations under the note are satisfied. The note was amended in January 2024, and subsequently amended in February 2024, to include a conversion provision whereby at any time prior to maturity date the lender has the right to convert any outstanding and unpaid principal and accrued interest of the note into shares of the Company's Series A Preferred Stock at a conversion price of $ 1.82 per share. In February 2024, the note of $ 0.04 million and accrued interest of $ 0.02 million was converted into 34,246 shares of the Company's Series A Preferred Stock. A loss on extinguishment of debt of $ 0.02 million was recorded in the condensed consolidated statement of operations in other income (expense). The total outstanding principal balance including accrued interest as of March 31, 2024 and December 31, 2023 was $ 0.0 million and $ 0.06 million, respectively. • On October 27, 2022, a $ 0.4 million note with interest at the rate of 12.0 % per annum and a maturity date of January 27, 2023 . The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5 % of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0 %. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest in the Company’s assets. The principal and interest of this loan has been paid as of March 31, 2024. The total outstanding principal balance including accrued interest as of March 31, 2024 and December 31, 2023 was $ 0.0 million and $ 0.01 million, respectively. • The Company borrowed $ 0.3 million in April 2023 and repaid $ 0.3 million in May 2023 upon closing of the Company’s IPO. • In August 2023, the Company borrowed $ 0.2 million in a non-interest bearing note and repaid $ 0.2 million. The principal of this loan was paid as of December 31, 2023. As of March 31, 2024 , $ 0 million of other related party promissory notes were outstanding and included within the loan payable on the condensed consolidated balance sheet. All notes were not paid upon maturity. These loans were in default as of period end due to outstanding interest. The Company accrued for the default fee on the date of default and the additional default interest following that date. Interest expense, including default interest, recorded in the condensed consolidated statement of operations was $ 0.02 million for the three months ended March 31, 2024. On September 30, 2022, related parties waived their rights to remedy in the event of default, which in effect releases the Company from the obligation of the incremental interest and fees, as well as the lender from their lien on and security interest in the Company’s assets. During 2022, multiple of the loans above with maturity dates in 2022 remained unpaid as of the maturity date. On September 30, 2022, those lenders waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest in the Company’s assets. Currently, the Company is renegotiating the terms of the loans. Loan payable consisted of the following as of March 31, 2024 and December 31, 2023: March 31, December 31, (in thousands) 2024 2023 Principal stockholder promissory notes 4,975 5,085 Other related party promissory notes - 721 Total Loan Payable $ 4,975 $ 5,806 Other Related Party Transactions In 2016, the Company entered into an agreement with Fuseproject, a design firm that designed the Company’s main product, its fitness mirror. As of March 31, 2024 and 2023 , the Company had incurred $ 0.0 million and $ 0.1 million, respectively, of expenses for design services provided by Fuseproject. In 2017, the Company entered into a royalty agreement with Fuseproject and agreed to pay 3 % of cumulative net sales up to $ 5.0 million and 1 % of cumulative net sales above $ 5.0 million, up to a maximum total royalty of $ 1.0 million. Regardless of the level of cumulative net sales, a guaranteed minimum payment of $ 0.2 million shall be paid in the first 12 months after the products initial retail release as an advance towards the royalty payments which was accrued as of March 31, 2024. As of March 31, 2024 the Company has accrued $ 0.2 million in royalty payments. In 2022, the Company entered into an agreement with Apeiron Advisory Ltd for promotion of the Company, participation in industry conferences, and ongoing structural advice and consulting. The agreement was terminated in 2023 and the Company is no longer receiving any advisory services from Apeiron Advisory Ltd. As of the three months ended March 31, 2024 and 2023 , the Company has incurred $ 0.0 million and $ 0.0 million, respectively, of expenses for such services provided by Apeiron Advisory Ltd. In March 2023, the Company issued $ 0.5 million of senior secured notes to a related party, with associated warrants, in lieu of future cash interest payments under the senior secured notes issued to such investor. In May 2023, the Company repaid the $ 0.5 million in senior secured notes to a related party. As discussed further in Note 10, in November 2023, the Company issued secured promissory notes of approximately $ 0.8 million with a related party. As discussed further in Note 11, in connected with issued secured promissory notes the Company entered into warrant agreements whereby the holders are eligible to receive warrants based on the occurrence of future events as defined in the agreement. The Company assumed secured promissory notes in connection with the acquisition of CLMBR, Inc.of approximately $ 0.5 million with a related party.

Acquisition

Acquisition	3 Months Ended
	Mar. 31, 2024
Business Combinations [Abstract]
Acquisition	21. Acquisition On October 6, 2023, the Company entered into an asset purchase agreement (the “Asset Purchase Agreement”) with CLMBR and CLMBR1, LLC (collectively, the “Sellers”) to purchase and acquire substantially all of the assets and assume certain liabilities of the Sellers. On January 22, 2024, the Company and the Sellers entered into an amended and restated Asset Purchase Agreement (the “Amended Agreement”). On February 2, 2024, pursuant to the Amended Agreement, the Company completed the acquisition for a total purchase price of approximately $ 15.9 million, consisting of (i) cash of $ 30,000 , (ii) shares of the Company’s common stock with a fair value of $ 1.0 million, 1,428,922 shares, (iii) shares of the Company’s non-voting Series B preferred stock with a fair value of $ 2.7 million, 1,500,000 shares, (iv) contingent consideration with a fair value of $ 1.3 million (as further described below), and (v) the retirement of $ 9.4 million of senior debt and $ 1.4 million in related fees, such retirement to be in the form of a $ 1.4 million cash payment to the lender of the senior debt and the issuance of an $ 8.0 million promissory note to such lender (the “Acquisition”). The CLMBR, Inc. acquisition was a strategic acquisition that helped accelerate the Company’s commercialization path and help achieve immediate scale, resulting in a high growth, profitable platform that sells connected fitness equipment and digital fitness services across B2B and B2C channels. The CLMBR, Inc. acquisition was accounted for as a purchase business combination in accordance with ASC 805 “Business Combinations.” Assets acquired and liabilities assumed were recorded in the accompanying condensed consolidated balance sheet at their estimated fair values as of February 2, 2024, with the remaining unallocated purchase price recorded as goodwill. The following table outlines the Company’s consideration transferred and the identifiable net assets acquired at their estimated fair value as of February 2024. The purchase price allocation is preliminary and subject to change, including the valuation of intangible assets. The amounts recognized will be finalized as the information necessary to complete the analysis is obtained, but no later than one year after the acquisition date. Consideration (in thousands) Cash Paid to Seller 30 Common stock issued 1,015 Series B preferred stock issued 2,688 Payoff of Vertical debt (plus accrued interest) 1,447 Retirement of Vertical Debt (including fees) 9,379 Fair value of earn-out consideration 1,300 . 15,859 Acquisition related costs (including in general and administrative in the condensed consolidated statement of operations and comprehensive loss) 764 Recognized amounts of identifiable assets acquired and liabilities assumed Cash 50 Accounts receivable, net of allowances 134 Inventories, net 3,490 Vendor deposits 61 Prepaid expenses and other current assets 63 Property and equipment, net 139 Right-of-use-assets 412 Intangible assets, net 6,900 Other assets 30 Accounts payable ( 3,557 ) Accrued expenses and other current liabilities ( 2,438 ) Operating lease liability, current portion ( 263 ) Deferred revenue ( 261 ) Loan payable ( 1,887 ) Operating lease liability, net of current portion ( 179 ) Total identifiable net assets 2,694 Goodwill 13,165 $ 15,859 Acquisition-related costs of $ 0.8 million were included in general and administrative expenses in the Company's statement of operations for the three months ended March 31, 2024. Compensation Arrangements In connection with the acquisition CLMBR, Inc. the Company has agreed to pay additional consideration in future periods. Certain employees of CLMBR, Inc. will be paid a total of $ 0.5 million of which $ 0.5 million will be paid in 2024. These payments are accounted for as transactions separate from the business combination as the payments are contingent upon continued employment and will be recorded as post-combination compensation expense in the Company's financial statements during the service period in general and administrative expenses for the three months ended March 31, 2024. Accrued Earn Out As part of the Acquisition of CLMBR, Inc. the Sellers shall be entitled to receive a contingent payment in the form of shares of the Company’s common stock (collectively, the “Earn-Out Shares”) calculated in the manner set forth in the Asset Purchase Agreement based on the 2024 Unit Sales (as defined in the Asset Purchase Agreement) and the volume-weighted average price (“VWAP”) for the Company’s common stock based on the 10 consecutive trading days ending on (and including) December 31, 2024, subject to the VWAP Collar. In addition, in the event the 2024 Unit Sales include at least 2,400 Units sold in the business-to-business channel, the Sellers shall be entitled to an additional number of Earn-Out Shares calculated in the manner set forth in the Asset Purchase Agreement subject to total maximum number of 22,665,681 Earn-Out Shares. The fair value of the contingent payment was $ 1.3 million as of March 31, 2024. The following unaudited pro forma condensed consolidated results of operations for the three months ended March 31, 2024 and 2023 present condensed consolidated information of the Company as if the CLMBR, Inc. acquisition had occurred as of January 1, 2023 (in thousands): Proforma Three Months Ended March 31, 2024 2023 (in thousands) Revenue $ 473 $ 1,187 Operating Loss ( 9,633 ) ( 22,632 ) Net Loss ( 11,608 ) ( 17,763 ) Net loss per share – basic and diluted $ ( 0.68 ) $ ( 1.81 ) The unaudited pro forma consolidated results for the three month periods were prepared using the acquisition method of accounting and are based on the historical financial information of CLMBR, Inc. and the Company. The unaudited pro forma consolidated results incorporate historical financial information for all significant acquisitions pursuant to SEC regulations since January 1, 2023. The historical financial information has been adjusted to give effect to pro forma adjustments that are: (i) directly attributable to the acquisition, (ii) factually supportable and (iii) expected to have a continuing impact on the combined results. The unaudited pro forma consolidated results are not necessarily indicative of what the Company’s consolidated results of operations actually would have been had it completed these acquisitions on January 1, 2023. The following unaudited condensed consolidated results of operations included in the condensed consolidated statements of loss for the three months ended March 31, 2024. Three Months Ended March 31, 2024 Revenue $ 267 Operating Loss ( 173 ) Net Loss ( 279 )

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	22. Subsequent Events The Company has evaluated subsequent events through the financial statement issuance date, May 15, 2024, pursuant to ASC 855-10 Subsequent Events. Loan Modification and Loan Restoration Agreement On April 24, 2024 (the “Effective Date”), the Company entered into a Loan Modification Agreement with the Lender (the “Modification Agreement”). Pursuant to the Modification Agreement, the Company agreed to make monthly payments of interest in the amount of $ 60,000 to the Lender. In addition, the Company agreed to make mandatory principal payments simultaneously with the closing of all future capital raises by the Company or any affiliate of the Company. The first principal payment will be the greater of (i) $ 3,000,000 (the “Minimum Payment”) or (ii) 20 % of the net amount raised from any source of debt, equity, synthetic equity instruments or otherwise less any reasonable expenses paid to third parties (the “Net Capital Raise”). At each capital raise thereafter, the Company shall make a mandatory principal payment to the Lender of 20 % of the Net Capital Raise. As of the Effective Date, the outstanding principal amount of the Loan was $ 4,957,863.06 . On April 24, 2024, the Company entered into a Loan Restoration Agreement with the Lender (the “Restoration Agreement”). Pursuant to the Restoration Agreement, in the event the aggregate amount of funds received by the Lender (net of all commissions, transfer fees or other transaction fees of any kind and taxes paid or payable as a result thereof) arising out of the disposition of the Preferred Stock, shares of the Company’s Common Stock issuable upon conversion of the Preferred Stock, if converted by the Lender, or any other securities of the Company issued to the Lender as a result of its holding the Preferred Stock (the aggregate amount of funds, the “Net Trade Value”) received by the Lender on or before December 31, 2024 is less than $ 3,000,000 , within ten (10) business days of written demand therefor, the Company shall pay the Lender the amount that is equal to $ 3,000,000 less the Net Trade Value. In the event the Net Trade Value is greater than $ 3,100,000 , any amount in excess of $ 3,100,000 being the “Excess Amount”, the Excess Amount shall be applied by the Lender as follows: a) Fifty percent ( 50 %) of the Excess Amount shall be distributed to the Lender as additional gain on the sale of the Preferred Stock; b) The remaining fifty percent ( 50 %) of the Excess Amount shall be applied by Lender as a partial payment by the Company of the Origination Fee, which equaled $ 1,550,000 and the Enhancement Fee, which equaled $ 750,000 ; c) After the application of the funds as set forth above and provided that the Minimum Payment in the Modification Agreement has not yet been received, such Minimum Payment shall be reduced by a percentage of the “Base Trade Value”, which is the Net Trade Value less the Excess Amount, in accordance with the formulas and schedule as set forth in the Restoration Agreement. By way of example, if the Lender realizes a Base Trade Value of $ 2,400,000 prior to receipt of the Minimum Payment, then a Discount Percentage of 40 % would apply, resulting in a reduction of the Minimum Payment to $ 1,800,000 , calculated as follows: ($ 2,400,000 / $ 3,000,000 ) x 50 % = 40 % (being the Discount Percentage) $ 3,000,000 x 60 % (being 1 – 0.40) = $ 1,800,000 (being the Minimum Payment)

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Unaudited Interim Financial Information	Unaudited Interim Financial Information The accompanying unaudited interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, or GAAP, for interim financial reporting and as required by Regulation S-X, Rule 10-01. The unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited condensed consolidated annual financial statements for the years ended December 31, 2023 and 2022 and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair statement of the Company’s condensed consolidated balance sheet as of March 31, 2024, the condensed consolidated statements of operations and comprehensive loss for the three months ended March 31, 2024 and 2023, the condensed consolidated statement of convertible preferred stock and stockholders' equity (deficit) as of March 31, 2024 and condensed consolidated statements of cash flows for the three months ended March 31, 2024 and 2023. The financial data and other information disclosed in these notes related to the three months ended March 31, 2024 and 2023 are unaudited. The results for the three months ended March 31, 2024, are not necessarily indicative of results to be expected for the year ending December 31, 2024 , any other interim periods, or any future year or period.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to revenue related reserves, the realizability of inventory, fair value measurements, useful lives of long lived assets, including property and equipment and finite lived intangible assets, product warranty, stock-based compensation expense, warrant liabilities, accrual of acquisition earn-outs, estimated legal accruals, valuation of deferred taxes, valuation of embedded derivatives, and commitments and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable. Actual results may differ from these estimates.
Segment Information	Segment Information Operating segments are defined as components of an enterprise for which separate and discrete information is available for evaluation by the chief operating decision-maker (“CODM”) in deciding how to allocate resources and assess performance. The Company has one operating segment, the development and sale of its at-home fitness technology platform. The Company’s chief operating decision maker, its chief executive officer, manages the Company’s operations on a consolidated basis for the purpose of allocating resources. As the Company has one reportable segment, all required segment financial information is presented in the condensed consolidated financial statements. The Company currently operates in the United States, the United Kingdom, and Taiwan. As of March 31, 2024 and 2023 , substantially all of the Company’s long-lived assets are held in the United States.
Cash	Cash Cash consists of cash on deposit in banks.
Deferred Offering Costs	Deferred Offering Costs The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A “ Expenses of Offering” . Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO. The Company incurred offering costs amounting to $ 4.6 million through the IPO and subsequently classified the costs to additional paid in capital in 2023.
Property and Equipment	Property and Equipment Property and equipment purchased by the Company are stated at cost less accumulated depreciation. Major updates and improvements are capitalized, while charges for repairs and maintenance which do not improve or extend the lives of the respective asset, are expensed as incurred. The Company capitalizes the cost of pre-production tooling which it owns under a supply arrangement. Pre-production tooling, including the related engineering costs the Company will not own or will not use in producing products under long-term supply arrangements, are expensed as incurred. Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives: Pre-production tooling 2 – 5 years Machinery and equipment 2 – 10 years Furniture and fixtures 3 – 5 years Leasehold improvements Lesser of lease term or estimated useful life
Inventories, net	Inventories, net Inventories, which are comprised of finished goods, are stated at the lower of cost or net realizable value, with cost determined using actual costs. The Company maintains inventory in a third-party warehouse. Reserves are established to reduce the cost of inventories to their estimated net realizable value and are reflected in cost of revenues in the condensed consolidated statement of operations. The Company assessed the obsolescence reserve by evaluating factors such as inventory levels, historical sales, and the remaining life of its products. Inventory losses are written-off against the reserve. Inventory not expected to be sold in the next twelve months is classified as long-term in the accompanying condensed consolidated balance sheets.
Vendor Deposits	Vendor Deposits Vendor deposits represent prepayments made to the third-party manufacturers of the Company’s inventory. In general, the Company’s manufacturers require that the Company pay a portion of the costs for a manufacturing purchase order in advance, with the remaining cost being invoiced upon delivery of the products. Prior to receipt of the goods, any costs associated with the prepayments made by the Company are reflected as vendor deposits on the Company’s condensed consolidated balance sheet.
Capitalized Studio Content	Capitalized Studio Content Capitalized Studio content costs include certain expenditures to develop video and live content for the Company’s customers. The Company capitalizes production costs for recorded content in accordance with ASC 926-20, Entertainment-Films - Other Assets - Film Costs. The Company recognizes capitalized content, net of accumulated amortization, within other non-current assets in the condensed consolidated balance sheets and recognizes the related amortization expense as a component of cost of revenue in the condensed consolidated statements of operations and comprehensive loss. Costs which qualify for capitalization include production costs, development costs, direct costs, labor costs, and production overhead. Expenditures for capitalized content are included within operating activities in the condensed consolidated statements of cash flows. Based on certain factors, including historical and estimated user viewing patterns, the Company amortizes individual titles within the Studio content library on a straight-line basis over a three-year useful life. The Company reviews factors impacting the amortization of the capitalized Studio content on an ongoing basis. Estimates related to these factors require considerable management judgment. The Company considered certain factors in determining the useful life of the content, including expected periods over which the content will be made available through the platform and related viewership, the lack of “obsolescence” of such content over such period given the nature of its videos (i.e., exercise classes which are not significantly impacted by changes in markets or customer preferences, and/or for which the content is expected to significantly change or evolve over time), and the expected significant growth of its subscriber base which will contribute to substantial increases in viewership over time given the recent launch of its product and membership offerings. Based on these factors, the Company has determined that a three-year (3-year) amortization period is reasonable for the content. The Company will continue to review factors impacting the amortization of the capitalized content on an ongoing basis. The Company’s business model is membership based as opposed to generating revenues at a specific title level. Therefore, all content assets are monetized as part of a single asset group. The content is assessed at the group level when an event or change in circumstances indicates a change in the expected usefulness of the content or that fair value may be less than unamortized cost. Unamortized costs are assessed for impairment regardless of whether the produced content is completed. To date, the Company has recognized one impairment with regards to the carrying value of its content portfolio. If circumstances in the future suggest that an impairment may exist, these aggregated content assets will be stated at the lower of unamortized cost or fair value. In addition, unamortized costs for assets that have been, or are expected to be, abandoned are written off. The unamortized cost of content is approximately $ 1.8 million and $ 2.4 million as of March 31, 2024 and December 31, 2023, re spectively.
Capitalized Software Costs	Capitalized Software Costs The Company capitalizes certain eligible software development costs incurred in connection with its internal use software in accordance with ASC 350-40, Internal-use Software and ASC 985, Software. These capitalized costs also relate to the Company’s Studio software that is accessed by its customers on a membership basis as well as certain costs associated with its information systems. Capitalized software costs are amortized over the estimated useful life is three years. Capitalization begins once the application development stage begins, management has authorized and committed to funding the project, it is probable the project will be completed, and the software will be used to perform the function intended. Internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use. The Company expenses all costs incurred that relate to planning and post-implementation phases of development. Intangible assets are assessed for impairment when events or circumstances indicate the existence of a possible impairment, and none were identified in the quarter ended March 31, 2024. During the three months ended March 31, 2024 and year ended December 31, 2023, the Company capitalized $ 0.0 million and $ 0.4 million, respectively, under ASC 350 included in intangible assets. During the three months ended March 31, 2024 and year ended December 31, 2023, the Company capitalized $ 0.5 million and $ 1.9 million, respectively, under ASC 985 included in other assets. Amortization is computed on a straight-line basis over the following estimated useful lives: Capitalized software and internal-use software  3 years
Music Royalty Fees	Music Royalty Fees The Company recognizes music royalty fees as these fees are incurred in accordance with the terms of the relevant license agreement with the music rights holder. The incurrence of such royalties is primarily driven by the number of paid subscribers each month and it is classified as cost of membership and training within the Company’s statement of operations. The Company’s license agreements with music rights holders generally include provisions for advance royalties as well as minimum guarantees. When a minimum guarantee is paid in advance, the guarantee is recorded as a prepaid asset and amortized over the shorter of the period consumed or the term of the agreement. As of March 31, 2024 and December 31, 2023 there were no music guarantee-related prepaids, respectively.
Fair Value Measurements	Fair Value Measurements Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Subsequent changes in fair value of these financial assets and liabilities are recognized in earnings when they occur. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurement or assumptions that market participants would use in pricing the assets or liabilities, such as inherent risk, transfer restrictions, and credit risk. The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: • Level 1 inputs are based on quoted prices in active markets for identical assets or liabilities. • Level 2 inputs are based on observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3 inputs are based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities, and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The Company’s material financial instruments consist primarily of cash and cash equivalents, accounts payable, accrued expenses, convertible notes, and warrants. The carrying amounts of current financial instruments, which include cash, accounts receivable, accounts payable and accrued expenses, contingent consideration, approximate their fair values due to the short-term nature of these instruments.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset (or asset group) to the future undiscounted cash flows expected to be generated by the assets (or asset group). If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds their fair value.
Leases	Leases The Company adopted the Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842) (“ASU 2016-02” or “ASC 842”) as of January 1, 2022, using the modified retrospective method and utilized the effective date as its date of initial application, with prior periods presented in accordance with previous guidance under Accounting Standards Codification (“ASC”) 840, Leases. At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present in the arrangement. Leases with a term greater than one year are recognized on the balance sheet as right-of-use assets and current and non-current lease liabilities, as applicable.
Bridge Notes	Bridge Notes As permitted under ASC Topic 825, Financial Instruments, we have elected the fair value option to account for our November 2023 Bridge Notes. In accordance with ASC Topic 825, we record these bridge notes at fair value with changes in fair value recorded as a component of other (expense) income, net in the condensed consolidated statement of operations and comprehensive loss. As a result of applying the fair value option, direct costs and fees related to the bridge notes were expensed as incurred and were not deferred. In addition, the bridge notes meet other applicable criteria for electing fair value option under ASC Topic 825. The November 2023 Bridge Notes were converted to Series A Preferred Stock in February 2024 and March 2024. As of March 31, 2024 and December 31, 2023, there were $ 0.0 million and $ 1.7 million, respectively of notes outstanding measured at fair value related to the November 2023 Bridge Notes.
Convertible Notes	Convertible Notes As permitted under ASC Topic 825, Financial Instruments, the Company has elected the fair value option to account for its November 2022 convertible notes. In accordance with ASC Topic 825, the Company records these convertible notes at fair value with changes in fair value recorded as a component of other (expense) income, net in the condensed consolidated statement of operations and comprehensive loss. As a result of applying the fair value option, direct costs and fees related to the convertible notes were expensed as incurred and were not deferred. In addition, the convertible notes meet other applicable criteria for electing fair value option under ASC Topic 825. In May 2023, upon closing of the Company's IPO, the convertible notes were converted into an aggregate of 565,144 shares of common stock. In connection with the Company’s issuance of the December 2023 Convertible Notes (the “December 2023 Notes”), the Company bifurcated the embedded conversion option and redemption rights and recorded embedded conversion option and redemption rights as a short term derivative liability in the Company’s balance sheet in accordance with FASB ASC 815, Derivatives and Hedging. The convertible debt and the derivative liability associated with the December 2023 Notes is presented on the condensed consolidated balance sheet as convertible note payable and the embedded derivatives, respectively. The convertible debt is carried at amortized cost. The derivative liability will be remeasured at each reporting period using the lattice model with changes in fair value recorded in the condensed consolidated statements of operations in other expense (income). See Note 10 for further details. The Company issued Convertible Notes in February 2024 (the “February 2024 Notes”). The convertible debt is presented in on the condensed consolidated balance sheet as convertible note payable. The convertible debt is carried at amortized cost. See Note 10 for further details.
Warrants	Warrants The Company account for common stock warrants as either equity-classified instruments or liability-classified instruments based on an assessment of the warrant terms. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all the requirements for equity classification under ASC 815, including whether the warrants are indexed to our Common Stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance, and, for liability-classified warrants, at each reporting period end date while the warrants are outstanding. The warrants are revalued on each subsequent balance sheet date until such instruments are exercised or expire, with any changes in the fair value between reporting periods recorded in the condensed consolidated statements of operations and comprehensive loss.
Commitments and Contingencies	Commitments and Contingencies Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. If a loss is reasonably possible and the loss or range of loss can be reasonably estimated, the Company discloses the possible loss or states that such an estimate cannot be made.
Revenue Recognition	Revenue Recognition On January 1, 2020, the Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASC 606”) and all subsequent amendments. As the Company had not recognized any revenue prior to the adoption of the new standard, there was no impact on the measurement or timing of revenue recognition as a result of the adoption. Revenue is recognized when control of the promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Refer to Note 3 for additional information.
Cost of Fitness Product Revenue	Cost of Fitness Product Revenue Cost of fitness product revenue relates to the Fitness Product costs, including manufacturing costs, duties and other applicable importing costs, shipping and handling costs, packaging, warranty replacement costs, fulfillment costs, warehousing costs, and certain allocated costs related to management, facilities, and personnel-related expenses associated with supply chain logistics. Cost of fitness product revenue also contains valuation losses related to the Company’s inventory lower of cost or market reserve.
Cost of Membership and Training	Cost of Membership and Training Membership costs include costs associated with the creation of content and training, including associated payroll, filming and production costs, other content specific costs, hosting fees, music royalties, amortization of capitalized software development costs, and warranty replacement and servicing costs associated with extended warranty contracts.
Advertising Costs	Advertising Costs Advertising and other promotional costs to market the Company’s products are expensed as incurred. Advertising expenses were $ 0.02 million and $ 0.2 million for the three months ended March 31, 2024 and 2023, respectively, and are included within sales and marketing expenses in the condensed consolidated statements of operations and comprehensive loss.
Research and Development Costs	Research and Development Costs Research and development expenses consist primarily of personnel- and facilities-related expenses, consulting and contractor expenses, tooling and prototype materials software platform expenses, and depreciation of property and equipment. Substantially all of the Company’s research and development expenses are related to developing new products and services and improving existing products and services. Research and development expenses are expensed as incurred.
Stock-Based Compensation	Stock-Based Compensation In December 2020, the Board of Directors adopted the 2020 Equity Incentive Plan (“the 2020 Plan”) and in April 2023, our board of directors adopted the 2023 Equity Incentive Plan (the “2023 Plan”). Stock-based awards are measured at the grant date based on the fair value of the award and are recognized as expense, net of actual forfeitures, on a straight-line basis over the requisite service period, which is generally the vesting period of the respective award. The Company estimates the fair value of stock options using the Black-Scholes option pricing model. The determination of the grant date fair value of stock awards issued is affected by a number of variables, including the fair value of the Company’s common stock, the expected common stock price volatility over the expected life of the awards, the expected term of the stock option, risk-free interest rates, and the expected dividend yield of the Company’s common stock. The Company derives its volatility from the average historical stock volatilities of several peer public companies over a period equivalent to the expected term of the awards. The Company estimates the expected term based on the simplified method for employee stock options considered to be “plain vanilla” options, as the Company’s historical share option exercise experience does not provide a reasonable basis upon which to estimate the expected term. The risk-free interest rate is based on the United States Treasury yield curve in effect at the time of grant. Expected dividend yield is 0.0 % as the Company has not paid and does not currently anticipate paying dividends on its common stock. Stock-based compensation expense is classified in the accompanying condensed consolidated statement of operations in the same manner in which the award recipient’s payroll costs are classified or in which the award recipient’s service payments are classified.
Foreign Currency Transactions	Foreign Currency Transactions The functional currency for the Company’s wholly-owned foreign subsidiaries, Interactive Strength UK and Interactive Strength Taiwan, is the United States dollar. All foreign currency transaction gains and losses are recognized in the condensed consolidated statements of operations and comprehensive loss through other income (expense). The Company recognized material currency transaction gains or losses during the three months ended March 31, 2024 and 2023.
Comprehensive Loss	Comprehensive Loss Comprehensive loss includes net loss as well as other changes in stockholders’ deficit that result from transactions and economic events other than those with stockholders. For the three months ended March 31, 2024 and 2023, comprehensive loss included $ 0.04 million of foreign currency transaction gains and $ 0.1 million of foreign currency transaction loses, respectively.
Loss Per Share	Loss Per Share The Company computes loss per share using the two-class method required for participating securities. The two-class method requires income available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The Company’s redeemable convertible preferred stock and common stock issued upon early exercise of stock options are participating securities. The Company considers any shares issued upon early exercise of stock options, subject to repurchase, to be participating securities because holders of such shares have non-forfeitable dividend rights in the event a cash dividend is declared on common stock. These participating securities do not contractually require the holders of such shares to participate in the Company’s losses. As such, net losses for the periods presented were not allocated to the Company’s participating securities. Basic loss per share is computed using the weighted-average number of outstanding shares of common stock during the period. Diluted earnings loss per share is computed using the weighted-average number of outstanding shares of common stock and, when dilutive, potential shares of common stock outstanding during the period. Potential shares of common stock consist of incremental shares issuable upon the assumed exercise of stock options, employee stock purchase plan (“ESPP”) shares to be issued, and vesting of restricted stock awards.
Income Taxes	Income Taxes The Company utilizes the asset and liability method for computing its income tax provision. Deferred tax assets and liabilities reflect the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities as well as operating loss, capital loss, and tax credit carryforwards, using enacted tax rates. Management makes estimates, assumptions, and judgments to determine the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against deferred tax assets. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent the Company believes recovery is not likely, establishes a valuation allowance. The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Interest and penalties related to unrecognized tax benefits, which to date have not been material, are recognized within income tax expense.
Goodwill and Intangible Assets with Indefinite Lives	Goodwill and Intangible Assets with Indefinite Lives Goodwill consists of the excess of cost over the fair value of net assets acquired in business combinations. The Company follows the provisions of ASC Topic 350, “Intangibles —Goodwill and Other”, which requires an annual impairment test for goodwill and intangible assets with indefinite lives. The Company may first choose to perform a qualitative evaluation of the likelihood of goodwill and intangible assets impairment. For the goodwill that was the result of current year acquisitions, the Company chose to perform a qualitative evaluation. If the Company determined a quantitative evaluation was necessary, the goodwill at the reporting unit was subject to a two-step impairment test. The first step compares the book value of a reporting unit, including goodwill, with its fair value. If the book value of a reporting unit exceeds its fair value, the Company completes the second step in order to determine the amount of goodwill impairment loss that should be recorded. In the second step, the Company determines an implied fair value of the reporting unit’s goodwill by allocating the fair value of the reporting unit to all of the assets and liabilities other than goodwill. For the periods presented, the Company did not recognize any goodwill impairment as the estimated fair value of its reporting units with goodwill exceeded the book value of these reporting units. For additional information refer to Note 6—Goodwill and Intangible Assets. The Company estimates the fair value of intangible assets based on an income approach using the relief-from-royalty method. This methodology assumes that, in lieu of ownership, a third party would be willing to pay a royalty in order to exploit the related benefits of these types of assets. This approach is dependent on a number of factors, including estimates of future growth and trends, royalty rates for this category of intellectual property, discount rates and other variables. The Company bases its fair value estimates on assumptions it believes to be reasonable, but which are unpredictable and inherently uncertain. Actual future results may differ from those estimates. The Company recognizes an impairment loss when the estimated fair value of the intangible asset is less than the carrying value. For the periods presented, the Company did not recognize any impairment of intangible assets with indefinite lives as the estimated fair value of its intangible assets with indefinite lives exceeded the book value of these reporting units. Identifiable Intangible Assets The Company follows the provisions of ASC Topic 360, “Property, Plant and Equipment”, which establishes accounting standards for the impairment of long-lived assets such as property, plant and equipment and intangible assets subject to amortization. The Company reviews long-lived assets to be held and-used for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. If the sum of the undiscounted expected future cash flows over the remaining useful life of a long-lived asset group is less than its carrying amount, the asset is considered to be impaired. Impairment losses are measured as the amount by which the carrying amount of the asset group exceeds the fair value of the asset. The Company estimates fair value using the expected future cash flows discounted at a rate commensurate with the risks associated with the recovery of the asset. During the three months ended March 31, 2024 and 2023, there was no impairment of the identified intangible assets. The Company’s intangible assets subject to amortization consist of developed technology, customer related intangibles, trademark and tradenames, and content that are amortized on a straight-line basis over the estimated useful lives of the related intangible asset. The estimated useful lives of the respective intangible assets range from 3 years to 13 years.
Business Combinations	Business Combinations The Company accounts for business combinations under the provisions of ASC 805, Business Combinations, which requires that the acquisition method of accounting be used for all business combinations. Assets acquired and liabilities assumed are recorded at the date of acquisition at their respective fair values. ASC 805 also specifies criteria that intangible assets acquired in a business combination must be recognized and reported apart from goodwill. Goodwill represents the excess purchase price over the fair value of the tangible net assets and intangible assets acquired in a business combination. Acquisition-related expenses are recognized separately from the business combinations and are expensed as incurred. If the business combination provides for contingent consideration, the Company records the contingent consideration at fair value at the acquisition date with changes in the fair value recorded through earnings.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”), or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company’s condensed consolidated financial statements upon adoption. The Company qualifies as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) and has elected not to “opt out” of the extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company will adopt the new or revised standard at the time public companies adopt the new or revised standard and will do so until such time that the Company either (i) irrevocably elects to “opt out” of such extended transition period or (ii) no longer qualifies as an emerging growth company. As noted below, certain new or revised accounting standards were early adopted. Accounting Pronouncements Not Yet Adopted ASU 2020-04 and ASU 2022-06 In March 2020, the FASB issued ASU 2020-04, “Reference rate reform (Topic 848): Facilitation of the effects of reference rate reform on financial reporting.” The ASU provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions affected by reference rate reform. The amendments apply only to contracts and hedging relationships that reference London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued due to reference rate reform. The amendments are elective and are effective upon issuance. In December 2022, the FASB issued ASU 2022-06, “Reference rate reform (Topic 848): Deferral of the sunset date of Topic 848” which defers the expiration date for Topic 848 from December 31, 2022 until December 31, 2024. The Company is currently evaluating the potential impact of adopting this new accounting guidance, but does not expect the adoption of the standard to have a material impact on its consolidated financial statements. ASU 2023-09 In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” The ASU modifies income tax disclosures by requiring (i) consistent categories and greater disaggregation of information in the rate reconciliations and (ii) the disclosure of income taxes paid disaggregated by jurisdiction, among other requirements. This ASU is effective for fiscal years beginning after December 31, 2024 and should be applied on a prospective basis, with the option to apply the standard retrospectively. Early adoption is permitted. We are currently evaluating the impact of the new standard, which is limited to financial statement disclosures. ASU 2023-07d In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” The amendments in the ASU improve reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. In addition, the amendments enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit and loss, and provide new segment disclosure requirements for entities with a single reportable segment, among other disclosure requirements. This ASU is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years after December 15, 2024 and should be applied retrospectively to all prior periods presented in the financial statements. Early adoption is permitted. We are currently evaluating the impact of the new standard, which is limited to financial statement disclosures.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Schedule of Property, Plant and Equipment	Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives: Pre-production tooling 2 – 5 years Machinery and equipment 2 – 10 years Furniture and fixtures 3 – 5 years Leasehold improvements Lesser of lease term or estimated useful life
Schedule of Amotization Computed on a Straight-line Basis	Amortization is computed on a straight-line basis over the following estimated useful lives: Capitalized software and internal-use software  3 years

Inventories, Net (Tables)

Inventories, Net (Tables)	3 Months Ended
	Mar. 31, 2024
Inventory Disclosure [Abstract]
Schedule of Inventories	Inventories consist of the following: March 31, December 31, (in thousands) 2024 2023 Finished products $ 6,074 $ 2,607 Finished products - Long Term 2,319 2,376 Raw materials - Long Term 578 532 Total inventories, net $ 8,971 $ 5,515

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	3 Months Ended
	Mar. 31, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Property and equipment consisted of the following: March 31, December 31, (in thousands) 2024 2023 Pre-production tooling $ 3,094 $ 3,094 Machinery and equipment 191 125 Leasehold improvements 186 113 Furniture and fixtures 25 25 Software and technology development asset 13 13 Total 3,509 3,370 Less: Accumulated depreciation ( 3,117 ) ( 2,926 ) Total property and equipment, net $ 392 $ 444

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Net (Tables)	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Identifiable Intangible Assets, Net	Identifiable intangible assets, net consist of the following: As of March 31, As of December 31, 2024 2023 (in thousands) Cost Accumulated Amortization Net Book Value Cost Accumulated Amortization Net Book Value Internal-Use Software $ 6,248 $ ( 4,515 ) $ 1,733 $ 6,248 $ ( 3,994 ) $ 2,254 Developed Technology 1,500 ( 41 ) 1,459 — — — Customer related 4,400 ( 78 ) 4,322 — — — Trademark and trade name 800 ( 15 ) 785 — — — Content 200 ( 11 ) 189 — — — Total identifiable intangible assets $ 13,148 $ ( 4,660 ) $ 8,488 $ 6,248 $ ( 3,994 ) $ 2,254
Schedule of Estimated Annual Amortization Expense	As of March 31, 2024, estimated annual amortization expense for each of the next five fiscal years is as follows: Fiscal Years Ending December 31, (in thousands) 2024 (remaining) 1,785 2025 1,389 2026 815 2027 648 2028 582 Thereafter 3,269 Total $ 8,488

Prepaid Expenses and Other Cu_2

Prepaid Expenses and Other Current Assets (Tables)	3 Months Ended
	Mar. 31, 2024
Prepaid Expenses and Other Current Assets Disclosure [Abstract]
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following: March 31, December 31, (in thousands) 2024 2023 Security deposit 96 66 Prepaid licenses 7 20 Research and development tax credit 516 516 Other receivables 20 20 Insurance 99 246 Other prepaid 60 65 Total prepaid expenses and other current assets $ 798 $ 933

Other Assets, Net (Tables)

Other Assets, Net (Tables)	3 Months Ended
	Mar. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Other Assets	Other assets consisted of the following: As of March 31, As of December 31, 2024 2023 (in thousands) Cost Accumulated Amortization Net Book Value Cost Accumulated Amortization Net Book Value Capitalized content costs $ 6,589 $ ( 4,753 ) $ 1,836 $ 6,589 $ ( 4,237 ) $ 2,352 Capitalized software $ 6,362 $ ( 3,472 ) $ 2,890 $ 5,879 $ ( 2,983 ) $ 2,896 Total other assets $ 12,951 $ ( 8,225 ) $ 4,726 $ 12,468 $ ( 7,220 ) $ 5,248

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	3 Months Ended
	Mar. 31, 2024
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses consisted of the following: March 31, December 31, (in thousands) 2024 2023 Accrued bonus $ 330 $ 25 Accrued payroll 124 26 Accrued PTO 21 21 Accrued legal settlement 2,250 — Accrued earn out 1,300 — Accrued royalties 211 208 Accrued professional fees 729 235 Customer deposits 375 46 Other accrued expenses and current liabilities 307 345 Total accrued expenses and other current liabilities $ 5,647 $ 906

Loss Per Share (Tables)

Loss Per Share (Tables)	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Schedule of Loss Per Share	The computation of loss per share is as follows: Three months ended March 31, 2024 2023 (in thousands, except share and per share amounts) (in thousands, Numerator: Net loss $ ( 11,394 ) $ ( 15,961 ) Net loss attributable to common stockholders $ ( 11,394 ) $ ( 15,961 ) Denominator: Weighted average common stock outstanding - 16,994,445 7,653,940 Net loss per share attributable to common $ ( 0.67 ) $ ( 2.09 )
Schedule of Potentially Dilutive Shares	The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive: March 31, 2024 2023 Warrants to purchase series Class A common stock (as — 92,296 Warrants to purchase series Class B common stock (as — 5,753 Warrants to purchase common stock 5,854,035 — Stock options to purchase common stock 3,411,732 1,784,263 Total 9,265,767 1,882,312

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2024
Debt Instrument [Line Items]
Summary of Debt	Debt consisted of the following: March 31, December 31, (in thousands) 2024 2023 Principal stockholder promissory notes $ 4,975 $ 5,085 Other related party promissory notes — 721 Term Loan 9,770 — Total Loan Payable 14,745 5,806 June 2023 notes — 1,379 November bridge notes — $ 1,717 Total Senior secured notes $ — $ 3,096 Embedded derivatives $ 68 $ 122 December 2023 convertible note 251 904 Other related party convertible notes 174 — Other convertible notes 706 — February 2024 convertible note 3,170 — Total Convertible note payable $ 4,301 $ 904 Total debt current $ 19,114 $ 9,928
Term Loan [Member]
Debt Instrument [Line Items]
Summary of Carrying Value of Convertible Note	The carrying value of the Term Loan is as follows: March 31, December 31, (in thousands) 2024 2023 Principal and interest $ 8,021 $ — Guarantee fees 2,348 — Unamortized debt discount ( 599 ) — Aggregate carrying value $ 9,770 $ —
Summary of Interest Expense On Convertible Note	Interest expense recognized on the Term Loan is as follows: March 31, March 31, (in thousands) 2024 2023 Contractual interest expense $ 58 $ — Amortization of debt discount 339 — Total $ 397 $ —
Convertible Notes [Member]
Debt Instrument [Line Items]
Summary of change in the balance of the Debt Instrument	The change in the balance of the Promissory notes as converted to convertible notes is as follows: August 2023 October 2023 November 2023 (in thousands) Promissory Notes Promissory Notes Promissory Notes Total Carrying value at December 31, 2023 $ — $ — $ — $ — Promissory notes assumed in connection with acquisition of CLMBR, Inc. 725 471 691 1,887 Loss on extinguishment of debt 239 155 — 394 Interest Expense — — 15 15 Conversion to Series A Preferred Stock ( 964 ) ( 626 ) — ( 1,590 ) Carrying value at March 31, 2024 $ — $ — $ 706 $ 706
Senior Secured Notes [Member]
Debt Instrument [Line Items]
Summary of change in the balance of the Debt Instrument	The change in the balance of the Senior Secured Notes is as follows: November 10, 2023 June 6, 2023 (in thousands) Bridge Notes Notes Total Carrying value at December 31, 2023 $ 1,717 $ 1,379 $ 3,096 Loss on extinguishment of debt 275 462 737 Change in estimated fair value of convertible notes 316 - 316 Interest Expense — 21 21 Conversion to Series A Preferred Stock ( 2,308 ) ( 1,862 ) ( 4,170 ) Carrying value at March 31, 2024 $ - $ - $ -
Summary of Carrying Value of Convertible Note	The carrying value of the Senior Secured Notes is as follows: March 31, December 31, (in thousands) 2024 2023 June 2023 $ — $ 1,379 November 2023 — 1,717 Aggregate carrying value $ — $ 3,096
December 2023 Convertible Notes [Member]
Debt Instrument [Line Items]
Summary of Carrying Value of Convertible Note	The carrying value of the December 2023 Note is as follows: March 31, December 31, (in thousands) 2024 2023 Principal and interest $ 1,251 $ 2,169 Unamortized debt discount ( 589 ) ( 801 ) Unamortized issuance costs ( 410 ) ( 464 ) Embedded derivative liability 68 122 Aggregate carrying value $ 320 $ 1,026
Summary of Interest Expense On Convertible Note	Interest expense recognized on the December 2023 Note is as follows: March 31, March 31, (in thousands) 2024 2023 Contractual interest expense $ 38 $ — Amortization of debt discount 211 — Amortization of debt issuance costs 122 — Total $ 371 $ —
February 2024 convertible note [Member]
Debt Instrument [Line Items]
Summary of Carrying Value of Convertible Note	The carrying value of the February 2024 Convertible Note is as follows: March 31, December 31, (in thousands) 2024 2023 Principal and interest $ 6,051 $ — Unamortized debt discount ( 1,912 ) — Unamortized issuance costs ( 969 ) — Aggregate carrying value $ 3,170 $ —
Summary of Interest Expense On Convertible Note	Interest expense recognized on the February 2024 Convertible Note is as follows: March 31, March 31, (in thousands) 2024 2023 Contractual interest expense $ 240 $ — Amortization of debt discount 436 — Amortization of debt issuance costs 221 — Total $ 897 $ —

Warrants (Tables)

Warrants (Tables)	3 Months Ended
	Mar. 31, 2024
Class of Warrant or Right [Line Items]
Schedule of Changes in Warrants Issued and Outstanding	The following is a schedule of changes in warrants issued and outstanding from December 31, 2023 to March 31, 2024: Common Common Common Total Common Stock Warrants Outstanding as of December 31, 2023 924,480 — — 924,480 Warrants issued 1,129,555 3,000,000 800,000 4,929,555 Warrants exercised — — — — Outstanding as of March 31, 2024 2,054,035 3,000,000 800,000 5,854,035
Warrants [Member]
Class of Warrant or Right [Line Items]
Schedule of Changes in Warrants Issued and Outstanding	The following is a schedule of changes in warrants issued and outstanding from December 31, 2022 to March 31, 2023: Class A Common Class B Common Total Warrants Outstanding as of December 31, 2022 92,296 5,753 98,049 Warrants issued — — — Warrants exercised — — — Outstanding as of March 31, 2023 92,296 5,753 98,049

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value of Liabilities Measured on Recurring Basis	Liabilities measured at fair value on a recurring basis as of March 31,2024 December 31, 2023 were as follows: Fair value measurements as of March 31, 2024 Level 1 Level 2 Level 3 Total (in thousands) Liabilities Embedded derivatives $ — $ — $ 68 $ 68 Accrued earn out — — 1,300 1,300 Warrants — — 937 937 Total $ — $ — $ 2,305 $ 2,305 Fair value measurements as of December 31, 2023 Level 1 Level 2 Level 3 Total (in thousands) Liabilities Embedded derivatives $ — $ — $ 122 $ 122 Bridge Notes — — 1,717 1,717 Warrants — — 591 591 Total $ — $ — $ 2,430 $ 2,430
Schedule of Fair Value Measurement of Liabilities Using Unobservable Inputs Reconciliation	The following tables summarize the activity for the Company Level 3 liabilities measured at fair value on a recurring basis for the three months ended March 31, 2024 : (in thousands) Derivatives Fair value at December 31, 2023 $ 122 Issuance of derivatives — Change in estimated fair value of financial instruments ( 54 ) Fair value at March 31, 2024 $ 68 November 10, 2023 (in thousands) Bridge Notes Fair value at December 31, 2023 $ 1,717 Loss on extinguishment of debt 275 Change in estimated fair value of convertible notes 316 Conversion to Series A Preferred Stock ( 2,308 ) Fair value at March 31, 2024 $ — November 10, 2023 December 7, 2023 Treadway Woodway Total (in thousands) Warrants Warrants Warrants Warrants Warrants Fair value at December 31, 2023 $ 165 $ 426 $ — $ — $ 591 Issuance of warrants — — 1,800 345 2,145 Change in estimated fair value of financial instruments ( 124 ) ( 179 ) ( 1,245 ) ( 251 ) ( 1,799 ) Exercise of stock warrants — — — — — Fair value at March 31, 2024 $ 41 $ 247 $ 555 $ 94 $ 937 (in thousands) Convertible Notes Fair value at December 31, 2022 $ 4,270 Issuance of convertible notes — Change in estimated fair value of financial instruments 80 Fair value at March 31, 2023 $ 4,350 November 13, 2022 (in thousands) Warrants Fair value at December 31, 2022 $ 3,004 Issuance of warrants — Change in estimated fair value of financial instruments ( 2,410 ) Fair value at March 31, 2023 $ 594

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Schedule of Future Minimum Rental Payments under Operating Leases	The following represents the Company’s minimum annual rental payments under operating leases for each of the next five years and thereafter: Fiscal Year Ending December 31, Operating (in thousands) 2024 (remaining) 270 2025 282 2026 78 2027 78 2028 33 Thereafter — Total future minimum lease payments 742 Less: imputed interest ( 72 ) Present value of operating lease liability $ 670 Less: current portion of lease liability 322 Non-current portion of lease liability 348 Present value of operating lease liability $ 670

Equity-Based Compensation (Tabl

Equity-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Summary of Compensation Cost Recognized	Presented below is a summary of the compensation cost recognized in the condensed consolidated statements of operations and comprehensive (loss ) for the three months ended March 31, 2024 and 2023. Three Months Ended March 31, 2024 2023 (in thousands) Research and development $ 1,231 $ 2,131 Sales and marketing 75 222 General and administrative 2,060 12,286 Total stock-based compensation expense $ 3,366 $ 14,639
Summary of Stock Option Activity	The following summary sets forth the stock option activity under the 2023 and 2020 Plan: Number of options Weighted average exercise price Weighted average remaining contractual term (in years) Aggregate intrinsic value (in thousands) Outstanding as of December 31, 2023 3,417,932 $ 2.53 9.3 $ 547 Granted — — Exercised — — Cancelled or forfeited ( 6,200 ) 0.51 Outstanding as of March 31, 2024 3,411,732 $ 2.53 9.0 $ — Options exercisable as of March 31, 2024 1,139,304 $ 1.64 8.8 $ — Options unvested as of March 31,2024 2,463,196 $ 3.16 9.1 $ —
Summary of Unvested Common Stock	A summary of unvested common stock from early option exercises that are subject to repurchase by the Company under the 2020 Plan is as follows: Early Option Exercises Number of options Weighted average exercise price Repurchase liability (in thousands) Unvested common stock as of December 31, 2023 13,720 $ — $ 8 Issued — — — Vested ( 3,272 ) — — Repurchased — — — Unvested common stock as of March 31, 2024 10,448 $ 8
Summary of Stock Option Valuation Assumptions	The fair value of each option was estimated at the grant date using the Black-Scholes method with the following assumptions: March 31, March 31, 2024 2023 Weighted-average risk-free interest rate (1) — % 3.6 % Weighted-average expected term (in years) — 6.03 Weighted-average expected volatility (2) — % 57.9 % Expected dividend yield — % — % (1) Based on U.S. Treasury seven-year constant maturity interest rate whose term is consistent with the expected term of the option. (2) Expected volatility is based on an analysis of comparable public company volatilities and adjusted for the Company’s stage of development.

Related Party Transactions (Tab

Related Party Transactions (Tables)	3 Months Ended
	Mar. 31, 2024
Related Party Transactions [Abstract]
Schedule of Loan Payable	Loan payable consisted of the following as of March 31, 2024 and December 31, 2023: March 31, December 31, (in thousands) 2024 2023 Principal stockholder promissory notes 4,975 5,085 Other related party promissory notes - 721 Total Loan Payable $ 4,975 $ 5,806

Acquisition (Tables)

Acquisition (Tables)	3 Months Ended
	Mar. 31, 2024
Business Combinations [Abstract]
Schedule of Consideration Transferred and Recognized Amounts of Identifiable Assets Acquired and Liabilities Assumed	The following table outlines the Company’s consideration transferred and the identifiable net assets acquired at their estimated fair value as of February 2024. Consideration (in thousands) Cash Paid to Seller 30 Common stock issued 1,015 Series B preferred stock issued 2,688 Payoff of Vertical debt (plus accrued interest) 1,447 Retirement of Vertical Debt (including fees) 9,379 Fair value of earn-out consideration 1,300 . 15,859 Acquisition related costs (including in general and administrative in the condensed consolidated statement of operations and comprehensive loss) 764 Recognized amounts of identifiable assets acquired and liabilities assumed Cash 50 Accounts receivable, net of allowances 134 Inventories, net 3,490 Vendor deposits 61 Prepaid expenses and other current assets 63 Property and equipment, net 139 Right-of-use-assets 412 Intangible assets, net 6,900 Other assets 30 Accounts payable ( 3,557 ) Accrued expenses and other current liabilities ( 2,438 ) Operating lease liability, current portion ( 263 ) Deferred revenue ( 261 ) Loan payable ( 1,887 ) Operating lease liability, net of current portion ( 179 ) Total identifiable net assets 2,694 Goodwill 13,165 $ 15,859 Acquisition-related costs of $ 0.8 million were included in general and administrative expenses in the Company's statement of operations for the three months ended March 31, 2024. Compensation Arrangements In connection with the acquisition CLMBR, Inc. the Company has agreed to pay additional consideration in future periods. Certain employees of CLMBR, Inc. will be paid a total of $ 0.5 million of which $ 0.5 million will be paid in 2024. These payments are accounted for as transactions separate from the business combination as the payments are contingent upon continued employment and will be recorded as post-combination compensation expense in the Company's financial statements during the service period in general and administrative expenses for the three months ended March 31, 2024. Accrued Earn Out As part of the Acquisition of CLMBR, Inc. the Sellers shall be entitled to receive a contingent payment in the form of shares of the Company’s common stock (collectively, the “Earn-Out Shares”) calculated in the manner set forth in the Asset Purchase Agreement based on the 2024 Unit Sales (as defined in the Asset Purchase Agreement) and the volume-weighted average price (“VWAP”) for the Company’s common stock based on the 10 consecutive trading days ending on (and including) December 31, 2024, subject to the VWAP Collar. In addition, in the event the 2024 Unit Sales include at least 2,400 Units sold in the business-to-business channel, the Sellers shall be entitled to an additional number of Earn-Out Shares calculated in the manner set forth in the Asset Purchase Agreement subject to total maximum number of 22,665,681 Earn-Out Shares. The fair value of the contingent payment was $ 1.3 million as of March 31, 2024. The following unaudited pro forma condensed consolidated results of operations for the three months ended March 31, 2024 and 2023 present condensed consolidated information of the Company as if the CLMBR, Inc. acquisition had occurred as of January 1, 2023 (in thousands): Proforma Three Months Ended March 31, 2024 2023 (in thousands) Revenue $ 473 $ 1,187 Operating Loss ( 9,633 ) ( 22,632 ) Net Loss ( 11,608 ) ( 17,763 ) Net loss per share – basic and diluted $ ( 0.68 ) $ ( 1.81 ) The unaudited pro forma consolidated results for the three month periods were prepared using the acquisition method of accounting and are based on the historical financial information of CLMBR, Inc. and the Company. The unaudited pro forma consolidated results incorporate historical financial information for all significant acquisitions pursuant to SEC regulations since January 1, 2023. The historical financial information has been adjusted to give effect to pro forma adjustments that are: (i) directly attributable to the acquisition, (ii) factually supportable and (iii) expected to have a continuing impact on the combined results. The unaudited pro forma consolidated results are not necessarily indicative of what the Company’s consolidated results of operations actually would have been had it completed these acquisitions on January 1, 2023. The following unaudited condensed consolidated results of operations included in the condensed consolidated statements of loss for the three months ended March 31, 2024. Three Months Ended March 31, 2024 Revenue $ 267 Operating Loss ( 173 ) Net Loss ( 279 )
Schedule of Unaudited Financial Information	The following unaudited pro forma condensed consolidated results of operations for the three months ended March 31, 2024 and 2023 present condensed consolidated information of the Company as if the CLMBR, Inc. acquisition had occurred as of January 1, 2023 (in thousands): Proforma Three Months Ended March 31, 2024 2023 (in thousands) Revenue $ 473 $ 1,187 Operating Loss ( 9,633 ) ( 22,632 ) Net Loss ( 11,608 ) ( 17,763 ) Net loss per share – basic and diluted $ ( 0.68 ) $ ( 1.81 ) The unaudited pro forma consolidated results for the three month periods were prepared using the acquisition method of accounting and are based on the historical financial information of CLMBR, Inc. and the Company. The unaudited pro forma consolidated results incorporate historical financial information for all significant acquisitions pursuant to SEC regulations since January 1, 2023. The historical financial information has been adjusted to give effect to pro forma adjustments that are: (i) directly attributable to the acquisition, (ii) factually supportable and (iii) expected to have a continuing impact on the combined results. The unaudited pro forma consolidated results are not necessarily indicative of what the Company’s consolidated results of operations actually would have been had it completed these acquisitions on January 1, 2023. The following unaudited condensed consolidated results of operations included in the condensed consolidated statements of loss for the three months ended March 31, 2024. Three Months Ended March 31, 2024 Revenue $ 267 Operating Loss ( 173 ) Net Loss ( 279 )

Description of Business and B_2

Description of Business and Basis of Presentation - Additional Information (Details) - USD ($)						1 Months Ended	3 Months Ended
	May 17, 2024	Apr. 24, 2024	Mar. 29, 2024	Feb. 02, 2024	May 31, 2023	May 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Jan. 26, 2024	Dec. 31, 2023
Subsidiary, Sale of Stock [Line Items]
Loss from operations							$ 9,441,000	$ 21,211,000
Net cash used in operating activities							(2,959,000)	$ (4,738,000)
Accumulated deficit							178,305,000			$ 166,911,000
Cash and cash equivalents							$ 0			$ 0
Common stock, par value							$ 0.0001			$ 0.0001
Common stock, shares Issued							19,433,801			14,192,083
Issuance of shares upon conversion, value							$ 866,000
Related fees							800,000
Series A Convertible Preferred Stock | Subsequent Event [Member]
Subsidiary, Sale of Stock [Line Items]
Debt instrument aggregate outstanding amount	$ 1,200,000
Issuance of common stock upon conversion, shares	1,153,981
Amended Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock				1,500,000
Purchase price of asset acquisition				$ 15,900,000
Contingent consideration				1,300,000
Retirement of senior debt				9,400,000
Related fees				1,400,000
Cash payment of retirement of senior debt				1,400,000
Issuance of promissory note				$ 8,000,000
Amended Agreement [Member] | Series B Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock upon conversion, shares				1,428,922
Issuance of shares upon conversion, value				$ 2,700,000
Amended Agreement [Member] | Cash [Member]
Subsidiary, Sale of Stock [Line Items]
Purchase price of asset acquisition				30,000
ASU 205-40 [Member]
Subsidiary, Sale of Stock [Line Items]
Loss from operations							9,400
Net cash used in operating activities							2,900,000
Accumulated deficit							178,300,000
Cash and cash equivalents							0
Total outstanding debt, current							19,100,000
Loans outstanding from relate parties							4,900,000
Debt instrument aggregate outstanding amount							$ 16,100,000
ASU 205-40 [Member] | Loan Modification Agreement [Member] | Subsequent Event [Member]
Subsidiary, Sale of Stock [Line Items]
Increasing stockholders deficit		$ 3,000,000
Maturity date		Dec. 31, 2024
ASU 205-40 [Member] | Series A Convertible Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock upon conversion, shares			1,500,000
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock, par value							$ 0.0001			$ 0.0001
Common stock, shares Issued							19,433,801			14,192,083
Issuance of common stock								8,676,924
Issuance of common stock upon conversion, shares							1,485,943
Issuance of shares upon conversion, value							$ 0
Common Stock [Member] | Amended Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Purchase price of asset acquisition				$ 1,000,000
Common Stock [Member] | ASU 205-40 [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock, par value									$ 0.0001
Common Stock [Member] | Minimum [Member] | ASU 205-40 [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock, par value									$ 1
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock, shares Issued					1,500,000	1,500,000
Share issue price					$ 8	$ 8
Investment Banking, Advisory, Brokerage, and Underwriting Fees and Commissions						$ 1,200,000
Dividends, common stock						$ 4,600,000
Dividends, common stock, total					$ 6,200,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		12 Months Ended
	May 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
General Partners' Offering Costs		$ 4,600
Unamortized cost of content		1,800		$ 2,400
Intangible assets impairment		0	$ 0
Advertising Expenses		$ 20	$ 200
Expected dividend yield		0%	0%
Foreign currency translation loss		$ 39	$ (115)
Notes outstanding		$ 4,975		5,806
Maximum [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Estimated useful lives of intangible assets		13 years
Minimum [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Estimated useful lives of intangible assets		3 years
November Bridge Notes [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Notes outstanding		$ 0		1,700
Intangible Assets [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Capitalized software		0		400
Other Assets [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Capitalized software		$ 500		$ 1,900
IPO [Member] | Convertible Notes Payable [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Issuance of common stock upon conversion, shares	565,144

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Schedule of Property, Plant and Equipment (Details)	Mar. 31, 2024
Pre - Production Tooling [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, estimated useful lives	5 years
Pre - Production Tooling [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, estimated useful lives	2 years
Machinery and Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, estimated useful lives	10 years
Machinery and Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, estimated useful lives	2 years
Furniture and Fixtures [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, estimated useful lives	5 years
Furniture and Fixtures [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, estimated useful lives	3 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]	Property, Plant and Equipment, Net

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Schedule of Amortization Computed on a Straight-line Basis (Details)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Capitalized software and internal-use software	3 years

Revenue Recognition - Additiona

Revenue Recognition - Additional Information (Details)	3 Months Ended
	Mar. 31, 2024
Maximum [Member]
Disaggregation of Revenue [Line Items]
Extended product warranty period	48 months
Minimum [Member]
Disaggregation of Revenue [Line Items]
Extended product warranty period	24 months

Inventories, Net - Schedule of

Inventories, Net - Schedule of Inventories (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Feb. 02, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Finished goods	$ 6,074		$ 2,607
Finished products - Long Term	2,319		2,376
Raw materials - Long Term	578		532
Total inventories, net	$ 8,971	$ 3,500	$ 5,515

Inventories, Net - Additional I

Inventories, Net - Additional Information (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Feb. 02, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Inventory, Net	$ 8,971	$ 3,500	$ 5,515

Property and Equipment, Net - S

Property and Equipment, Net - Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Pre-production tooling	$ 3,094	$ 3,094
Machinery and equipment	191	125
Leasehold improvements	186	113
Furniture and fixtures	25	25
Software and technology development asset	13	13
Property, Plant and Equipment, Gross, Total	3,509	3,370
Less: Accumulated depreciation	(3,117)	(2,926)
Total property and equipment, net	$ 392	$ 444

Property and Equipment, Net - A

Property and Equipment, Net - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 0.2	$ 0.3

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets, Net - Schedule of Identifiable Intangible Assets, Net (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Cost	$ 13,148	$ 6,248
Accumulated Amortization	(4,660)	(3,994)
Total	8,488	2,254
Internal-Use Software
Finite-Lived Intangible Assets [Line Items]
Cost	6,248	6,248
Accumulated Amortization	(4,515)	(3,994)
Total	1,733	2,254
Developed Technology
Finite-Lived Intangible Assets [Line Items]
Cost	1,500	0
Accumulated Amortization	(41)	0
Total	1,459	0
Customer Related
Finite-Lived Intangible Assets [Line Items]
Cost	4,400	0
Accumulated Amortization	(78)	0
Total	4,322	0
Trademark and Trade Name
Finite-Lived Intangible Assets [Line Items]
Cost	800	0
Accumulated Amortization	(15)	0
Total	785	0
Content
Finite-Lived Intangible Assets [Line Items]
Cost	200	0
Accumulated Amortization	(11)	0
Total	$ 189	$ 0

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets, Net - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Feb. 02, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 1,697	$ 1,323
Goodwill	13,231		$ 13,200	$ 0
Intangible assets, net	8,488		$ 6,900	$ 2,254
Identifiable Intangible Assets
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 700	$ 500

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets, Net - Schedule of Estimated Annual Amortization Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Intangible Assets, Net (Excluding Goodwill) [Abstract]
2024 (remaining)	$ 1,785
2025	1,389
2026	815
2027	648
2028	582
Thereafter	3,269
Total	$ 8,488	$ 2,254

Prepaid Expenses and Other Cu_3

Prepaid Expenses and Other Current Assets- Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Prepaid Expense and Other Assets, Current [Abstract]
Security deposits	$ 96	$ 66
Prepaid licenses	7	20
Research and development tax credit	516	516
Other receivables	20	20
Insurance	99	246
Other prepaid	60	65
Total prepaid expenses and other current assets	$ 798	$ 933

Other Assets, Net - Schedule of

Other Assets, Net - Schedule of Other Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Cost	$ 12,951	$ 12,468
Accumulated Amortization	(8,225)	(7,220)
Net Book Value	4,726	5,248
Capitalized Content Costs Member
Cost	6,589	6,589
Accumulated Amortization	(4,753)	(4,237)
Net Book Value	1,836	2,352
Capitalized Software Member
Cost	6,362	5,879
Accumulated Amortization	(3,472)	(2,983)
Net Book Value	$ 2,890	$ 2,896

Other Assets, Net - Additional

Other Assets, Net - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Amortization expense	$ 1	$ 0.8

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Payables and Accruals [Abstract]
Accrued bonus	$ 330	$ 25
Accrued payroll	124	26
Accrued PTO	21	21
Accrued legal settlement	2,250	0
Accrued earn out	1,300	0
Accrued royalties	211	208
Accrued professional fees	729	235
Customer deposits	375	46
Other accrued expenses and current liabilities	307	345
Total accrued expenses and other current liabilities	$ 5,647	$ 906

Accrued Expenses and Other Cu_4

Accrued Expenses and Other Current Liabilities - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Business Acquisition [Line Items]
Accrued legal settlement	$ 2,250		$ 0
Accrued earn out	$ 1,300		$ 0
Asset Purchase Agreement [Member]
Business Acquisition [Line Items]
Weighted Average Threshold Consecutive Trading Days	10 days	10 days
Sale of stock number of shares issued in transaction	2,400
Maximum number of earn-out shares	22,665,681

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023	Feb. 18, 2020
Debt Instrument [Line Items]
Total Senior secured notes	$ 4,975	$ 5,806
Embedded derivatives	68	122
Total Convertible note payable	4,301	904
Total debt current	19,114	9,928
June 2023 Notes [Member]
Debt Instrument [Line Items]
Total Loan Payable	0	1,379
November Bridge Notes [Member]
Debt Instrument [Line Items]
Total Senior secured notes	0	1,717
Senior Secured Notes [Member]
Debt Instrument [Line Items]
Total Senior secured notes	0	3,096
Principal Stockholder Promissory Notes[Member]
Debt Instrument [Line Items]
Total Loan Payable	4,975	5,085
Other Related Party Promissory Notes [Member]
Debt Instrument [Line Items]
Total Loan Payable	0	721
Promissory Notes [Member]
Debt Instrument [Line Items]
Total Senior secured notes	706	0
Embedded Derivatives [Member]
Debt Instrument [Line Items]
Embedded derivatives	68	122
December 2023 Convertible Notes [Member]
Debt Instrument [Line Items]
Embedded derivatives	68	122
Total Convertible note payable	251	904
Other Related Party Convertible Notes [Member]
Debt Instrument [Line Items]
Total Convertible note payable	174	0	$ 200
Other Convertible Notes [Member]
Debt Instrument [Line Items]
Total Convertible note payable	706	0
February 2024 convertible note [Member]
Debt Instrument [Line Items]
Total Convertible note payable	3,170	0
Term Loan [Member]
Debt Instrument [Line Items]
Total Loan Payable	9,770	0
Loans Payable [Member]
Debt Instrument [Line Items]
Total Loan Payable	$ 14,745	$ 5,806

Debt - Additional Information (

Debt - Additional Information (Details) - USD ($)

1 Months Ended

3 Months Ended

Apr. 24, 2024

Mar. 29, 2024

Feb. 01, 2024

Dec. 07, 2023

Nov. 10, 2023

Feb. 18, 2020

Feb. 29, 2024

Jan. 31, 2024

Nov. 30, 2023

Oct. 31, 2023

Aug. 31, 2023

Jun. 30, 2023

May 31, 2023

Mar. 31, 2023

Nov. 30, 2022

Mar. 31, 2024

Mar. 31, 2023

Dec. 31, 2023

Debt Instrument [Line Items]

Convertible Notes losses

$ 100,000

$ 100,000

Convertable amount

$ 866,000

0

Senior secured notes issued

0

$ 2,000,000

Proceeds from long-term lines of credit

$ 800,000

500,000

500,000

Series A preferred stock [Member]

Debt Instrument [Line Items]

Warrant exercise price

$ 0.5626

Series A Convertible Preferred Stock [Member]

Debt Instrument [Line Items]

Issuance upon conversion of convertible notes, shares

1,500,000

Senior Secured Notes [Member]

Debt Instrument [Line Items]

Senior secured notes issued

$ 2,000,000

Warrant exercise price

$ 0.0001

$ 0.0001

Repayments of senior secured notes

$ 500,000

$ 2,000,000

Convertible Notes Payable [Member]

Debt Instrument [Line Items]

Conversion of common stock, shares

565,144

June 2023 Notes [Member]

Debt Instrument [Line Items]

Interest rate

10%

Debt instrument, conversion price per share

$ 1.82

Debt Instrument, Redemption Price, Percentage

100%

Conversion of common stock, shares

769,567

Gain (loss) on extinguishment of debt

$ 500,000

Senior secured notes issued

$ 15,800,000

10% senior secured notes due [Member]

Debt Instrument [Line Items]

Maturity date

Jun. 25, 2025

November 2023 [Member]

Debt Instrument [Line Items]

Debt instrument, conversion price per share

$ 1.8

Loan Modification Agreement [Member] | Subsequent Event [Member]

Debt Instrument [Line Items]

Debt Instrument, face amount

$ 4,957,863.06

Loan Modification Agreement [Member] | Term Loan [Member] | Subsequent Event [Member]

Debt Instrument [Line Items]

Increasing stockholders deficit

$ 3,000,000

Maturity date

Dec. 31, 2024

Promissory Notes [Member]

Debt Instrument [Line Items]

Gain (loss) on extinguishment of debt

(394,000)

Promissory Notes [Member] | Asset Purchase Agreement [Member]

Debt Instrument [Line Items]

Debt Instrument, face amount

$ 1,900,000

Promissory Notes [Member] | August 2023 [Member]

Debt Instrument [Line Items]

Gain (loss) on extinguishment of debt

(239,000)

Promissory Notes [Member] | August 2023 [Member] | Asset Purchase Agreement [Member]

Debt Instrument [Line Items]

Debt Instrument, face amount

$ 500,000

Interest rate

15%

Debt instrument, conversion price per share

$ 1.82

Maturity date

Aug. 31, 2026

Conversion of common stock, shares

398,352

Gain (loss) on extinguishment of debt

$ (200,000)

Promissory Notes [Member] | October 2023 [Member]

Debt Instrument [Line Items]

Gain (loss) on extinguishment of debt

(155,000)

Promissory Notes [Member] | October 2023 [Member] | Asset Purchase Agreement [Member]

Debt Instrument [Line Items]

Debt Instrument, face amount

$ 300,000

Interest rate

15%

Debt instrument, conversion price per share

$ 1.82

Maturity date

Oct. 15, 2026

Conversion of common stock, shares

258,929

Gain (loss) on extinguishment of debt

$ (200,000)

Promissory Notes [Member] | October 2023 [Member] | Series A preferred stock [Member] | Asset Purchase Agreement [Member]

Debt Instrument [Line Items]

Loss on change in fair value upon conversion to Series A Preferred Stock

600,000

Promissory Notes [Member] | November 2023 [Member]

Debt Instrument [Line Items]

Gain (loss) on extinguishment of debt

0

Promissory Notes [Member] | November 2023 [Member] | Asset Purchase Agreement [Member]

Debt Instrument [Line Items]

Debt Instrument, face amount

$ 700,000

700,000

Interest rate

12%

Maturity date

Jan. 31, 2025

Other Related Party Convertible Notes [Member]

Debt Instrument [Line Items]

Interest rate

12%

Maturity date

Feb. 18, 2021

Proceeds from long-term lines of credit

$ 100,000

Other Related Party Convertible Notes [Member] | Maturity Date - February 18, 2021

Debt Instrument [Line Items]

Debt Instrument, face amount

$ 200,000

Preferred stock at a conversion price

$ 2

November 2022 Convertible Notes [Member]

Debt Instrument [Line Items]

Debt Instrument, face amount

$ 4,400,000

Interest rate

6%

Scheduled maturity date

12 months

Proceeds from issuance of Preferred Stock - Series A, net of issuance costs

$ 10,000,000

November 2022 Convertible Notes [Member] | Series A-2 [Member]

Debt Instrument [Line Items]

Stock price

$ 47.67

Vertical Investors LLC [Member] | Term Loan [Member]

Debt Instrument [Line Items]

Debt Instrument, face amount

$ 8,000,000

Guarantee fees

$ 2,300,000

Maturity date

Jun. 28, 2024

November Bridge Notes [Member]

Debt Instrument [Line Items]

Interest rate

3%

Debt instrument, conversion price per share

$ 1.82

$ 1.5

Maturity date

Nov. 10, 2024

Loss on change in fair value

$ (300,000)

Conversion of common stock, shares

219,780

Gain (loss) on extinguishment of debt

$ (300,000)

Percentage of original issuance discount

15%

Proceeds from long-term lines of credit

$ 1,900,000

Step-up interest rate

8%

November Bridge Notes [Member] | Related Party [Member]

Debt Instrument [Line Items]

Proceeds from long-term lines of credit

$ 800,000

November Bridge Notes [Member] | Series A preferred stock [Member]

Debt Instrument [Line Items]

Conversion of common stock, shares

538,039

December 2023 Convertible Notes [Member]

Debt Instrument [Line Items]

Debt Instrument, face amount

$ 2,200,000

$ 1,251,000

$ 2,169,000

Issuance upon conversion of convertible notes, shares

1,485,943

Interest rate

7%

Debt instrument, conversion price per share

$ 1.25

Maturity date

Dec. 07, 2024

Conversion price as a percentage

92%

Event of default, Conversion price as percentage

80%

Interest rate of Convertible note

14%

Convertible notes gains

$ 100,000

Convertable amount

900,000

Percentage of original issuance discount

8%

February 2024 convertible note [Member]

Debt Instrument [Line Items]

Debt Instrument, face amount

6,051,000

$ 0

Interest rate

2%

Debt instrument, conversion price per share

$ 2

Maturity date

Dec. 15, 2024

Interest rate of Convertible note

4%

Total principal payments

$ 100,000

Senior secured notes issued

$ 6,000,000

Debt - Summary of change in the

Debt - Summary of change in the balance of Debt Instrument (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($)
Debt Instrument [Line Items]
Carrying value at the beginning of the year	$ 5,806
Carrying value at the end of the year	4,975
November 10, 2023 Bridge Notes [Member]
Debt Instrument [Line Items]
Carrying value at the beginning of the year	1,717
Carrying value at the end of the year	0
Promissory Notes [Member]
Debt Instrument [Line Items]
Carrying value at the beginning of the year	0
Promissory notes assumed in connection with acquisition of CLMBR, Inc.	1,887
Loss on extinguishment of debt	394
Interest Expense	15
Carrying value at the end of the year	706
Promissory Notes [Member] | Series A preferred stock [Member]
Debt Instrument [Line Items]
Conversion to Series A Preferred Stock	(1,590)
Promissory Notes [Member] | August 2023 [Member]
Debt Instrument [Line Items]
Carrying value at the beginning of the year	0
Promissory notes assumed in connection with acquisition of CLMBR, Inc.	725
Loss on extinguishment of debt	239
Interest Expense	0
Carrying value at the end of the year	0
Promissory Notes [Member] | August 2023 [Member] | Series A preferred stock [Member]
Debt Instrument [Line Items]
Conversion to Series A Preferred Stock	(964)
Promissory Notes [Member] | October 2023 [Member]
Debt Instrument [Line Items]
Carrying value at the beginning of the year	0
Promissory notes assumed in connection with acquisition of CLMBR, Inc.	471
Loss on extinguishment of debt	155
Interest Expense	0
Carrying value at the end of the year	0
Promissory Notes [Member] | October 2023 [Member] | Series A preferred stock [Member]
Debt Instrument [Line Items]
Conversion to Series A Preferred Stock	(626)
Promissory Notes [Member] | November 2023 [Member]
Debt Instrument [Line Items]
Carrying value at the beginning of the year	0
Promissory notes assumed in connection with acquisition of CLMBR, Inc.	691
Loss on extinguishment of debt	0
Interest Expense	15
Carrying value at the end of the year	706
Promissory Notes [Member] | November 2023 [Member] | Series A preferred stock [Member]
Debt Instrument [Line Items]
Conversion to Series A Preferred Stock	0
Senior Secured Notes [Member]
Debt Instrument [Line Items]
Carrying value at the beginning of the year	3,096
Loss on extinguishment of debt	737
Change in estimated fair value of convertible notes	316
Interest Expense	21
Carrying value at the end of the year	0
Senior Secured Notes [Member] | Series A preferred stock [Member]
Debt Instrument [Line Items]
Conversion to Series A Preferred Stock	(4,170)
Senior Secured Notes [Member] | June 6, 2023 Notes [Member]
Debt Instrument [Line Items]
Carrying value at the beginning of the year	1,379
Loss on extinguishment of debt	462
Change in estimated fair value of convertible notes	0
Interest Expense	21
Carrying value at the end of the year	0
Senior Secured Notes [Member] | June 6, 2023 Notes [Member] | Series A preferred stock [Member]
Debt Instrument [Line Items]
Conversion to Series A Preferred Stock	(1,862)
Senior Secured Notes [Member] | November 10, 2023 Bridge Notes [Member]
Debt Instrument [Line Items]
Carrying value at the beginning of the year	1,717
Loss on extinguishment of debt	275
Change in estimated fair value of convertible notes	316
Interest Expense	0
Carrying value at the end of the year	0
Senior Secured Notes [Member] | November 10, 2023 Bridge Notes [Member] | Series A preferred stock [Member]
Debt Instrument [Line Items]
Conversion to Series A Preferred Stock	$ (2,308)

Debt - Summary of Carrying Valu

Debt - Summary of Carrying Value of Debt Instrument (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023	Dec. 07, 2023
Debt Instrument [Line Items]
Embedded derivatives	$ 68	$ 122
Term Loan [Member]
Debt Instrument [Line Items]
Principal and interest	8,021	0
Guarantee fees	2,348	0
Unamortized debt discount	(599)	0
Aggregrate carrying value	9,770	0
Senior Secured Notes [Member]
Debt Instrument [Line Items]
Aggregrate carrying value	0	3,096
Senior Secured Notes [Member] | June 2023 Notes [Member]
Debt Instrument [Line Items]
Aggregrate carrying value	0	1,379
Senior Secured Notes [Member] | November Bridge Notes [Member]
Debt Instrument [Line Items]
Aggregrate carrying value	0	1,717
December 2023 Convertible Notes [Member]
Debt Instrument [Line Items]
Principal and interest	1,251	2,169	$ 2,200
Unamortized debt discount	(589)	(801)
Unamortized issuance costs	(410)	(464)
Embedded derivatives	68	122
Aggregrate carrying value	320	1,026
February 2024 convertible note [Member]
Debt Instrument [Line Items]
Principal and interest	6,051	0
Unamortized debt discount	(1,912)	0
Unamortized issuance costs	(969)	0
Aggregrate carrying value	$ 3,170	$ 0

Debt - Summary of Interest Expe

Debt - Summary of Interest Expenses On Debt Instrument (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Term Loan [Member]
Debt Instrument [Line Items]
Contractual interest expense	$ 58	$ 0
Amortization of debt discount	339	0
Total	397	0
Promissory Notes [Member]
Debt Instrument [Line Items]
Total	15
Promissory Notes [Member] | August 2023 [Member]
Debt Instrument [Line Items]
Total	0
Promissory Notes [Member] | October 2023 [Member]
Debt Instrument [Line Items]
Total	0
Promissory Notes [Member] | November 2023 [Member]
Debt Instrument [Line Items]
Total	15
Senior Secured Notes [Member]
Debt Instrument [Line Items]
Total	21
Senior Secured Notes [Member] | November Bridge Notes [Member]
Debt Instrument [Line Items]
Total	0
December Two Thousand Twenty Three Convertible Notes [Member]
Debt Instrument [Line Items]
Contractual interest expense	38	0
Amortization of debt discount	211	0
Amortization of debt issuance costs	122	0
Total	371	0
February 2024 convertible note [Member]
Debt Instrument [Line Items]
Contractual interest expense	240	0
Amortization of debt discount	436	0
Amortization of debt issuance costs	221	0
Total	$ 897	$ 0

Warrants - Schedule of Changes

Warrants - Schedule of Changes in Warrants Issued and Outstanding (Details) - shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Class of Warrant or Right [Line Items]
Outstanding warrant, Beginning balance		98,049
Warrants issued		0
Warrants exercised		0
Outstanding warrant, Ending balance		98,049
Common Stock Warrants Decmber 7, 2023 [Member]
Class of Warrant or Right [Line Items]
Outstanding warrant, Beginning balance	924,480
Warrants issued	1,129,555
Warrants exercised	0
Outstanding warrant, Ending balance	2,054,035
Common Stock Warrants February 1, 2024 [Member]
Class of Warrant or Right [Line Items]
Outstanding warrant, Beginning balance	0
Warrants issued	3,000,000
Warrants exercised	0
Outstanding warrant, Ending balance	3,000,000
Common Stock Warrants Woodway [Member]
Class of Warrant or Right [Line Items]
Outstanding warrant, Beginning balance	0
Warrants issued	800,000
Warrants exercised	0
Outstanding warrant, Ending balance	800,000
Common Stock Warrants [Member]
Class of Warrant or Right [Line Items]
Outstanding warrant, Beginning balance	924,480
Warrants issued	4,929,555
Warrants exercised	0
Outstanding warrant, Ending balance	5,854,035
Class A Common Stock Warrants [Member]
Class of Warrant or Right [Line Items]
Outstanding warrant, Beginning balance		92,296
Warrants issued		0
Warrants exercised		0
Outstanding warrant, Ending balance		92,296
Class B Common Stock Warrants [Member]
Class of Warrant or Right [Line Items]
Outstanding warrant, Beginning balance		5,753
Warrants issued		0
Warrants exercised		0
Outstanding warrant, Ending balance		5,753

Warrants - Additional Informati

Warrants - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
	Feb. 01, 2024	Mar. 31, 2024	Mar. 31, 2023	May 31, 2024	Mar. 29, 2024	Feb. 20, 2024	Dec. 07, 2023	Nov. 13, 2022	Jul. 31, 2021
Class of Warrant or Right [Line Items]
Common stock, warrant				3,080,778
Fair value of warrants		$ (1,799)	$ (2,410)
Series A Preferred Stock [Member]
Class of Warrant or Right [Line Items]
Common stock, warrant					2,054,035
Warrant strike price					$ 0.5626
Series A Preferred Stock [Member] | Minimum [Member]
Class of Warrant or Right [Line Items]
Warrant strike price					$ 1.5
November Bridge Warrants [Member]
Class of Warrant or Right [Line Items]
Fair value of warrants		100
Warrants [Member] | November 2022 Convertible Notes [Member]
Class of Warrant or Right [Line Items]
Common stock, warrant								92,296
Fair value of warrants			2,400
Warrants [Member] | December 7, 2023 Warrants [Member]
Class of Warrant or Right [Line Items]
Fair value of warrants		200
Warrants [Member] | December 7, 2023 Warrants [Member] | December 2023 Convertible Notes [Member]
Class of Warrant or Right [Line Items]
Common stock, warrant							924,480
Warrant strike price							$ 1.25
Warrants [Member] | Treadway Warrants [Member]
Class of Warrant or Right [Line Items]
Fair value of warrants		1,200
Warrants [Member] | Treadway Warrants [Member] | February 2024 Note [Member]
Class of Warrant or Right [Line Items]
Common stock, warrant	3,000,000
Issuance of convertible note	$ 6,000
Warrants [Member] | Woodway Warrants [Member]
Class of Warrant or Right [Line Items]
Common stock, warrant						800,000
Warrant strike price						$ 1.25
Fair value of warrants		$ 300
Warrants [Member] | Class A Common Stock Warrants [Member]
Class of Warrant or Right [Line Items]
Fair value of warrants			$ 2,400
Warrants [Member] | Class A Common Stock Warrants [Member] | November 2022 Convertible Notes [Member]
Class of Warrant or Right [Line Items]
Common stock, warrant								92,296
Warrant strike price								$ 0.01
Warrants contractual term								10 years
Warrants [Member] | Class B Common Stock Warrants [Member]
Class of Warrant or Right [Line Items]
Warrant strike price									$ 0.01
Warrants contractual term									7 years
Warrant One [Member] | Treadway Warrants [Member]
Class of Warrant or Right [Line Items]
Common stock, warrant	1,500,000
Warrant strike price	$ 1.25
Warrant Two [Member] | Treadway Warrants [Member]
Class of Warrant or Right [Line Items]
Warrant strike price	$ 1.75

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($)				1 Months Ended	3 Months Ended
	Feb. 20, 2024	Feb. 01, 2024	Dec. 07, 2023	May 31, 2023	Mar. 31, 2024	Mar. 31, 2023	May 31, 2024	Mar. 29, 2024	Dec. 31, 2023	Nov. 10, 2023	Nov. 13, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value liabilities, measurements transfers between levels					$ 0
Derivative liability					$ 937,000				$ 591,000
Risk free rate					0%	3.60%
Fair value of warrants					$ (1,799,000)	$ (2,410,000)
Change in fair value of convertible notes					$ 316,000	$ 80,000
Warrant to purchase shares of common stock							3,080,778
Common stock, warrant							3,080,778
Asset Purchase Agreement [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Weighted Average Threshold Consecutive Trading Days					10 days	10 days
Sale of stock number of shares issued in transaction					2,400
Maximum number of earn-out shares					22,665,681
Fair value of contingent payments					$ 1,300,000
Embedded Derivaties [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain on change in fair value					$ 50,000
November 10, 2023 Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability										$ 200,000
Risk free rate					4.20%
Fair value of warrants					$ 100,000
December 7, 2023 Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability			$ 500,000
Risk free rate			4.20%
Fair value of warrants					200,000
Common share price								$ 0.5626
Warrant to purchase shares of common stock									2,054,035
Common stock, warrant									2,054,035
Treadway Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability		$ 1,800,000
Risk free rate		4.20%
Fair value of warrants					1,200,000
Warrant to purchase shares of common stock		3,000,000
Issuance of Convertible Note		$ 6,000,000
Common stock, warrant		3,000,000
Woodway Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	$ 300,000
Risk free rate	4.20%
Fair value of warrants					300,000
Convertible Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Change in fair value of convertible notes						$ 80,000
Conversion of common stock, shares				565,144
November 2022 Convertible Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Conversion of common stock, shares				565,144
November 2022 Convertible Notes [Member] | Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of warrants						$ 2,400,000
Warrant to purchase shares of common stock											92,296
Common stock, warrant											92,296
Bridge Note Financing [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loss on extinguishment of debt					$ (275,000)
Bridge Note Financing [Member] | Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Discount rate					21%
Derivative liability										$ 1,700,000
Minimum [Member] | December 7, 2023 Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Common share price								$ 1.5
Series A Convertible Preferred Stock | Bridge Note Financing [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Change in fair value of convertible notes					$ 300,000
Loss on extinguishment of debt					(300,000)
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure					0				$ 0
Liabilities, fair value disclosure					$ 0

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Fair Value of Liabilities Measured on Recurring Basis (Details) - Fair Value, Recurring [Member] - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities fair value disclosure	$ 2,305	$ 2,430
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities fair value disclosure	0	0
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities fair value disclosure	0	0
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities fair value disclosure	2,305	2,430
Bridge Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities fair value disclosure		1,717
Bridge Notes [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities fair value disclosure		0
Bridge Notes [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities fair value disclosure		0
Bridge Notes [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities fair value disclosure		1,717
Accrued Earn Out [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities fair value disclosure	1,300
Accrued Earn Out [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities fair value disclosure	0
Accrued Earn Out [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities fair value disclosure	0
Accrued Earn Out [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities fair value disclosure	1,300
Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities fair value disclosure	937	591
Warrants [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities fair value disclosure	0	0
Warrants [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities fair value disclosure	0	0
Warrants [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities fair value disclosure	937	591
Embedded Derivaties [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities fair value disclosure	68	122
Embedded Derivaties [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities fair value disclosure	0	0
Embedded Derivaties [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities fair value disclosure	0	0
Embedded Derivaties [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities fair value disclosure	$ 68	$ 122

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Fair Value Measurement of Liabilities Using Unobservable Inputs Reconciliation (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Derivative [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value, beginning balance	$ 122
Issuance of liabilities	0
Change in estimated fair value of financial instruments	(54)
Fair value, ending balance	68
Convertible Notes [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value, beginning balance		$ 4,270
Issuance of liabilities		0
Change in estimated fair value of financial instruments		80
Fair value, ending balance		4,350
Bridge Notes [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value, beginning balance	1,717
Loss on extinguishment of debt	275
Change in estimated fair value of convertible notes	316
Conversion to Series A Preferred Stock	(2,308)
Fair value, ending balance	0
November 10, 2023 Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value, beginning balance	165
Issuance of liabilities	0
Change in estimated fair value of financial instruments	(124)
Exercise of stock warrants	0
Fair value, ending balance	41
December 7, 2023 Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value, beginning balance	426
Issuance of liabilities	0
Change in estimated fair value of financial instruments	(179)
Exercise of stock warrants	0
Fair value, ending balance	247
Treadway Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value, beginning balance	0
Issuance of liabilities	1,800
Change in estimated fair value of financial instruments	(1,245)
Exercise of stock warrants	0
Fair value, ending balance	555
Woodway Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value, beginning balance	0
Issuance of liabilities	345
Change in estimated fair value of financial instruments	(251)
Exercise of stock warrants	0
Fair value, ending balance	94
Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value, beginning balance	591	3,004
Issuance of liabilities	2,145	0
Change in estimated fair value of financial instruments	(1,799)	(2,410)
Exercise of stock warrants	0
Fair value, ending balance	$ 937	$ 594

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Feb. 02, 2024	Dec. 31, 2023	Jan. 01, 2022
Leases [Abstract]
Right-of-use-assets	$ 641		$ 400	$ 283	$ 300
Lease liabilities	$ 670		$ 400		$ 300
Description of Operating lease arrangements, expiring period	Operating lease arrangements primarily consist of office and warehouse leases expiring at various years through 2028. The facility leases have original lease terms of two to seven years and contain options to extend the lease up to 5 years or terminate the lease.
Weighted average discount rate	9.50%			9.49%
Weighted average remaining lease term	2 years 8 months 12 days			4 years 5 months 1 day
Short-term leases cost	$ 10	$ 30
Operating lease cost	80	20
Total operating lease cost	90	50
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 0	$ 0

Leases - Schedule of Future Min

Leases - Schedule of Future Minimum Rental Payments under Operating Leases (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Feb. 02, 2024	Dec. 31, 2023	Jan. 01, 2022
Leases [Abstract]
2024 (remaining)	$ 270
2025	282
2026	78
2027	78
2028	33
Thereafter	0
Total future minimum lease payments	742
Less: imputed interest	(72)
Present value of operating lease liability	670	$ 400		$ 300
Less: current portion of lease liability	322		$ 54
Non-current portion of lease liability	348		$ 229
Present value of operating lease liability	$ 670	$ 400		$ 300

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Thousands		12 Months Ended
	Mar. 07, 2024	Dec. 31, 2017	Mar. 31, 2024
Loss Contingencies [Line Items]
Maximum total royalty payments		$ 1,000
Guaranteed minimum payment of royalty			$ 200
Monetary arbitration award	$ 2,250
Maximum [Member]
Loss Contingencies [Line Items]
Percentage of cumulative net sales		3%
Cumulative net sales		$ 5,000
Minimum [Member]
Loss Contingencies [Line Items]
Percentage of cumulative net sales		1%
Cumulative net sales		$ 5,000

Stockholders' Deficit - Additio

Stockholders' Deficit - Additional Information (Details) - $ / shares	3 Months Ended
	Mar. 31, 2024	May 31, 2024	Apr. 18, 2024	Mar. 29, 2024	Dec. 31, 2023	Feb. 28, 2023	Jan. 31, 2023	Dec. 31, 2022
Class of Warrant or Right [Line Items]
Common stock shares authorized	900,000,000				900,000,000
Common stock, par value	$ 0.0001				$ 0.0001
Common stock, shares Issued	19,433,801				14,192,083
Common stock, shares outstanding	19,433,801				14,192,083
Common stock, warrant		3,080,778
Preferred stock, shares authorized	200,000,000
Preferred stock, par value	$ 0.0001
Class A Common Stock [Member] | Rights Offering [Member]
Class of Warrant or Right [Line Items]
Common stock, shares Issued	9,749,439					8,677,001	8,677,001	1,072,438
Price per share						$ 0.51
Series A Preferred Stock [Member]
Class of Warrant or Right [Line Items]
Common stock, warrant				2,054,035
Preferred stock, shares authorized	5,000,000
Preferred stock, dividend rate, percentage	8%
Percentage of common stock outstanding regarding voluntary conversion	19.99%
Series A Preferred Stock [Member] | Maximum [Member]
Class of Warrant or Right [Line Items]
Preferred stock, shares authorized			7,000,000
Series A Preferred Stock [Member] | Minimum [Member]
Class of Warrant or Right [Line Items]
Preferred stock, shares authorized			5,000,000
Preferred stock conversion period	12 months
Series B Preferred Stock [Member]
Class of Warrant or Right [Line Items]
Preferred stock, shares authorized	1,500,000
Percentage of common stock outstanding regarding voluntary conversion	19.99%
Debt instrument, conversion price per share	$ 2
Series B Preferred Stock [Member] | Minimum [Member]
Class of Warrant or Right [Line Items]
Preferred stock conversion period	24 months
Common Stock [Member]
Class of Warrant or Right [Line Items]
Common stock shares authorized	900,000,000				900,000,000
Common stock, par value	$ 0.0001				$ 0.0001
Common stock, shares Issued	19,433,801				14,192,083
Common stock, shares outstanding	19,433,801				14,192,083

Equity-Based Compensation - Add

Equity-Based Compensation - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended		3 Months Ended		12 Months Ended
	Jun. 30, 2023	Jan. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Capitalized amount of stock based compensation			$ 200	$ 400
Weighted-average grant date fair value per option			$ 0	$ 18.86
Awards granted, straight-line using third-party valuation (in dollars per share)				$ 6.08		$ 30
Fair value of common stock for awards granted		$ 19.27
Restricted Stock
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grants in period			0
Stock Appreciation Rights (SARs)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grants in period			0
2023 and 2020 Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Capitalized amount of stock based compensation			$ 3,400	$ 14,600
Number of options, Granted	1,294,998		0
Number of accelerated vested shares		5,938
Number of repriced option awards		301,537
Recognized stock compensation expense			$ 3,366	14,639
Unrecognized stock-based compensation expense			$ 13,500		$ 17,100
Additional Expense		$ 500
Weighted-average period expected to be recognized			1 year 6 months		1 year 8 months 12 days
2023 and 2020 Equity Incentive Plan [Member] | Employee Stock Option
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of options, Granted			0
2023 and 2020 Equity Incentive Plan [Member] | Software Costs
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Capitalized amount of stock based compensation			$ 200	$ 400

Equity-Based Compensation - Sum

Equity-Based Compensation - Summary of Compensation Cost Recognized (Details) - 2023 and 2020 Equity Incentive Plan [Member] - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation cost recognized	$ 3,366	$ 14,639
Research and development
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation cost recognized	1,231	2,131
Sales and marketing
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation cost recognized	75	222
General and administrative
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation cost recognized	$ 2,060	$ 12,286

Equity-Based Compensation - S_2

Equity-Based Compensation - Summary of Stock option activity (Details) - 2023 and 2020 Equity Incentive Plan [Member] - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended	12 Months Ended
	Jun. 30, 2023	Mar. 31, 2024	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]
Number of options, Outstanding as of December 31, 2023		3,417,932
Number of options, Granted	1,294,998	0
Number of options, Exercised		0
Number of options, Cancelled or forfeited		(6,200)
Number of options, Outstanding as of March 31, 2024		3,411,732	3,417,932
Number of options, Options exercisable as of March 31, 2024		1,139,304
Number of options, unvested as of March 31,2024		2,463,196
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Outstanding as of December 31, 2023		$ 2.53
Granted		0
Exercised		0
Cancelled or forfeited		0.51
Outstanding as of March 31, 2024		2.53	$ 2.53
Options exercisable as of March 31, 2024		1.64
Ending balance of March 31, 2024		$ 3.16
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTerm [Abstract]
Balance		9 years	9 years 3 months 18 days
Options exercisable		8 years 9 months 18 days
Options unvested		9 years 1 month 6 days
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValue [Abstract]
Outstanding, aggregate intrinsic value, outstanding		$ 0	$ 547
Options exercisable		0
Unvested, aggregate intrinsic value		$ 0

Equity-Based Compensation - S_3

Equity-Based Compensation - Summary of Unvested Common Stock (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted average exercise price, Issued	$ 0	$ 18.86
2020 Plan Early Exercise
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Beginning as of December 31, 2023	13,720
Issued	0
Vested	(3,272)
Repurchased	0
Ending balance of March 31, 2024	10,448
Beginning as of December 31, 2023	$ 0
Weighted average exercise price, Issued	0
Weighted average exercise price, Vested	0
Weighted average exercise price, Repurchased	$ 0
Beginning Balance, Repurchase liability	$ 8
Repurchase liability, Issued	0
Repurchase liability, Vested	0
Repurchase liability, Repurchased	0
Ending Balance, Repurchase liability	$ 8

Equity-Based Compensation - S_4

Equity-Based Compensation - Summary of Stock Option Valuation Assumptions (Details)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Weighted-average risk-free interest rate	0%	3.60%
Weighted-average expected term (in years)	0 years	6 years 10 days
Weighted-average expected volatility	0%	57.90%
Expected dividend yield	0%	0%

Concentration of Credit Risk _2

Concentration of Credit Risk and Major Customers and Vendors - Additional Information (Details)	3 Months Ended
	Mar. 31, 2024 Customer Vendor	Mar. 31, 2023 Vendor Customer
Sales Revenue [Member] | Cash And Cash Equivalents [Member] | Customer Concentration Risk [Member]
Product Information [Line Items]
Number of customer | Customer	0	0
Sales Revenue [Member] | Cash And Cash Equivalents [Member] | Customer Concentration Risk [Member] | Minimum [Member]
Product Information [Line Items]
Percentage of total revenue	10%	10%
Finished Goods Purchased [Member] | Supplier Concentration Risk [Member] | Vendor Three [Member]
Product Information [Line Items]
Number of vendors		3
Finished Goods Purchased [Member] | Supplier Concentration Risk [Member] | Vendor Three [Member] | Minimum [Member]
Product Information [Line Items]
Percentage of total revenue		10%
Finished Goods Purchased [Member] | Supplier Concentration Risk [Member] | No Vendor [Member]
Product Information [Line Items]
Number of vendors	0
Finished Goods Purchased [Member] | Supplier Concentration Risk [Member] | No Vendor [Member] | Minimum [Member]
Product Information [Line Items]
Percentage of total revenue	10%

Benefit Plans - Additional Info

Benefit Plans - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Retirement Benefits [Abstract]
Benefit plans cost	$ 0	$ 0

Loss Per Share - Schedule of Lo

Loss Per Share - Schedule of Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Numerator:
Net loss	$ (11,394)	$ (15,961)
Net loss attributable to common stockholders	$ (11,394)	$ (15,961)
Denominator:
Weighted average common stock outstanding - basic	16,994,445	7,653,940
Weighted average common stock outstanding - diluted	16,994,445	7,653,940
Net loss per share attributable to common stockholders - basic	$ (0.67)	$ (2.09)
Net loss per share attributable to common stockholders - diluted	$ (0.67)	$ (2.09)

Loss Per Share - Schedule of Po

Loss Per Share - Schedule of Potentially Dilutive Shares (Details) - shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	9,265,767	1,882,312
Warrants to Purchase Series Class A Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	92,296
Warrants to Purchase Series Class B Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	5,753
Warrants to Purchase Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	5,854,035	0
Stock Options to Purchase Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	3,411,732	1,784,263

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)															1 Months Ended							3 Months Ended		12 Months Ended
	Oct. 27, 2022	Feb. 22, 2021	Feb. 12, 2021	Jan. 12, 2021	Nov. 02, 2020	Jun. 15, 2020	Jun. 09, 2020	Mar. 20, 2020	Feb. 18, 2020	Dec. 31, 2019	Nov. 28, 2019	Oct. 21, 2019	Aug. 28, 2019	May 17, 2019	Feb. 29, 2024	Jan. 31, 2024	Nov. 30, 2023	Aug. 31, 2023	May 31, 2023	Apr. 30, 2023	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2017	Dec. 31, 2023
Related Party Transaction [Line Items]
Proceeds from long-term lines of credit																	$ 800,000				$ 500,000	$ 500,000
Royalty Expense																								$ 1,000,000
Convertible note payable																						4,301,000			$ 904,000
Loss on fair value of convertible notes																						(316,000)	$ (80,000)
Senior Secured Notes [Member]
Related Party Transaction [Line Items]
Repayment of senior secured notes to related party																			$ 500,000		2,000,000
Promissory Notes [Member]
Related Party Transaction [Line Items]
Gain (loss) on extinguishment of debt																						(394,000)
Principal Stockholder Promissory Notes
Related Party Transaction [Line Items]
Proceeds from long-term lines of credit			$ 600,000					$ 300,000			$ 300,000		$ 1,000,000	$ 2,000,000
Interest rate			5%					5%			5%		5%	2.50%
Maturity date			Jun. 12, 2022					Mar. 20, 2022			Aug. 28, 2021		Aug. 28, 2021	May 17, 2021
Fee Percentage			5%					5%			5%		5%	5%
Additional Percentage			10%					10%			10%		10%	7.50%
Loan Payable																						5,000,000
Accrued interest and default interest																						1,500,000
Interest expense including default interest																						90,000	100,000
Principal Stockholder Promissory Notes | Maturity Date - May 17, 2021
Related Party Transaction [Line Items]
Debt Instrument, face amount																						2,700,000			2,700,000
Principal Stockholder Promissory Notes | Maturity Date - August 28, 2021
Related Party Transaction [Line Items]
Debt Instrument, face amount																						1,500,000			1,400,000
Principal Stockholder Promissory Notes | Maturity Date - November 28, 2019
Related Party Transaction [Line Items]
Debt Instrument, face amount																						300,000			400,000
Principal Stockholder Promissory Notes | Maturity Date - March 20, 2022
Related Party Transaction [Line Items]
Debt Instrument, face amount																						200,000			200,000
Principal Stockholder Promissory Notes | Maturity Date - June 12, 2022
Related Party Transaction [Line Items]
Debt Instrument, face amount																						300,000			400,000
Other Related Party Promissory Notes [Member]
Related Party Transaction [Line Items]
Proceeds from long-term lines of credit	$ 400,000	$ 40,000		$ 300,000	$ 50,000	$ 100,000	$ 75,000		$ 100,000	$ 200,000		$ 200,000
Interest rate	12%	12%		12%	5%	7.50%	5%		12%	12%		12%
Maturity date	Jan. 27, 2023	Jun. 22, 2022		Jun. 12, 2022	Jun. 02, 2022	Jun. 15, 2021	Jun. 09, 2022		Feb. 18, 2021	Sep. 30, 2021		Oct. 21, 2021
Proceeds from issuance of related party loans																				$ 300,000
Payment made to related party										$ 200,000									$ 300,000
Fee Percentage	5%	5%		5%	5%	5%	5%		5%	5%		5%
Additional Percentage	17%	17%		17%	10%	12.50%	10%		17%	17%		17%
Loan Payable																						0
Interest expense including default interest																						20,000
Gain (loss) on extinguishment of debt		$ (20,000)		$ (100,000)
Other Related Party Promissory Notes [Member] | Noninterest bearing note
Related Party Transaction [Line Items]
Proceeds from issuance of related party loans																		$ 200,000
Payment made to related party																		$ 200,000
Other Related Party Promissory Notes [Member] | Maturity Date - June 12, 2022
Related Party Transaction [Line Items]
Debt Instrument, face amount															$ 100,000							0			400,000
Preferred stock at a conversion price																$ 1.82
Issuance upon conversion of convertible notes, shares															242,602
Other Related Party Promissory Notes [Member] | Maturity Date - June 12, 2022 | Note
Related Party Transaction [Line Items]
Debt Instrument, face amount															$ 300,000
Other Related Party Promissory Notes [Member] | Maturity Date - September 30, 2021
Related Party Transaction [Line Items]
Debt Instrument, face amount																						0			50,000
Other Related Party Promissory Notes [Member] | Maturity Date - February 18, 2021
Related Party Transaction [Line Items]
Debt Instrument, face amount																						200,000			200,000
Preferred stock at a conversion price																2
Other Related Party Promissory Notes [Member] | Maturity Date - June 22, 2022
Related Party Transaction [Line Items]
Debt Instrument, face amount															$ 20,000							0			60,000
Preferred stock at a conversion price																1.82
Issuance upon conversion of convertible notes, shares															34,246
Other Related Party Promissory Notes [Member] | Maturity Date - June 22, 2022 | Note
Related Party Transaction [Line Items]
Debt Instrument, face amount															$ 40,000
Other Related Party Promissory Notes [Member] | Maturity Date - January 27, 2023
Related Party Transaction [Line Items]
Debt Instrument, face amount																						0			10,000
Other Related Party Convertible Notes [Member]
Related Party Transaction [Line Items]
Proceeds from long-term lines of credit									$ 100,000
Interest rate									12%
Maturity date									Feb. 18, 2021
Convertible note payable									$ 200,000													174,000			$ 0
Other Related Party Convertible Notes [Member] | Maturity Date - February 18, 2021
Related Party Transaction [Line Items]
Debt Instrument, face amount																						200,000
Preferred stock at a conversion price																$ 2
Other Related Party Transactions
Related Party Transaction [Line Items]
Contingent Royalty Obligation																						200,000
Other Related Party Transactions | Maximum [Member]
Related Party Transaction [Line Items]
Royalty Expense																						1,000,000
Other Related Party Transactions | Minimum [Member]
Related Party Transaction [Line Items]
Guaranteed Royalty payment																						$ 200,000
Other Related Party Transactions | Royalty Arrangement, One Percentage of Cumulative Net Sales above 5 Million
Related Party Transaction [Line Items]
Royalty Payment Percentage																						1%
Licensing and royalty income																						$ 5,000,000
Other Related Party Transactions | Royalty Arrangement, three Percentage of Cumulative Net Sales up to 5 Million [Member]
Related Party Transaction [Line Items]
Royalty Payment Percentage																						3%
Licensing and royalty income																						$ 5,000,000
Other Related Party Transactions | Fuseproject
Related Party Transaction [Line Items]
Due to Related Parties																					100,000	0	100,000
Other Related Party Transactions | Apeiron Advisory Ltd
Related Party Transaction [Line Items]
Due to Related Parties																					$ 0	$ 0	$ 0

Related Party Transactions - Sc

Related Party Transactions - Schedule of Loan Payable (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Related Party Transaction [Line Items]
Notes Payable, Total	$ 4,975	$ 5,806
Principal Stockholder Promissory Notes | Related Party [Member]
Related Party Transaction [Line Items]
Notes Payable, Total	4,975	5,085
Other Related Party Promissory Notes [Member] | Related Party [Member]
Related Party Transaction [Line Items]
Notes Payable, Total	$ 0	$ 721

Acquisition - Additional Inform

Acquisition - Additional Information (Details) - USD ($)			3 Months Ended
	Feb. 02, 2024	Oct. 06, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Asset Acquisition [Line Items]
Issuance of shares upon conversion, value			$ 866,000
Related fees			800,000
Fair value of the contingent payment			$ 1,300,000		$ 0
Common Stock [Member]
Asset Acquisition [Line Items]
Issuance of common stock upon conversion, shares			1,485,943
Issuance of shares upon conversion, value			$ 0
Issuance of stock, shares				8,676,924
Asset Purchase Agreement [Member]
Asset Acquisition [Line Items]
Weighted Average Threshold Consecutive Trading Days			10 days	10 days
Sale of stock number of shares issued in transaction			2,400
Maximum number of earn-out shares			22,665,681
Amended Agreement [Member]
Asset Acquisition [Line Items]
Purchase price of asset acquisition	$ 15,900,000
Issuance of stock, shares	1,500,000
Contingent consideration	$ 1,300,000
Retirement of senior debt	9,400,000
Related fees	1,400,000
Cash payment of retirement of senior debt	1,400,000
Issuance of promissory note	$ 8,000,000
Amended Agreement [Member] | Series B Preferred Stock [Member]
Asset Acquisition [Line Items]
Issuance of common stock upon conversion, shares	1,428,922
Issuance of shares upon conversion, value	$ 2,700,000
Amended Agreement [Member] | Common Stock [Member]
Asset Acquisition [Line Items]
Purchase price of asset acquisition	1,000,000
Amended Agreement [Member] | Cash [Member]
Asset Acquisition [Line Items]
Purchase price of asset acquisition	$ 30,000
CLMBR, Inc. [Member]
Asset Acquisition [Line Items]
Contingent consideration		$ 500,000	$ 500,000

Acquisition - Schedule of Consi

Acquisition - Schedule of Consideration Transferred and Recognized Amounts of Identifiable Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands		3 Months Ended
	Feb. 02, 2024	Mar. 31, 2024	Dec. 31, 2023	Jan. 01, 2022
Restructuring Cost and Reserve [Line Items]
Acquisition related costs (including in general and administrative in the condensed consolidated statement of operations and comprehensive loss)		$ 800
Cash		0	$ 0
Accounts receivable, net of allowances		177	1
Inventories, net		6,074	2,607
Vendor deposits		1,830	1,815
Prepaid expenses and other current assets		798	933
Property and equipment, net		392	444
Right-of-use-assets	$ 400	641	283	$ 300
Intangible assets, net	6,900	8,488	2,254
Other assets		4,726	5,248
Accounts payable		(13,251)	(10,562)
Accrued expenses and other current liabilities		(5,647)	(906)
Operating lease liability, current portion		(322)	(54)
Deferred revenue		(192)	(77)
Loan payable		(14,745)	(5,806)
Operating lease liability, net of current portion		(348)	(229)
Goodwill	13,200	$ 13,231	$ 0
CLMBR, Inc.
Restructuring Cost and Reserve [Line Items]
Cash Paid to Seller	30
Payoff of Vertical debt (plus accrued interest)	1,447
Retirement of Vertical Debt (including fees)	9,379
Fair value of earn-out consideration	1,300
Consideration	15,859
Acquisition related costs (including in general and administrative in the condensed consolidated statement of operations and comprehensive loss)	764
Cash	50
Accounts receivable, net of allowances	134
Inventories, net	3,490
Vendor deposits	61
Prepaid expenses and other current assets	63
Property and equipment, net	139
Right-of-use-assets	412
Intangible assets, net	6,900
Other assets	30
Accounts payable	(3,557)
Accrued expenses and other current liabilities	(2,438)
Operating lease liability, current portion	(263)
Deferred revenue	(261)
Loan payable	(1,887)
Operating lease liability, net of current portion	(179)
Total identifiable net assets	2,694
Goodwill	13,165
Recognized amounts of identifiable assets acquired and liabilities assumed	15,859
CLMBR, Inc. | Series B Preferred Stock [Member]
Restructuring Cost and Reserve [Line Items]
Stock issued	2,688
CLMBR, Inc. | Common Stock [Member]
Restructuring Cost and Reserve [Line Items]
Stock issued	$ 1,015

Acquisition - Schedule of Unaud

Acquisition - Schedule of Unaudited Pro Forma Financial Information (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Business Acquisition [Line Items]
Revenue	$ 267
Operating Loss	(173)
Net Loss	(279)
CLMBR, Inc.
Business Acquisition [Line Items]
Revenue	473	$ 1,187
Operating Loss	(9,633)	(22,632)
Net Loss	$ (11,608)	$ (17,763)
Net loss per share, basic	$ (0.68)	$ (1.81)
Net loss per share, diluted	$ (0.68)	$ (1.81)

Subsequent Events - Additional

Subsequent Events - Additional Information (Details) - USD ($)	May 17, 2024	Apr. 24, 2024	May 31, 2024
Subsequent Event [Line Items]
Warrant to purchase shares of common stock			3,080,778
Subsequent Event [Member] | Series A Convertible Preferred Stock
Subsequent Event [Line Items]
Issuance of common stock upon conversion, shares	1,153,981
Debt instrument aggregate outstanding amount	$ 1,200,000
Subsequent Event [Member] | Series A Convertible Preferred Stock
Subsequent Event [Line Items]
Issuance of common stock upon conversion, shares	155,784
Debt instrument aggregate outstanding amount	$ 300,000
Subsequent Event [Member] | Loan Modification Agreement [Member]
Subsequent Event [Line Items]
Monthly payments of interest		$ 60,000
Debt Instrument, face amount		$ 4,957,863.06
Debt instrument, description		The first principal payment will be the greater of (i) $3,000,000 (the “Minimum Payment”) or (ii) 20% of the net amount raised from any source of debt, equity, synthetic equity instruments or otherwise less any reasonable expenses paid to third parties (the “Net Capital Raise”). At each capital raise thereafter, the Company shall make a mandatory principal payment to the Lender of 20% of the Net Capital Raise.
Net capital raise, percentage		20%
Subsequent Event [Member] | Loan Modification Agreement [Member] | Minimum [Member]
Subsequent Event [Line Items]
Debt Instrument, face amount		$ 3,000,000
Subsequent Event [Member] | Loan Restoration Agreement [Member]
Subsequent Event [Line Items]
Net trade value		3,000,000
Net trade value excess amount		$ 3,100,000
Percentage of net trade value excess amount		50%
Remaining percentage of net trade value excess amount		50%
Excess amount origination fee		$ 1,550,000
Excess amount enhancement fee		750,000
Base trade value		$ 2,400,000
Discount percentage		40%
Reminder of discount percentage		60%
Subsequent Event [Member] | Loan Restoration Agreement [Member] | Maximum [Member]
Subsequent Event [Line Items]
Net trade value		$ 3,000,000
Subsequent Event [Member] | Loan Restoration Agreement [Member] | Minimum [Member]
Subsequent Event [Line Items]
Net trade value		3,000,000
Net trade value minimum payment		$ 1,800,000